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Environmental exposures that alter epigenetic marks can have phenotypic consequences for 
multiple generations. Prenatal nutrition and environmental stressors have been shown to frequently alter 
DNA methylation at retrotransposon-associated metastable epialleles and imprinted germline differentially 
methylated regions (gDMRs). Such frequent alterations suggest that these loci may be especially 
susceptible to epigenetic perturbation. Previously, we used whole-genome bisulfite sequencing (WGBS) of 
wildtype (WT) mouse embryonic stem cells (mESCs) and three mutant mESCs with altered DNA 
methyltransferase (DNMT) enzymes: loss of “maintenance” DNMT1 (1KO; Dnmt1-/-), loss of “de novo” 
DNMT3a/3b (DKO; Dnmt3a-/-/Dnmt3b-/-), and loss of “maintenance” and “de novo” DNMTs (TKO; 
Dnmt1-/-/Dnmt3a-/-/Dnmt3b-/-) to demonstrate a division of labor between DNMT1 and DNMT3a/3b to 
suppress distinct types of retrotransposons (i.e., DNMT1-maintained or DNMT3a/3b-maintained regions). 
Here we show that DNA methylation maintenance at imprinted gDMRs requires DNMT1 and 
DNMT3a/3b. Characterization of rescued-1KO mESCs (r1KO; Dnmt1-/- with exogenous Dnmt1 cDNA) 
revealed that loss of methylation at known imprinted loci in 1KO cells was not rescued by exogenous 
DNMT1. We developed a computational method, Non-Rescued DMRs (NORED), to identify 2500 
NORED regions (FDR = 0.02) genome-wide. We implemented a second computational approach, 
MethylMosaic, to identify 2500 genomic regions (FDR = 0.2) with bimodal read-level methylation, a 
characteristic that arises at gDMRs from one parental allele being fully methylated and the other being 
unmethylated. Overlap of the two methods, identified 207 regions, named as bimodal NORED, including 
19 of 21 known gDMRs. To determine whether DNMT1-maintained or bimodal NORED regions are more 
susceptible to environmental perturbation than other genomic features, we compared fetal liver methylomes 
from male C57BL/6J mice that exposed in utero to Bisphenol A (BPA) through maternal supplemented diet 
(0 µg/kg bw/d, 10 µg/kg bw/d, or 10 mg/kg bw/d). We then identified DNA methylation-associated 
pathway perturbation to discover potential molecular mediators of metabolic abnormalities observed in 
male mice. In summary, distinct DNA methylation maintenance paradigms and epigenetic characteristics 
found at germline imprints and retrotransposons influenced susceptibility to altered methylation from 
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Part A–Elusive inheritance: Transgenerational effects and epigenetic inheritance in human 
environmental disease 
(Originally published as: Martos S.N., Tang W-Y, Wang Z. Elusive inheritance: Transgenerational effects 
and epigenetic inheritance in human environmental disease. Prog Biophys Mol Biol. Elsevier Ltd; 2015 
Jul;118(1-2):44–54. PMID: 25792089) 
Abstract 
Epigenetic mechanisms involving DNA methylation, histone modification, histone variants and 
nucleosome positioning, and noncoding RNAs regulate cell-, tissue-, and developmental stage-specific 
gene expression by influencing chromatin structure and modulating interactions between proteins and 
DNA. Epigenetic marks are mitotically inherited in somatic cells and may be altered in response to internal 
and external stimuli. The idea that environment-induced epigenetic changes in mammals could be inherited 
through the germline, independent of genetic mechanisms, has stimulated much debate. Many experimental 
models have been designed to interrogate the possibility of transgenerational epigenetic inheritance and 
provide insight into how environmental exposures influence phenotypes over multiple generations in the 
absence of any apparent genetic mutation. Unexpected molecular evidence has forced us to reevaluate not 
only our understanding of the plasticity and heritability of epigenetic factors, but of the stability of the 
genome as well. Recent reviews have described the difference between transgenerational and 
intergenerational effects; the two major epigenetic reprogramming events in the mammalian lifecycle; these 
two events making transgenerational epigenetic inheritance of environment-induced perturbations rare, if at 
all possible, in mammals; and mechanisms of transgenerational epigenetic inheritance in non-mammalian 
eukaryotic organisms. This paper briefly introduces these topics and mainly focuses on (1) 
transgenerational phenotypes and epigenetic effects in mammals, (2) environment-induced 
intergenerational epigenetic effects, and (3) the inherent difficulties in establishing a role for epigenetic 
inheritance in human environmental disease. 
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1. Introduction  
Barker et al. postulated that organs undergo developmental programming in utero that 
predetermines subsequent physiological and metabolic adaptations during adult life (Barker et al., 1993; 
Hales and Barker, 2001). Classic examples include association between low birth weight and a greater risk 
of coronary heart disease, hypertension, stroke, depression, type 2 diabetes, and osteoporosis in later life 
(Barker et al., 1993; Fernandez-Twinn and Ozanne, 2006; Gluckman and Hanson, 2004). The observation 
from the Dutch famine studies also provided a proof of this concept. The paradigm is rooted in the process 
of developmental plasticity (Bateson et al., 2004) that argues that most human organs, prior to full 
maturation, are capable of re-directing their course of development based on early life clues that forecast 
later-life demands. It is thought that a fetal environment can alter various organ systems, rendering the 
individual more susceptible to disease in later life when there is a chance to encounter a second, disease-
promoting stimulus (Burdge et al., 2008). Epigenetics now underpins the developmental reprogramming by 
demonstrating the molecular relationship between the environment and gene expression (Jirtle and Skinner, 
2007; Tang and Ho, 2007).  
Within the last decade, studies have been published, suggesting the possibility of transgenerational 
epigenetic effects in mammals (Anway et al., 2005; Padmanabhan et al., 2013; Rassoulzadegan et al., 
2006). These observations force us to question whether environment-altered epigenetic marks can be 
inherited over generations to contribute to human disease. We now present the possible epigenetic 
mechanisms underlying the developmental plasticity (adaptive epigenetic variations) and epigenetic 
inheritance towards exogenous environmental factors and whether these epigenetic effects persist in 
subsequent generations. We briefly define transgenerational, discuss how mammalian epigenetic 
reprogramming should prevent most epigenetic marks from persisting across multiple generations, and 
summarize established mechanisms of transgenerational epigenetic inheritance in non-mammalian 
eukaryotic organisms. Then we review mammalian models demonstrating transgenerational phenotypes 
and environment-induced intergenerational epigenetic effects. Finally, we discuss the difficulties in 
establishing a role for epigenetic inheritance in human environmental disease and why this necessitates an 
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understanding of the molecular basis underlying transgenerational phenotypes to determine potential 
implications for human health.  
1.1. Transgenerational versus intergenerational epigenetic effects  
Many studies have described intergenerational effects as evidence for transgenerational 
inheritance. However, correcting the misconception that these two terms are interchangeable is necessary 
for progress to be made in the study of epigenetic inheritance in human disease. Clarifying these definitions 
will allow researchers to develop and choose appropriate model systems for examining environmental 
influences on intergenerational and transgenerational phenotypes and associated mechanisms. In mammals, 
pregnant females exposed to environmental factors, such as nutrition, hormones, toxicants, or stress can 
affect fetal development. Such in utero exposures can also affect developing germ cells within the fetus 
(Skinner, 2008). Environment-induced epigenetic changes are referred to as intergenerational when they 
occur in the adult female organism (F0), the first generation of offspring (F1), or the second generation of 
offspring (F2), because the adult, the fetus, and the primordial germ cells (PGCs) would be directly 
exposed to the inducing agent. Effects may be transgenerational only when observed in subsequent 
generations (F3 or later) in the absence of exposure to the inducing agent or environmental factor that 
initiated the change. Effects observed in the male germline during the second-generation offspring (F2) 
may be transgenerational when induced during exposure to the adult male (F0) and his germline (F1). 
Importantly, this does not imply that all epigenetic effects in F3 after gestational female exposure or F2 
after male exposure are necessarily epigenetic inheritance. Parental effects (Daxinger and Whitelaw, 2012; 
Whitelaw and Whitelaw, 2008), recapitulation (Waterland, 2014) and DNA sequence changes (Heard and 
Martienssen, 2014) should be excluded. For example, that seminal fluid can affect the uterine environment 
(Bromfield, 2014; Robertson, 2005) and impact offspring phenotype (Bromfield et al., 2014) implies that 
paternal effects could also influence developing PGCs (F2), independent of germline-transmitted effects. 
Examples of non-germline maternal effects are described later in Sections 2.2 and 2.4. Several reviews 
have previously described distinguishing between intergenerational and transgenerational effects in greater 
detail (Daxinger and Whitelaw, 2012; Heard and Martienssen, 2014; McCarrey, 2014; Schmidt, 2013; 
Skinner, 2013). Up to date, the majority of environmental toxicants are shown to influence somatic cells (in 
	
	 5 
F0 and/or F1 germ cell) via epigenetic mechanisms and induce disease phenotypes in mammals but not 
transmit those epigenetic effects into F3 (mother exposed) or F2 (father exposed). Transgenerational 
inheritance of epigenetic changes is commonly shown in plants only. Limited studies have demonstrated 
that environmental toxicants are able to promote transgenerational inheritance of phenotypes and diseases 
states in mammals. Findings from either aspect can help us to define the exposure window to the 
nutritional, hormonal, or stress/ toxin environments that may induce the adaptive and/or heritable 
epigenetic changes on the developing embryo and its germline, and cause disease phenotypes in subsequent 
generations.  
1.2. Epigenetic reprogramming in mammals  
An understanding of the resetting of epigenetic marks during development is needed to investigate 
the role of epigenetic inheritance in human disease. Within the mammalian life-cycle, the genome 
undergoes two global epigenetic reprogramming events, once in the zygote and second in the developing 
PGCs, reviewed in (Cowley and Oakey, 2012; Hackett and Surani, 2012; Heard and Martienssen, 2014; 
McCarrey, 2014). For zygote reprogramming after fertilization, the paternal genome is rapidly 
demethylated, and the maternal genome is passively demethylated; after implantation, genome-wide de 
novo methylation occurs and is completed by embryonic day 6.5 (E6.5) in mice (Smith et al., 2012). 
Regions of the mouse genome resistant to zygotic reprogramming include imprinted differentially 
methylated regions (DMRs), intracisternal A particles (IAPs), and L1Md_A retroelements, a family of long 
interspersed elements (LINEs) (Smith et al., 2012). Coincident with post-fertilization demethylation, the 
mammalian zygote undergoes a process, maternal-to-zygotic transition, during which maternal RNAs are 
degraded, and the embryonic genome becomes transcriptionally active. The timing of zygote genome 
activation varies across species (1–2-cell stage in mice and 4–8-cell stage in humans) and prior to this, pre-
ovulation-accumulated maternal RNAs and proteins direct developmental processes, reviewed in (Li et al., 
2013; Tadros and Lipshitz, 2009). 
Germline reprogramming has indeed raised the question as to how these ‘reprogrammed’ marks 
are being inherited. Gamete imprinting via DNA methylation machinery is reported as establishment of 
epigenetic patterns for future generations (Trasler, 2006). Following post-implantation de novo 
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methylation, cells in the epiblast are induced to become PGCs and global demethylation occurs (E6.5 to 
E9.5); a subset of specific sequences, including imprinted DMRs, maintain methylation until E10.5 and are 
then demethylated by E13.5 (Seisenberger et al., 2012). After E13.5 sex-specific de novo methylation 
occurs: in males, methylation of germ cells is completed by birth; in females, methylation occurs between 
birth and puberty (Cowley and Oakey, 2012; Smallwood et al., 2011). At E13.5, mouse PGCs are 
extremely hypomethylated, but site-specific resistance to demethylation occurs for some IAPs, as well as 
single-copy genomic regions including, some CpG islands (CGIs) and non-CGI promoters near IAPs 
(Seisenberger et al., 2012). A recent study identified 4730 regions, including 233 single-copy regions, that 
maintained greater than 40 percent CpG methylation on E13.5 in female mouse PGCs (Hackett et al., 
2013b; Waterland, 2014). That “two rounds of epigenetic erasure leave little chance for inheritance of 
epigenetic marks, whether programmed, accidental, or environmentally induced,” argues against 
transgenerational epigenetic inheritance in mammals (Heard and Martienssen, 2014). Indeed, for 
transgenerational epigenetic inheritance to occur, epigenetic factors would have to either evade or 
otherwise be protected from global erasure/degradation during reprogramming. More studies on the 
underlying mechanisms of how environmental factors modulate the epigenetic modifications in germ cells 
are required in the future. The reversible and responsive nature of epigenetic modifications toward the 
environment leads us to wonder whether this reprogramming will persist or be further modified throughout 
the course of life of the organism.  
1.3. Transgenerational epigenetic inheritance in eukaryotic organisms  
Mechanisms of transgenerational epigenetic inheritance have been demonstrated mostly in plants 
and non-mammalian animal models. Transcriptional silencing in plants and non-mammalian animal models 
indicate that small RNA may initiate stable chromatin silencing that can then be inherited over generations 
(Heard and Martienssen, 2014). Often associated with transposable elements or repeats, RNA-Dependent 
DNA Methylation (RdDM) and paramutation, in plants, depend on RNA interference (RNAi), reviewed in 
Heard and Martienssen (2014). Plant epigenetic reprogramming and epiallele transmission are discussed in 
(Kawashima and Berger, 2014). Described as a “conversion-type phenomenon” (Coe, 1959) to explain the 
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heritable and reversible induction of phenotype (Brink, 1956), paramutation involves one allele inducing a 
heritable epigenetic change in the other without DNA sequence modification (de Vanssay et al., 2012).  
Paramutation in the fruit fly, Drosophila melanogaster, establishes transgenerational silencing of 
transposable elements. Silencing is mediated by Piwi-interacting RNAs (piRNAs), small RNAs that 
interact with Argonaute-family proteins in the Piwi clade (Stuwe et al., 2014). Transcribed from transposon 
sequence-enriched genomic regions, termed piRNA clusters, primary piRNAs are then processed and 
incorporated into Piwi proteins to silence target sequences (Brennecke et al., 2007). In addition to 
recognizing established transposable elements, the piRNA pathway can recognize new transposable 
elements that invade the host genome. Insertion of an exogenous sequence into a piRNA cluster results in 
repression of similar sequences in euchromatic regions of the genome (Muerdter et al., 2012; Roche and 
Rio, 1998; Ronsseray et al., 2003) and novel transposons can become integrated into piRNA clusters once 
an organism has been exposed (Khurana et al., 2011). Stable transgenerational epigenetic inheritance (over 
50 generations) via paramutation is initiated when maternally inherited piRNAs, transmitted through oocyte 
cytoplasm, lead to de novo silencing of homologous regions on the paternal allele (de Vanssay et al., 2012).  
In the roundworm, Caenorhabditis elegans, dsRNA or piRNA can initiate epigenetic silencing via 
the RNAi/chromatin pathway, which involves RNAi factors, chromatin proteins, and histone 
methyltransferases (Heard and Martienssen, 2014). Epigenetic silencing at endogenous genes and 
transgenes can last more than 20 generations and depends on rrf1, an RNA-dependent RNA polymerase 
(Heard and Martienssen, 2014). Additional details for small RNA-mediated transgenerational inheritance in 
C. elegans are reviewed in (Castel and Martienssen, 2013).  
Many of these established pathways and factors implicated in transgenerational epigenetic 
inheritance in non-mammalian models have not been thoroughly explored in mammalian models. Studies 
attempting to identify non-genetic inheritance in mammalian models should expand the scope of their 
studies to include similar potential mechanisms.  
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2. Transgenerational phenotypes in mammals  
The discovery that vinclozolin, an anti-androgenic fungicide classified as nonmutagenic, could 
produce transgenerational (F1 through F4) effects on male fertility and altered DNA methylation patterns in 
F2 and F3 sperm (Anway et al., 2005) lead to the hypothesis that environment-induced epigenetic changes, 
inherited through the germline, could contribute to disease. Since then, a number of environmental 
chemicals have been demonstrated to induce transgenerational phenotypes. In spite of this, a clearly 
defined molecular basis for inheritance, presumed to be epigenetic, has yet to been established (Schmidt, 
2013). The proposed mechanism is that “epimutations” induced in the male germline become “imprinted-
like” allowing them to escape post-fertilization DNA methylation erasure; the altered epigenome then leads 
to altered transcriptomes in somatic cells resulting in adult-onset diseases (Nilsson and Skinner, 2014; 
Skinner et al., 2013a). However, DNA sequence changes cannot be ruled out when genes responsible for 
phenotypes are unknown (Heard and Martienssen, 2014). Here we review the studies demonstrating 
transgenerational phenotypes and associated epigenetic changes induced by environments.  
2.1. Transgenerational effects of environmental exposures  
In the initial study of vinclozolin (Anway et al., 2005), gestating female (F0) rats were exposed to 
vinclozolin between days E8 and E15, corresponding with epigenetic reprogramming of germs cells and 
sex determination. Following transient gestational exposure to F0 females, F1, F2, F3, and F4 adult males 
had significantly increased spermatogenic apoptosis, decreased sperm number, and reduced sperm motility. 
Similar effects on sperm were observed in offspring of vinclozolin-lineage F2 males crossed with untreated 
females, but not in vinclozolin-lineage F2 females crossed with untreated males, suggesting that the 
phenotype is transmitted through the male, but not female parent. PCR amplification of methylation-
sensitive restriction enzyme digested DNA demonstrated altered DNA methylation patterns in F2 (4 out of 
8) and F3 (2 out of 5) vinclozolin-treated lineages. The transgenerational increase in spermatogenic cell 
apoptosis was replicated in inbred Fisher and outbred Sprague Dawley rat strains (Anway et al., 2006a). 
Subsequent studies found additional adult disease phenotypes after female F0 vinclozolin exposure, 
including prostate abnormalities in F1–F4 males (Anway and Skinner, 2008), severe anemia during 
pregnancy in F1–F3 females (Nilsson et al., 2008), and sexually dimorphic changes in anxiety behaviors 
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(Skinner et al., 2008). These studies demonstrate that transgenerational manifestation of vinclozolin-
induced phenotypes depends on the sex of the offspring and originate from exposure during specific 
developmental intervals. Additionally, transcriptome characterizations found mRNA expression of 196 
genes to be consistently different in testis among the F1–F3 vinclozolin-lineage animals compared to the 
F1–F3 controls (Anway et al., 2008). Affected genes had roles histone modification, chromatin remodeling, 
and DNA methylation, including significant reductions of Dnmt3a in F1–F2, Dnmt1 in F1–F3, Dnmt3L in 
F1–F3, and Ehmt1 in F1–F3 (Anway et al., 2008). Altered expression of these epigenetic enzymes provides 
the possibility that epigenetic processes could be involved. Transcriptome alternations in prostate (F3 
males) (Anway and Skinner, 2008), Sertoli cells (Guerrero-Bosagna et al., 2013), and hippocampus and 
amygdala (F3 males and females) (Skinner et al., 2008) have also been reported.  
In contrast, a different group exposed outbred female (F0) Wistar rats to vinclozolin during 
gestation (E6 to E15) and reported no adverse transgenerational anti-androgenic effects in F1–F4 male 
offspring for two separate studies (SCHNEIDER et al., 2008; Schneider et al., 2013). The first study 
reported decreased and the second reported increased spermatogenic cell apoptosis in F1–F3 male offspring 
after maternal F0 vinclozolin treatment. A study by an additional independent research group, using inbred 
Sprague-Dawley rats, reported no effects on spermatogenesis in F1 or F2 males after maternal (F0) 
exposure to vinclozolin (Inawaka et al., 2009). The reason is undetermined, but the discrepancy suggests 
the possible influence of genetic variations among strains (Heard and Martienssen, 2014; Inawaka et al., 
2009; Schneider et al., 2013). Additionally, the original research group (Anway et al.) reported intraspecies 
differences in susceptibility to vinclozolin in mouse strains after F0 female exposure during gestation (E7 
to E13). Inbred 129 mice were not sensitive to vinclozolin-induced prostate, kidney, or testis phenotypes, 
but apoptosis of spermatogenic cells occurred; whereas, outbred F3-generation CD-1 mice developed 
prostate, kidney, and testis abnormalities (Guerrero-Bosagna et al., 2012). A second group exposed inbred 
FVB/N mice to vinclozolin during gestation (E10 to E18) and reported changes in CpG methylation at five 
imprinted DMR in sperm; paternally imprinted genes decreased and maternally imprinted genes increased 
(Stouder and Paoloni-Giacobino, 2010). Methylation changes were observed in F1 through F3 but appeared 
to be returning to normal methylation levels by F3. Sperm motility was reduced in F1, but not in F2 and F3. 
Although not a genome-wide analysis, this suggests that CpG methylation changes at imprinted genes were 
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not correlated with phenotype (Schneider et al., 2013). Alternatively, these results may not be comparable 
to the previously described studies because exposure was extended to E18, which overlaps with the 
androgen receptor vulnerability window (Schneider et al., 2013) and, therefore, was not limited to germ cell 
reprogramming and sex determination. Herein, it suggests that the experimental designs and exposure 
windows determine the transgenerational effect of vinclozolin in epigenome.  
Since the initial vinclozolin study, a number of endocrine-disrupting chemicals (EDCs), including 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Manikkam et al., 2012b), permethrin and N,N-diethyl-meta-
toluamide (DEET) mixture (Manikkam et al., 2012c), jet fuel JP-8 (Tracey et al., 2013), plastics mixture 
(bisphenol-A (BPA), bis (2-ethylhexyl)phthalate (DEHP), dibutyl phthalate (DBP)) (Manikkam et al., 
2013), dichlorodiphenyltrichloroethane (DDT) (Skinner et al., 2013b), and methoxychlor (Manikkam et al., 
2014) have been assessed for phenotypes and DNA methylation changes in F3 rat sperm using similar 
designs as the original vinclozolin study. Transgenerational phenotypes observed in rats include prostate 
and kidney disease (Anway and Skinner, 2008; Anway et al., 2006b; Manikkam et al., 2012b; 2012c; 
2012a; 2013; Tracey et al., 2013), mammary tumors (Anway et al., 2006b), abnormalities of the immune 
system (Anway et al., 2006b; Tracey et al., 2013), neurological and behavioral effects (Crews et al., 2012; 
2007; Gillette et al., 2014; Skinner et al., 2008), reproductive effects (Guerrero-Bosagna et al., 2013; 
Nilsson et al., 2008; 2012), altered mate preference (Skinner et al., 2014), and obesity (Skinner et al., 
2013b; Tracey et al., 2013), reviewed in (Crews et al., 2014; Nilsson and Skinner, 2014). In addition to the 
paternally-transmitted phenotypes, recent studies demonstrate that some effects from DDT and 
methoxychlor are transmitted maternally (Manikkam et al., 2014; Skinner et al., 2013b). Independent 
research groups have also reported transgenerational phenotypes from exposure to EDCs or other 
environmental factors. Effects observed in mice from gestational (F0) exposure were altered gene 
expression, social interaction, and social recognition (Wolstenholme et al., 2012; 2013) from BPA; adipose 
depot size, increased adipocytes, and fatty livers from tributyltin (TBT) (Chamorro-García et al., 2013); 
spermatogonial stem cell defects from di-(2-ethylhexyl) phthalate (DEHP) (Doyle et al., 2013); and 
hyperactivity from nicotine (Zhu et al., 2014). Taken together, these studies suggest that vinclozolin is not 
unique in its ability to induce transgenerational effects and that gestational exposure can lead to a diverse 
array of phenotypic consequences in subsequent generations.  
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Epimutations have been proposed as potential evidence for transgenerational epigenetic 
inheritance of toxicant-induced disease phenotypes (Nilsson et al., 2012). DMR, considered to be 
epimutated if reproducible in three experiments, in gene promoters were determined in F3 male rat sperm: 
48 for vinclozolin (Guerrero-Bosagna et al., 2010), 50 for dioxin, 33 for jet fuel (Manikkam et al., 2012a), 
197 for plastics mixture, 361 for pesticides mixture, 39 for DDT, and 37 for methoxychlor (Manikkam et 
al., 2014). The locations of the epimutations appear to be unique to the chemicals as there is little overlap 
between most pair-wise comparisons and no overlap among all chemicals; plastics mixture and pesticides 
mixture had the most overlap, with 109 epimutations in common (Manikkam et al., 2014). Sperm from F3 
vinclozolin-lineage CD-1 mice had 66 promoters with 68 differentially methylated regions (Guerrero-
Bosagna et al., 2012). These results indicate that the effect a toxicant has on the epigenome exhibits some 
chemical specificity.  
The window of susceptibly for induction of epimutations in the rat, E7/8 to E14/15, is equivalent 
to E6/7 to E12/13 in the mouse, which coincides with global demethylation in PGCs and hypomethylation, 
but excludes the remethylation phase (Section 1.2) (McCarrey, 2014). Differentially expressed genes and 
epimutations were determined in germ cells from male F3 vinclozolin-lineage rats on E13 (PGCs) and E16 
(prospermatogonia) (Skinner et al., 2013a). There were 592 differentially expressed genes between 
vinclozolin-lineage germ cells and controls at E13 and 148 at E16, with only 25 at both E13 and E16 
(Skinner et al., 2013a). E13 PGCs had 24 epimutations and E16 prospermatogonia had 13 epimutations, 
with only one gene promoter in common; neither E13 nor E16 cells had epimutations in common with 
those previously identified in male F3 vinclozolin-lineage mature sperm. This finding does not support 
specific CpG methylation-based epimutation(s) being programmed in PGCs and directly transmitted from 
sperm to offspring for the inheritance of vinclozolin phenotypes. Unfortunately, there are disadvantages in 
using a rat model to study potential epigenetic mechanisms involved in the transgenerational inheritance of 
the observed disease phenotypes. Extrapolating from findings in mice (Section 1.2), we assume that 
reprogramming-resistant regions could exist in the rat genome as well. Determining whether rat 
epimutations would be resistant to post-fertilization reprogramming is hindered in that much less is known 
about the rat genome and epigenome, compared to the mouse and human genomes. For example, genome-
wide, base-resolution DNA methylation profiling across different stages of embryonic and germ cell 
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development have not yet been published for the rat. Furthermore, genomic regions resistant to germline 
erasure in the mouse are often associated with transposable elements or repeats and likely display 
interspecies differences in position and regulation, which prevents direct extrapolation of resistant loci from 
the mouse genome to the rat genome (Sections 1.2, 2.4 and 4.3).  
Overall, attributing these transgenerational effects on disease susceptibility to non-genetic 
mechanisms is supported by differential DNA methylation observed in sperm of the F3 generation 
following gestational exposure of F0 females to nonmutagenic toxicants compared to unexposed controls. 
Perturbations to epigenetic regulatory enzymes suggest that these phenotypes involve epigenetic processes. 
Currently, there is not enough detailed molecular evidence to demonstrate the transgenerational 
maintenance of toxicant-induced epigenetic status (i.e., an epigenetic mark altered by exposure that is 
present in the offspring and inherited from the parental germline (Waterland, 2014)) or to conclusively rule 
out confounders, such as DNA sequence changes, parental effects, or recapitulation. For these reasons, the 
specific mechanisms of heritability for these toxicant-induced transgenerational effects need to be 
elucidated. Research is also needed to clarify how the epimutations affect gene regulation and disease 
etiology (Nilsson and Skinner, 2014).  
2.2. Mutation-induced epigenetic instability and transgenerational phenotypes  
A recent mouse study demonstrated the importance of accounting for parental effects in 
experimental models for exploring mechanisms of transgenerational inheritance in mammals. In the study, 
they found that the disruption of folate metabolism caused by a mutation in the methionine synthase 
reductase (Mtrr) gene of F0 females or males caused epigenetic perturbations and lead to growth defects 
and congenital malformations (Padmanabhan et al., 2013). Effects persisted through generations F2–F4 of 
wild-type offspring derived from wild-type mothers (F1). F0 metabolic deficiencies could potentially alter 
reproductive phenotypes in F1 wild-type mothers (e.g., affect F1 uterine development). If the F1 (wild-
type) maternal environment were responsible for the observed adverse developmental outcomes and 
epigenetic perturbations, then F3 germ cells developing in F2 fetuses would be considered exposed to the 
altered maternal environment (F1 phenotype) caused by the Mtrr mutation in the F0 generation. To 
separate potential maternal effects from those directly caused by F0 grandparental Mtrr-deficiency on F2 
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gametes, embryo transfer experiments were conducted on grandprogeny (F2). Results from these 
experiments implicated maternal uterine environment in growth defects and maternal grandparental Mtrr-
deficiency in transgenerational congenital malformations. Affected wild-type grandprogeny (F2) derived 
from Mtrr-deficient F0 males or females were determined to have epigenetic instability, indicated by 
alterations in DNA methylation at imprinted DMRs in placentas; whereas, phenotypically normal wild-type 
litters (F1) from Mtrr-deficient F0 males did not display epigenetic instability. Taken together this suggests 
some phenotypic effects initiated by maternal grandparental Mtrr deficiency are transmitted through the 
germ cells and are, at least in part, mediated by epigenetic mechanisms.  
2.3. RNA-mediated paramutation-like effects  
In addition to toxicant- and mutation-induced transgenerational effects, RNA-mediated, 
paramutation-like effects have been described in mice. In this example, wild-type offspring derived from a 
parent (male or female) heterozygous for an engineered, mutated allele, Kittm1Alf, displayed the mutant 
phenotype, white feet and tail tips (Rassoulzadegan et al., 2006). The phenotype was still partially visible in 
F2 but disappeared gradually in subsequent generations. The inheritance of the phenotype, despite the 
absence of genetic inheritance of the Kittm1Alf allele, suggests the possibility of epigenetic inheritance. 
Microinjection of RNA isolated from Kittm1Alf heterozygote sperm or brain, miR-221, or miR-222 into 
fertilized eggs was sufficient to induce the phenotype (Rassoulzadegan et al., 2006), which indicates RNA-
mediated effects. The transgenerational inheritance does not occur in other Kit null alleles without a 
transgene insertion (Daxinger and Whitelaw, 2012), which raises the question of whether similar 
phenomena would arise naturally. The same group demonstrated that the injection of other microRNAs into 
fertilized eggs results in the transgenerational inheritance of additional phenotypes but did not lead to a 
stable increase in microRNAs to pass to the next generation (Grandjean et al., 2009; Wagner et al., 2008). 
This observation suggests that the transmission to subsequent generations is initiated, but not maintained, 
by the same RNA molecules. Furthermore, establishment of the paramutant-like phenotypes requires 
Dnmt2, responsible for methylation of cytosine in RNA (Kiani et al., 2013). While initiated by the transfer 
of RNA from sperm to offspring, the molecular basis for how the observed phenotypes are inherited 
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throughout generations has not been established. Importantly, these studies establish that RNA-mediated 
epigenetic mechanisms might play a similar role in mammalian transgenerational inheritance, as they do in 
plants and non-mammalian animal models.  
2.4. Transgenes and metastable epialleles  
The non-mendelian inheritance of transcription activity at transgenes is presumed to be epigenetic 
because inbred littermates have variable transcription (Daxinger and Whitelaw, 2012). Variable expression 
and non-mendelian inheritance patterns of endogenous genes at metastable epialleles, defined as “allele[s] 
at which the epigenetic state can switch and establishment is a probabilistic event” (Rakyan et al., 2002), 
are often associated with transposable elements and are thought to result from incomplete reprogramming 
of epigenetic marks (Rakyan et al., 2001).  
For example, the agouti locus (A) controls pigmentation of the mouse, the coat color phenotype of 
Avy/a heterozygotes ranges from yellow to various degrees of yellow background with black mottling to 
pseudoagouti (i.e., resembles wild-type agouti pattern) (Dickies, 1962). Coat color correlates with other 
varied phenotypes observed in genotypically similar littermates, including obesity and susceptibility to 
tumor formation (Wolff, 1978). Furthermore, the maternal and grandmaternal, but not the paternal, 
phenotype affects the distribution of phenotypes among offspring derived from Avy/a heterozygotes 
crossed with a/a homozygotes (Morgan et al., 1999; Wolff, 1978), suggesting that phenotypic variation is 
mediated by maternal factors. The Avy mutation, caused by an IAP element insertion 100 kb upstream of 
the transcription start site for the wild-type coding sequence, drives ubiquitous, constitutive transcription of 
a gene that has tissue- and stage-specific expression in wild-type mice (Bultman et al., 1992; Duhl et al., 
1994; Waterland and Jirtle, 2003). Varying degrees of epigenetic silencing, indicated by hypermethylation 
at the IAP of the Avy locus, suppresses transcription of agouti gene to generate mottled and pseudoagouti 
phenotypes (Morgan et al., 1999).  
Physiologic and metabolic differences among mothers were thought to explain dependence of 
offsprings' phenotype on maternal phenotype (Wolff, 1971; 1978). Embryo transfer experiments (to 
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separate maternal environment from germline effects) indicate that phenotype distribution results from 
inheritance, not maternal environment (Morgan et al., 1999). Interestingly, characterization of CpG 
methylation in gametes, zygotes, and blastocysts demonstrated that the Avy allele undergoes dynamic post-
fertilization DNA methylation reprogramming consistent with established genome-wide patterns (Blewitt et 
al., 2006). That is paternal Avy allele was dramatically reduced (from 73% to 15%) within 9–11 h after 
fertilization, indicating active demethylation; maternal Avy allele was not rapidly demethylated (69% 
methylation in zygote), but was completely unmethylated by the blastocyst stage (Blewitt et al., 2006). 
Thus, CpG methylation at the Avy allele is not likely the epigenetic mark responsible for the 
transgenerational phenotypes (Daxinger and Whitelaw, 2012), because it is erased within the mammalian 
lifecycle. In Aiapy mice, which are similar to Avy mice in that DNA methylation at an IAP insertion 
inversely correlates with agouti expression and determines the distribution of offspring phenotypes 
(Michaud et al., 1994), low expression of maternal oocyte-specific Dnmt1 isoform shifted offspring coat 
distribution toward yellow (Gaudet et al., 2004). This result indicates that the pre-implantation control of 
agouti expression contributes to adult phenotype (Gaudet et al., 2004); however, whether the Aiapy 
epiallele escapes post-fertilization reprogramming or whether the Avy/a phenotypes are similarly dependent 
on oocyte-specific Dnmt1 has not been reported.  
3. Environment-induced intergenerational epigenetic effects  
Currently, studies showing transgenerational epigenetic inheritance towards environmental stimuli 
are limited. Nonetheless, a number of human and animal studies have demonstrated that toxicant exposure 
and nutritional status during pregnancy can affect epigenetic marks in developing offspring, which provides 
a molecular explanation for increased disease susceptibility from fetal exposures (Bailey and Fry, 2014; 
Hilakivi-Clarke, 2014; O'Hagan and Tang, 2013; Soubry et al., 2014; Waterland, 2014). The Agouti viable 
yellow (Avy) mouse model is, perhaps, the most well characterized animal model demonstrating a role for 
environmental factors in phenotypic variation through alteration of DNA methylation. Methyl 
supplementation of female (F0) diet during gestation shifted the distribution of offspring (F1) (Wolff et al., 
	
	 16 
1998) and grand offspring (F2) (Cropley et al., 2006) phenotypes toward pseudoagouti when the Avy allele 
is inherited from F0 males to F1 females to F2 offspring, indicating intergenerational effects from F0 
gestational exposure. Gestational methyl supplementation-induced phenotypic changes correlated with the 
degree of CpG methylation at the IAP insertion site (Waterland and Jirtle, 2003). Similarly, maternal 
methyl supplementation increased CpG methylation of the AxinFu metastable epiallele and shifted the 
phenotype distribution of offspring (Waterland et al., 2006). Environment-mediated epigenetic regulation 
of the mutant allele(s) provides a molecular basis for the phenotypic variation observed among these 
isogenic mice.  
Other environmental exposures during gestation have also been shown to affect offspring 
phenotype and CpG methylation of the Avy epiallele. Genistein, a soy phytoestrogen, induced 
hypermethylation and shifted offspring distribution toward pseudoagouti (Dolinoy et al., 2006). Bisphenol 
A (BPA), an estrogenic chemical used to manufacture plastics and resins, induced hypomethylation and 
shifted offspring distribution toward yellow, but methyl donor or genistein supplemented maternal diets 
were able to counter the effects of BPA on coat color distribution (Dolinoy et al., 2007b). However, methyl 
donor-induced hypermethylation, indicated by coat color, was not inherited transgenerationally through the 
female germline (Waterland et al., 2007).  
Animal models involving dietary manipulation have demonstrated the importance of gestational 
nutrition in determining offspring disease susceptibility. In utero exposure to high-fat diet in mice is shown 
to induce paternal obesity with increase in adiposity and initiate intergenerational transmission of obesity 
and insulin resistance in two generations of offspring accompanied with changes in sperm microRNA 
content and germ cell methylation status (Fullston et al., 2013). In contrast, caloric restriction during 
pregnancy alters DNA methylation in the sperm of F1 offspring mice at regions resistant to zygotic 
reprogramming. Although these changes do not persist in F2 tissues, the results suggests in utero nutritional 
exposures during critical windows of germ cell development can impact the male germline methylome that 
may influence the risk of metabolic disease in the offspring (Radford et al., 2014). Nonetheless, another 
group demonstrated no changes in male germline DNA methylation in a dietary protein restriction model 
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(Carone et al., 2010). Overall, it is clear that both toxicants and nutrients can induce epigenetic changes 
with intergenerational phenotypic consequences. Certainly, in animal models, the exposure window to the 
environmental stimuli is critical for the establishment of intergenerational epigenetic changes.  
4. Establishing a role for epigenetic inheritance in human environmental disease  
4.1. Transgenerational human disease  
Evidence of transgenerational epigenetic inheritance in plant and animal models suggests that it 
may be a ubiquitous phenomenon in eukaryotic organisms and could plausibly occur in mammals. 
Evidence from mammalian animal studies indicates that epigenetic instability resulting from deficiency in 
folate metabolism, initiated by a genetic mechanism, can cause transgenerational outcomes and that 
environmental and dietary factors can affect DNA methylation intergenerationally in mammals. Several 
human cohorts like famine and DES exposure demonstrated the intergenerational effect of nutrients and 
EDCs on disease phenotypes (Bygren et al., 2014; Klip et al., 2002; Veenendaal et al., 2013; 2012). 
However, whether environmental perturbations induce epigenetic changes and these changes can be 
transgenerationally inherited through epigenetic mechanisms to influence human disease susceptibility 
remains unknown. Furthermore, distinguishing between epigenetic inheritance and epigenetic biomarkers 
remains challenging, especially in humans. Few epidemiological studies that demonstrate intergenerational 
and possibly transgenerational associations have assessed the following conditions: paternal line food 
supply, maternal line famine and prenatal nutrition, smoking, and paternal line betel-quid chewing, recently 
reviewed in (Pembrey et al., 2014).  
4.2. Limitations of human epidemiology studies  
That we have evidence for transgenerational epigenetic inheritance in animal models with 
relatively short lifespans and generation times, such as D. melanogaster and C. elegans is not surprising. In 
addition to the time required for multi- or transgenerational studies in humans, limited sample availability 
makes it difficult to study dynamic genome-epigenome interactions (Section 4.4). While often sufficient for 
identification of stable biomarkers, human samples do not necessarily provide adequate mechanistic insight 
needed to establish epigenetic inheritance and rule out genetic inheritance, parental effects, and 
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recapitulation. Furthermore, human samples are often limited to those that are minimally invasive, such as 
blood, urine, saliva, skin, and post-mortem samples, which are inadequate for studying the complex 
epigenetic dynamics that occur during development (Section 1.2). Finally, the inability to completely 
control for other environmental exposures makes it difficult to identify relevant epigenetic and genetic 
changes for a particular factor and rule out confounding effects from other environmental influences.  
4.3. Limitations of interspecies extrapolation of phenotypes  
Animal models can be used to study molecular mechanisms in organisms over multiple lifecycles 
and throughout development. It is tempting to extrapolate phenotypic consequences of environment-
induced epigenetic changes (e.g., adverse outcomes from toxicant exposure) observed in animal models to 
humans. While similar epigenetic mechanisms likely apply to humans, perturbations to these mechanisms 
may not necessarily affect the same endogenous gene(s) or pathway(s) as in animal models. For example, 
estimates suggest that mice and humans have 30 percent of imprinted genes in common (Skaar et al., 2012) 
and IAP elements, responsible for the lability of the agouti epiallele (Sections 2.4 and 3), are not found 
within the human genome. Therefore, direct interspecies extrapolation of phenotypes identified in rodent 
models may be insufficient for explaining particular human traits or disease susceptibility. However, other 
families of transposable elements within the human genome could impart similar characteristics to 
endogenous human genes. A mechanistic understanding of interspecies genomic and epigenomic 
differences would be particularly important in extrapolating effects observed in rodents involving imprinted 
genes, mouse IAPs, and other transposable elements to humans.  
One study demonstrated interspecies differences in the regulation of retrotransposons at 
transcription start sites (TSSs) in mouse and human genomes using multiple cell and tissue types for each 
species (Faulkner et al., 2009). The comparison used cap analysis gene expression (CAGE) followed by 
high-throughput sequencing, which provides detailed information on activity at TSSs by capturing and 
sequencing the first 20 nucleotides from the 5 prime end of full-length cDNAs. They found that 
approximately 18.1 percent of mouse and 31.4 percent of human TSSs were located within repetitive 
elements, but only 5.2 percent of mouse and 2.8 percent of human TSSs with more than 100 CAGE tags 
were from retrotransposons. This finding indicates that although abundant throughout mammalian 
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genomes, TSSs of retrotransposons tend have lower transcription than non-repeat TSSs. Furthermore, 
transcription from repetitive element-associated TSSs differed between cell and tissue types. Interestingly, 
transcription of retrotransposons was poorly conserved between mice and humans, even in comparable 
tissue types. Although whether this reflects species-specific epigenetic regulation of transposable elements 
or differences between human and mice retrotransposon families was not determined. Overall, this genome-
wide characterization of transcription at repetitive elements in both mouse and human cells/tissues suggests 
that regulation of retrotransposons in mammalian genomes displays species specificity and that variation 
also occurs within a species among different developmental stages and tissue types. These differences 
might need to be taken into account to extrapolate from rodent models to human diseases.  
The dependence on transposable elements for both metastable epialleles and inherited 
paramutations suggests that transposable element-associated genes that escape DNA methylation erasure in 
both zygotes (Borgel et al., 2010; Smallwood et al., 2011) and PGCs (Guibert et al., 2012; Hackett et al., 
2013b) could be candidate regions to explore for heritable epialleles in mammals. With bioinformatic 
approaches and bisulfite sequencing, a recent study identified retrotransposon-derived candidate epialleles 
in the mouse genome (Ekram et al., 2012). Identification of similar candidate regions within the rat and 
human genomes would be useful for understanding interspecies similarities and differences in genomic 
regions that have the potential to provide insight into potential transgenerational epigenetic inheritance in 
mammals.  
4.4. Genome-epigenome dynamics  
DNA methylation exhibits some sequence context specificity, indicating that genetic variation 
among individuals could result in DNA methylation differences (Schübeler, 2012). At the same time, 
maintaining genome integrity requires suppression of retrotransposition activity, accomplished via 
epigenetic regulation (Ishiuchi and Torres-Padilla, 2014). This observation has lead others to propose that 
environmental factors could result in primary, secondary, or tertiary epimutations, reviewed in (McCarrey, 
2014). Briefly, primary epimutations would be initiated by an epigenetic change that is then inherited via 
epigenetic mechanisms with no changes to DNA sequence (Whitelaw and Whitelaw, 2008). Secondary 
epimutations would be initiated by a genetic change that causes an epigenetic change that is subsequently 
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inherited by either genetic or epigenetic mechanisms (Whitelaw and Whitelaw, 2008). Tertiary 
epimutations would be initiated by an epigenetic change that causes a genetic change(s) (McCarrey, 2012). 
The apparent reciprocal dependence between the epigenome and genome suggests a dynamic interaction, 
which makes it difficult to establish whether epigenetic differences are the initial cause or consequence of 
DNA sequence variation, especially when the only available molecular evidence is static and temporality 
must be inferred.  
5. Potential implications for human environmental health and disease  
Without conclusive mechanistic evidence either for or against transgenerational epigenetic 
inheritance of environment-induced epigenetic changes in mammals, assessing the human health 
implications is somewhat speculative. Assuming (1) that transgenerational epigenetic inheritance occurs in 
mammals and we have yet to find a mechanism, (2) that because of their common use in biomedical 
research we would most likely establish such a mechanism in rodent models, and (3) that environment-
induced perturbations to these epigenetic factors could also be inherited, we would still need to extrapolate 
those mechanisms to human diseases. Molecular mechanisms in the most general sense should be 
applicable to humans. If, for example, a transposon silencing-based mechanism were to be implicated in 
any transgenerational disease phenotypes observed in rodent models (Section 2.1), it would be possible for 
a similar silencing mechanism to occur in humans. However, interspecies differences in families of 
transposable elements, their insertions sites, and their influences on gene regulation (Levin and Moran, 
2011) suggest that similarly regulated genomic features may not affect the same genes in humans as in 
animal models. Fortunately, the increasing wealth of genomic and epigenomic data should allow us to 
extrapolate molecular mechanisms from rodent models to identify similar regions of the human genome 
based on characteristic genomic and epigenomic features. After we identify distinctive features of 
transgenerational inheritance in the rodent models, our next step would be to uncover details of analogous 
or homologous mechanisms in humans, and then to identify potential genes affected, and finally, to connect 
changes in expression of these genes to phenotypic (e.g., disease) consequences.  
Alternatively, the observed environment-induced transgenerational phenotypes could be 
epigenetic manifestations of heritable genetic mutations or transmitted by other non-genetic mechanisms. 
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Given the rarity of transgenerationally-inherited, environment-induced epigenetic changes in plants, in 
which mechanisms of transgenerational epigenetic inheritance have been established (Heard and 
Martienssen, 2014), combined with the rarity of epialleles reported in mammals, other scenarios could 
explain many examples of transgenerational phenotypes observed in mammals. A recent study assessing 
DNA methylation of 614 individuals from 117 families consisting of monozygotic or dizygotic twins and 
their parents found that similarity in DNA methylation between relatives could be accounted for largely by 
genetic heritability of DNA sequence variants (McRae et al., 2014). Under a genetic inheritance scenario, 
we would still need detailed mechanistic information to determine affected genes and understand possible 
human phenotypes, especially if the DNA sequence variations were found to occur in noncoding areas of 
mammalian genomes.  
6. Conclusions  
Environmental conditions, such as toxicant exposure and metabolic deficiencies, can influence 
phenotypes and change epigenetic marks over multiple generations. However, whether these altered 
epigenetic marks are evidence of transgenerational epigenetic inheritance of environmental effects remains 
unknown. The demonstrated mechanisms for transgenerational epigenetic inheritance in other eukaryotic 
organisms and transgenerational epigenetic silencing of transposable elements in the mammalian genome 
suggests that it would be plausible for similar processes to exist in mammals. Then, it is not difficult to 
imagine that environmental conditions could alter these epigenetic processes. Although the two epigenetic 
reprogramming events within the mammalian lifecycle would make the transmission of epigenetic marks 
across multiple generations unlikely, some repetitive elements and single-copy loci resist germline erasure 
and some repetitive elements and imprinted loci resist early embryonic erasure. However, the rarity of 
epialleles and their association with silencing transposable elements in mammals leaves the possibility that 
toxicant or metabolic-induced epigenetic instability could give rise to de novo insertion mutations resulting 
from reactivation of transposable elements in offspring that were presumed to be isogenic. The mammalian 
lifecycle further complicates distinguishing between germline transmission and environmental influences, 
especially parental, as subsequent generations are never truly independent of their predecessors in natural, 
as opposed to experimental, mammalian systems.  
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Many transgenerational phenotypes appear to be mediated, if not inherited, by epigenetic 
processes. As such, distinguishing among epigenetic, genetic, and metabolic contributions to human 
environmental diseases will continue to be active areas of research and debate. Demonstrating whether 
transgenerational epigenetic inheritance occurs in mammals will require detailed genetic, epigenetic, 
transcriptomic, and metabolic profiling of well-controlled animal models with well-documented pedigrees. 
Novel cell-based and in vitro approaches for studying dynamic molecular processes will be needed to 
identify epigenetic factors involved and rule out possible confounding from non-germline parental and 
grandparental influences on offspring, such as those introduced by behavioral, metabolic, or microbiotic 
factors. Regardless of whether transgenerational phenotypes are transmitted via epigenetic or other 
mechanisms, extrapolating findings to understand the role that environmental perturbations play in human 
disease susceptibility necessitates a quantitative and integrated understanding of the interactions among the 
environment and the genome, epigenome, transcriptome, and metabolome at different stages of human 
development.  
Part B–Aims and Objectives 
It is increasingly important to understand how epigenetic states are established and maintained to 
determine how the plasticity and heritability of epigenetic marks, such as DNA methylation, contribute to 
mechanisms of toxicity from developmental exposures. Due to the ability of genomic imprints and certain 
transposable elements to resist either the post-fertilization or germline specification phases of DNA 
methylation reprogramming(Cowley and Oakey, 2012; Seisenberger et al., 2012), parent-of-origin 
dependent regulation of imprinted genes and epigenetic silencing of transposable elements are of particular 
interest for investigating molecular mechanisms of intergenerational and potential transgenerational 
inheritance from environmental exposures. To identify epigenetic characteristics of these genomic features 
that would render them vulnerable to epigenetic perturbation, we analyzed whole-genome bisulfite 
sequencing (WGBS) from mouse embryonic stems cells (mESCs) with disrupted DNA methyltransferase 
(DNMT) enzymes and from male mice exposed in utero to Bisphenol A (BPA). 
Mouse embryonic stem cells (mESCs) are pluripotent cells derived from the inner cell mass of 
preimplantation embryos (Hackett et al., 2013a; Nichols and Smith, 2009). As such, mESCs represent an 
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early embryonic stage capable of differentiating into either somatic tissues or primordial germ cells 
(Hackett and Surani, 2012). Therefore, detailed knowledge of how epigenetic marks are maintained 
throughout the genome at this critical stage of early embryonic development should provide insights into 
epigenetic inheritance paradigms. Three DNA methyltransferase (DNMT) enzymes are responsible for 
adding methyl groups to DNA in mammals. DNMT1 is classified as the “maintenance” enzyme because it 
localizes to replication foci (Leonhardt et al., 1992) and has a preference for hemimethylated DNA (Bestor 
and Ingram, 1983; Gruenbaum et al., 1982). DNMT3a and DNMT3b are considered “de novo” 
methyltranferases due to their role in establishing new methylation patterns in during embryonic 
development (Okano et al., 1999). This leads to the traditional two-step model, whereby DNMT3a/3b 
establishes and DNMT1 maintains DNA methylation patterns (Fig. 1.1). However, this model is limited in 
its inability to predict the diversity in DNA methylation changes observed throughout the genome in 
response to environmental or genetic influences.  
 
Figure 1.1 Two-step model for DNA methylation. 
Previously, we applied whole-genome bisulfite sequencing (WGBS) to characterize methylomes 
of wildtype (WT) mESCs (J1; ATTC SCRC-1010) and three mutant mESCs with altered DNA 
methyltransferase (DNMT) enzymes: loss of “maintenance” DNMT (1KO; Dnmt1-/-), loss of “de novo” 
DNMTs (DKO; Dnmt3a-/-/Dnmt3b-/-), and loss of “maintenance” and “de novo” DNMTs (TKO; Dnmt1-/-
/Dnmt3a-/-/Dnmt3b-/-). We demonstrated that, in general, CpG sites throughout the mouse genome rely on 
activity from both “maintenance” and “de novo” DNMTs in mESCs to some extent (Li et al., 2015). We 
also identified loci that were predominantly DNMT1 maintained or preferentially DNMT3a/3b maintained. 
DNMT1-maintained regions were enriched in long terminal repeats (LTRs), including Intracisternal A 
	
	 24 
Particle (IAP) elements. DNMT3a/3b-maintained regions were enriched in long interspersed nuclear 
elements (LINEs). This lead to our proposed “coordination and division of labor” model for DNA 
methylation maintenance (Fig. 1.2). Because of this, we postulated that DNA methylation maintenance 
paradigms of genomic regions might influence their susceptibility to heritable toxicant-induced epigenetic 
perturbation.  
 
Figure 1.2 Coordination and division of labor model for DNA methylation maintenance. 
Aim 1: Identify genomic regions in mESCs that share DNA methylation characteristics found at germline-
imprinted regions 
Genomic imprints are established in a sex-specific manner during germ cell development, leading 
to germline differentially methylated regions (gDMRs) between sperm and oocytes (MacDonald and Mann, 
2013). Unlike the majority CpG sites throughout the genome, DNA methylation at imprinted gDMRs is not 
erased during post-fertilization reprogramming (Smith et al., 2014). This unique paradigm of epigenetic 
inheritance results in one highly methylated allele and one undermethylated allele in diploid mammalian 
zygotes. Furthermore, loss of DNA methylation in Dnmt1-/- mESCs can be partially rescued at most 
genomic regions with exogenous Dnmt1 cDNA expression (Tucker et al., 1996). In contrast, loss of DNA 
methylation at several imprinted differentially methylated regions (DMRs) could not be rescued (Tucker et 
al., 1996). Chapter 2 focuses on developing and applying bioinformatic methods to identify regions that 
share the characteristics of bimodal methylation patterns and non-restorable DNMT1-dependent DNA 
methylation loss throughout the mouse genome. 
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Aim 2: Determine whether DNA methylation characteristics associated with gDMRs and transposable 
elements increase susceptibility to epigenetic perturbation from prenatal exposure to Bisphenol A (BPA) 
Exposure to endocrine disrupting chemicals, such as BPA, during early development can increase 
later life disease risk for cancers (Acevedo et al., 2013; Bindhumol et al., 2003; Dhimolea et al., 2014; 
Fenton et al., 2012; Ho, 2006; Jenkins et al., 2009; Maffini et al., 2006; Prins and Ho, 2010; Soto et al., 
2013; Tang et al., 2012; Weinhouse et al., 2014), cardiovascular disease (Lang et al., 2008; Melzer et al., 
2010), metabolic abnormalities (Angle et al., 2013; Chou et al., 2011; Harley et al., 2013; Hatch et al., 
2010; Li et al., 2014; Miyawaki et al., 2007; Somm et al., 2009; Stojanoska et al., 2017; Wei et al., 2011; 
Zoeller et al., 2005), and neurological disorders (Nakagami et al., 2009; Perera and Herbstman, 2011; Zhou 
et al., 2009). In mice, perinatal exposure to BPA alters DNA methylation at several imprinted genes 
(Susiarjo et al., 2013) and retrotransposon-associated metastable epialleles (Anderson et al., 2012; Dolinoy 
et al., 2007b). In Chapter 3, we examine whether genomic regions sharing epigenetic characteristics 
observed in mESCs at imprinted loci or transposable elements render them more likely to experience BPA-
induced DNA methylation changes. Identification of regions of high susceptibility to epigenetic toxicity 
should improve the ability of researchers to connect molecular targets with disease phenotypes to develop a 
mechanistic understanding of how developmental exposures lead to diseases later in life and across 
multiple generations.  
Aim 3: Determine potential functional relevance of epigenetic perturbation for metabolic phenotypes  
Maternal gestational exposure to BPA has been demonstrated to lead to metabolic abnormalities in 
male offspring for two generations, in mice (Susiarjo et al., 2015). To gain a broad perspective into 
potential DNA methylation-mediated effects, in Chapter 4, we use whole-genome bisulfite sequencing to 





Two approaches reveal a new paradigm of ‘switchable or genetics-influenced allele-
specific DNA methylation (ASM)’ with potential in human disease 
Chapter 2–Two approaches reveal a new paradigm of ‘switchable or genetics-influenced allele-specific 




(SNM developed algorithms for NORED and MethylMosaic, implemented bioinformatics analyses, and 
wrote Results and Methods Sections pertaining to those analyses. SNM contributed to writing Abstract, 
Introduction, and Discussion.) 
Abstract 
Imprinted genes, important for development and neurological function, are vulnerable to 
nutritional/environmental influences during early embryonic development, thereby contributing to the onset 
of disease in adulthood. Allelic methylation at several germline imprints has been reported as DNMT1-
dependent. However, which of two epigenetic attributes, DNMT1-dependence or allelic methylation, 
renders them susceptible to environmental stressors has not been determined. We therefore sought to detect 
regions throughout the genome that exhibited DNMT1-dependence and/or had bimodal methylation 
patterns. Herein we have developed an approach, referred to as NORED, to identify 2468 maintenance 
DNMT1-dependent DNA methylation patterns. We further use a genetic variation-independent approach 
(referred to as MethylMosaic) to detect 2487 regions with bimodal distribution of hypermethylated or 
hypomethylated reads. Combined, two approaches identified 207 regions, including known imprinted 
germline ASMs, which were lost in DNMT-deficient cells and had bimodal methylation. Unexpectedly, we 
identified regions that although both DNMT1-dependent and bimodal, do not display parent-of-origin 
dependent allelic methylation in reciprocal cross ESCs. Further focused studies on candidate ASMs from 
two loci, Hcn2 (epilepsy and chronic pain) and Park7 (Parkinson’s disease), revealed a new paradigm. 
Genetic variation in Cast allele at Hcn2 locus introduces a transcription factor binding site for MTF-1 that 
coincides with a predisposition for allelic hypomethylation in a reciprocal cross with either C57 or 129 
strains, whereas genetic differences at Park7 locus do not affect allelic ratio of highly and lowly methylated 
reads. That is, each allele of the latter exhibits similar propensity to be either hypo- or hypermethylated, 
suggesting a “random, switchable” ASM. Together with published results, our data on ASMs raise a 
possibility of regional “autosomal chromosome inactivation (ACI)”-like mechanism controlling a subset of 





Environmental factors impact human health (Dai and Wang, 2014; Jirtle and Skinner, 2007; 
Rappaport and Smith, 2010). For example, a high fat diet contributes to the pathogenesis of obesity and 
type 2 diabetes (Heydemann, 2016; Leung et al., 2016), and low nutrition during early embryonic 
development may link to cardiovascular diseases in later life (Barker and Osmond, 1986); and exposure to 
endocrine disrupting chemicals such as Bisphenol A increases the susceptibility to diseases including 
neurological disorders (Nakagami et al., 2009; Perera and Herbstman, 2011; Zhou et al., 2009), heart 
diseases (Lang et al., 2008; Melzer et al., 2010) and cancers (Acevedo et al., 2013; Bindhumol et al., 2003; 
Dhimolea et al., 2014; Fenton et al., 2012; Ho, 2006; Jenkins et al., 2009; Maffini et al., 2006; Prins and 
Ho, 2010; Soto et al., 2013; Tang et al., 2012; Weinhouse et al., 2014). These factors contribute to disease 
pathogenesis, largely via epigenetic mechanisms (Choi and Friso, 2010; Dai and Wang, 2014; Feil and 
Fraga, 2012; Jirtle and Skinner, 2007; Leung et al., 2016). Altered epigenetic patterns have been involved 
in numerous human diseases. A notable example is that cancer cells are characterized by genome-wide 
hypomethylation and region-specific hypermethylation. Additional examples include abnormal 
hypomethylation of genes involved in autoimmune diseases such as systemic lupus erythematosus (Jeffries 
and Sawalha, 2011). For mechanistic insights of such alteration in diseases, investigators have been 
focusing on exposure-induced changes in expression or function of DNA methyltransferases (DNMTs) 
(Choi and Friso, 2010). Many publications report altered expression of DNMT1, the maintenance enzyme 
for transmitting DNA methylation patterns in generations of somatic cells (Choi and Friso, 2010). 
However, DNMT-dependent alterations of DNA methylation in diseases remain to be determined. A 
systematic examination of DNMT-dependent methylation regions via global profiling of DNMT-deficient 
cells will significantly improve our understanding of such alterations in diseases. 
Imprinted genes are associated with monoallelic methylation and monoallelic gene expression. As 
such, they are considered particularly vulnerable to environmental exposure (Lambertini, 2014; Murphy 
and Hoyo, 2013; Susiarjo et al., 2013). Monoallelic expression of imprinted genes is controlled by germline 
allele-specific methylation (ASM; traditionally called as differentially-methylated-region (DMR)). For 
these germline ASMs (gASMs), CpG sites at the imprinting control regions of one parental allele are 
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methylated, whereas these of another allele are unmethylated. When examined by bisulfite Sanger 
sequencing, half of PCR clones in those regions are hypermethylated and half are hypomethylated, thereby 
showing bimodal methylation patterns. Importantly, these gASMs/DMRs are considered stable during the 
cycles of global demethylation and remethylation during early embryo development (Bartolomei and 
Ferguson-Smith, 2011). Once these ASMs have been altered due to exposure in sperms and/or oocytes, 
such alteration could be carried as “epigenetic memories” to somatic cells. Numerous studies focus on the 
alteration of these ASM-controlled imprinted genes for understanding of “developmental origin of adult 
disease” and “transgenerational epigenetic inheritance” of disease (Martos et al., 2015; Murphy and Hoyo, 
2013). However, most current studies use a candidate approach that targets several imprinted ASMs (or 
imprinted genes), particularly Igf2 (Murphy and Hoyo, 2013). For example, in a widely cited study, the 
methylation level of several CpG sites of Igf2 ASM from Dutch famine patients was shown to be 
maintained after decades (Heijmans et al., 2008). Limited work has been done to systematically examine all 
gASMs, including their exact sizes and the possibility of unknown gASMs. Such a genome-wide 
examination will be helpful for understanding the pathogenesis and diagnosis of human 
diseases/syndromes. 
In addition to the above-mentioned parent-of-origin specific monoallelic expression, the 
mammalian genome has a surprisingly large number of genes showing random monoallelic expression 
(RME) (Deng et al., 2014; Eckersley-Maslin et al., 2014; Gendrel et al., 2014; Lo et al., 2003; Yan et al., 
2002). Although genetic variants can affect expression, such monoallelic expression is unexpected, as the 
conventional notion is that non-imprinted genes on autosomal chromosomes should be either bialellically 
expressed or biallelically repressed. Monoallelic gene expression was previously thought to occur only at 
imprinted loci or genes from X chromosomes for which one chromosome (paternal or maternal) is 
randomly inactivated in females (Tycko, 2010). However, recent studies found that the monoallelic 
expression of non-imprinted, autosomal genes does not seem to be a sporadic phenomenon, but a conserved 
feature in both the mouse genome (Deng et al., 2014; Eckersley-Maslin et al., 2014; Gendrel et al., 2014) 
and the human genome (Lo et al., 2003; Yan et al., 2002). While RMEs seem to occur frequently, the 
underlying mechanism remains elusive. Two recent investigations suggest epigenetic mechanism cannot 
account for RME (Eckersley-Maslin et al., 2014; Gendrel et al., 2014). In addition, the role of 
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monoallelically expressed genes in both development and diseases such as cancers (Chen et al., 2008) 
needs urgent investigation (see the significance as exemplified by this work later).  
Monoallelic methylation (i.e., imprinted ASM) or expression has been provided as a rationale to 
explain why imprinted genes are susceptible to nutritional and environmental influences. With similar 
monoallelic methylation/expression, it is reasonable to expect that other ASMs or RMEs would 
demonstrate similar vulnerability. However, the molecular explanation for these expectations remains to be 
fully explored. Early studies have identified several gASMs as highly DNMT1-dependent in 
preimplantation embryos (Tucker et al., 1996). Specifically, global methylation substantially recovered in 
‘rescued’ DNMT1-deficient embryonic stems cells (ESCs), whereas the methylation at several gASMs, 
which had been abolished in DNMT1-deficient ESCs, was not restored in ‘rescued’ DNMT1-deficient 
ESCs (Tucker et al., 1996). Notably, while DNMT1-deficiency is embryonic lethal (Li et al., 1992), 
‘rescued’ DNMT1-deficient ESCs could contribute to viable adult chimeras (Tucker et al., 1996). In 
contrast, overexpression of DNMT1, which resulted in de novo methylation at the unmethylated allele of 
Igf2, was embryonic lethal (Biniszkiewicz et al., 2002). Taken together, these early studies suggest that 
while DNMT1 is required to maintain imprinted ASMs, hypermethylation is not compatible with 
embryonic viability, whereas hypomethylation of the methylated allele for some gASMs may be tolerated. 
If the finding of DNMT1-dependent DNA methylation loss in preimplantation embryos can be extended to 
additional imprinted gASMs, then this apparent vulnerability could provide an alternate explanation for 
why gASMs of imprinted genes are considered especially susceptible to environmental influences. Yet, this 
raises the question as to which of two epigenetic attributes, DNMT1-dependence or allelic methylation, 
renders gASMs susceptible to environmental stressors. Furthermore, it raises the question as to whether 
additional genomic regions display non-restorable DNMT1-dependent methylation loss. 
To provide mechanistic insights for questions above, herein we investigate regions throughout the 
genome that exhibit DNMT1-dependence and/or have bimodal methylation patterns. We begin with 
examining DNA methylation patterns associated with genomic imprinting, which is complementary to our 
previous investigation of methylation patterns associated with gene transcription and genome stability (i.e., 
suppression of transposable elements) (Li et al., 2015). Based on the loss of gASMs/DMRs in Dnmt1 
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knockout (1KO) ESCs and failure to restore the loss in 1KO cells with exogenous expression of Dnmt1 
cDNA, we developed a new approach, “non-rescued DMR (NORED)”, identifying genomic regions 
dependent on DNMT1. Among these regions, many are bona fide imprinted gASMs with the expected 
bimodal methylation patterns, as unveiled by our “MethylMosaic” analyses. In addition to the known 
imprinted gASMs, MethylMosaic analyses also identify genomic regions showing bimodal methylation 
patterns. We next generate four independent mouse ESC lines from hybrid mice and demonstrate that some 
NORED regions with bimodal methylation patterns show allelic methylation, but in a parent-of-origin 
independent fashion. Intriguingly, genetic differences at Hcn2/Polrmt locus predisposed Cast allele to be 
hypomethylated in cross with either 129 or C57, whereas genetic differences at Park7 locus did not. Their 
shared features (e.g., allelic hyper-/hypomethylation) with X chromosome inactivation (XCI) raise the 
possibility that many genes on autosomal chromosomes are controlled by regional “autosomal chromosome 
inactivation (ACI).” 
2. Results 
All gASMs are lost in DNMT1-deficient ESCs, whereas specific loci exhibit resistance to methylation loss 
in DNMT3a/3b-deficient ESCs 
To determine DNA methylation patterns’ impacts on gene transcription, genome stability, and 
genomic imprinting, we have characterized the base resolution DNA methylomes of wild type (WT, J1 
ESC line) and DNMT-deficient ESCs, including the loss of maintenance DNMT1 (Dnmt1-/-, 1KO), of two 
de novo DNMT3a/3b (Dnmt3a-/-/3b-/-, DKO), and of all three (Dnmt1-/-/3a-/-/3b-/-, TKO; Supplemental Fig. 
S2.1A–B, D–E). Genome-wide, average methylation was 0.727, 0.176, 0.157, and 0.006 in WT, 1KO, 
DKO, and TKO, respectively. Previously, we reported on the distinct roles of DNMT1-dependent and -
independent methylation patterns in suppression of transposable elements and the complete 
hypomethylation on induction of only small number of genes in the mouse genome (Li et al., 2015). Herein 
we focused our study on DNA methylation patterns at imprinted loci.  
DNA methylation is essential for genomic imprinting (Branco et al., 2008; Li et al., 1993). To 
determine the extent to which gASMs are dependent on maintenance DNMT1 or de novo DNMT3a/b for 
	
 32 
methylation maintenance, we compared the methylation levels of 21 well-characterized gASMs found in 
common between two sources (Arnaud, 2010; MacDonald and Mann, 2013) among WT, 1KO, DKO, and 
TKO ESCs (Fig. 2.1A and Supplemental Table S2.1). Except for 1KO versus DKO, pairwise comparisons 
were significant (Bonferroni corrected p < 0.05). Methylation levels of imprinted gASMs were significantly 
reduced in 1KO, DKO, and TKO compared to WT (Bonferroni corrected p = 1.1 x 10-5; Fig. 2.1A and 
Supplemental Table S2.1). Compared to TKO, imprinted gASMs had significantly higher methylation in 
both 1KO (Bonferroni-corrected p = 5.7 x 10-6) and DKO (Bonferroni-corrected p = 6.3 x 10-4; Fig. 2.1A 
and Supplemental Table S2.1). However, methylation of imprinted gASMs did not differ significantly 
between 1KO and DKO (Bonferroni-corrected p = 0.085; Fig. 2.1A and Supplemental Table S2.1). 
Therefore, in general, methylation maintenance at known gASMs is dependent on activity from DNMT1 
and DNMT3a/3b in ESCs. 
Targeted studies at a few gASMs have reported “near complete” abolishment of allelic 
methylation upon the loss of DNMT1 in preimplantation embryos (Biniszkiewicz et al., 2002; Hirasawa et 
al., 2008). To compare these reported results with our findings, we examined the methylation level at 
individual loci. Although “near complete” methylation loss was not quantitatively defined (Hirasawa et al., 
2008), loci presented had at most five percent methylation. From our data of 1KO ESCs, only two gASMs 
had greater than five percent methylation: Rasgrf1 (12.2%) and H19 (6.6%; Fig. 2.1A and Supplemental 
Table S2.1). Methylation at other imprinted loci, including Gtl2 (Meg3) and Mest, is indeed abolished (Fig. 
2.1A–C and Supplemental Table S2.1). This is consistent with reports that DNMT1 is necessary for the 
maintenance of imprinted gASMs (Biniszkiewicz et al., 2002; Hirasawa et al., 2008). 
Contrary to the indispensable role of maintenance DNMT1 above, de novo activities of 
DNMT3a/3b were reported to be dispensable for the maintenance of two paternally methylated DMRs, H19 
and Gtl2, as neither DMR was affected. For another paternally methylated locus, Rasgrf1, the reduced 
methylation was attributed to an unusual repeat structure at this region (Hirasawa et al., 2008). However, 
using our base-resolution methylome data (which covers the entire gASM instead of a portion as in 
(Hirasawa et al., 2008)), we found that methylation at H19 and Rasgrf1 was substantially reduced, whereas 
Gtl2 only decreased by 0.18 (Fig. 2.1A–B and Supplemental Table S2.1). In total, eight gASMs (which 
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represent both maternally and paternally methylated loci) had greater than five percent methylation in DKO 
(DNMT3a/3b-deficient and DNMT1 intact) ESCs: Gtl2 (30.6%), Peg13/Trappc9 (16.2%), Rasgrf1 
(15.9%), Peg3 (15.0%), Inpp5f-v2 (12.7%), H19 (12.3%), Plagl1 (9.5%), and Nespas-GnasXL (8.1%; 
Supplemental Table S2.1). Strikingly, Mest and remaining gASMs were completely abolished (Fig. 2.1A, C 
and Supplemental Table S2.1), suggesting an indispensable role of DNMT3a/3b in the maintenance of 
certain gASMs.		
 
Figure 2.1 Germline ASMs (gASMs) are lost in DNMT1-deficient ESCs, whereas specific loci exhibit 
resistance to methylation loss in DNMT3a/3b-deficient ESCs. (A) Genome-wide profiling of gASM 
methylation level in WT and DNMT mutant mouse ESCs. Each line represents a single gASM. Eleven 
gASMs (unlabeled) have average methylation levels consistent with expectation for one methylated allele 
and one methylated allele in WT, experience near complete loss of methylation in 1KO and DKO, and 
complete methylation loss in TKO. Rasgrf1 and H19 gASMs have methylation levels somewhat higher 
than expectation for one methylated allele and one methylated allele in WT, retain partial methylation in 
1KO and DKO, and experience complete loss of methylation in TKO. Six gASMs (Peg13, Gtl2, Peg3, 
Inpp5f-V2, Plagl1, and Nespas-Gnas XL) have methylation levels consistent with expectation for one 
methylated allele and one methylated allele in WT, experience near complete loss of methylation in 1KO, 
retain partial methylation in in DKO, and experience complete loss of methylation in TKO. Gnas 1A has 
partial methylation in WT and experiences near complete loss of methylation in WT, 1KO, and TKO. 
Slc38a4 has low methylation in in WT, 1KO, DKO, and TKO. Genome-wide, average methylation was 
0.727, 0.176, 0.157, and 0.006 in WT, 1KO, DKO, and TKO, respectively. See Supplemental Table S2.1 
for locus-specific methylation levels. (B) Gtl2 gASM is abolished in 1KO cells. In contrast, DKO cells 
retain partial methylation patterns. (C) Methylation at Mest locus is completely abolished in both 1KO and 
DKO cells. (B–C) Blue bars indicate NORED regions. Gray bars indicate gASMs. 
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Altogether, we conclude that DNMT1 is necessary, but not sufficient to maintain methylation at 
gASMs and specific loci exhibit partial resistance to methylation loss in the absence of DNMT3a/3b. These 
facts reveal the previously unappreciated coordination between de novo and maintenance activities to 
maintain methylation patterns. These facts are different from the traditional view/model of ‘DNMT3a/3b 
for initiating methylation and DNMT1 for maintaining afterward.’	
Loss of methylation was not rescued at gASMs  
Recognizing that important gASMs require DNMT1 for maintenance of DNA methylation, we 
wondered whether loss of methylation at these loci could be restored once it had been abolished. Literature 
search indicated that exogenous expression of Dnmt1 cDNA did not restore methylation at a few gASMs 
(Biniszkiewicz et al., 2002). To extend this finding to other well-characterized gASMs, we expressed 
Dnmt1 cDNA in 1KO cells to characterize the base resolution DNA methylome of ‘rescued 1KO’ ESCs 
(Dnmt1-/- + Dnmt1 cDNA, r1KO; Supplemental Fig. S2.1C). Global average methylation in r1KO (0.369) 
increased to approximately 50.8 percent of WT levels, whereas average 1KO levels were 24.1 percent that 
of WT (Supplemental Fig. S2.1F). Therefore, we consider global methylation to be substantially restored in 
r1KO ESCs. In contrast, average methylation for gASMs decreased to 0.023 (5.4 percent of WT levels at 
these loci) in 1KO and recovered to only 0.045 (10.8 percent of WT levels at these loci) in r1KO (Fig. 2.2A 




Figure 2.2 Loss of methylation was not rescued at gASMs and other specific loci. (A) Profiling of 
gASM methylation level in 1KO and DNMT1-rescued 1KO (r1KO) ESCs. For most gASMs, low 
methylation in 1KO is not substantially increased by exogenous expression Dnmt1 cDNA in r1KO ESCs. 
Genome-wide, average methylation was 0.369 for r1KO cells. See Supplemental Table S2.3 for locus-
specific details. (B) False discovery rate of NORED. (C) The 19 gASMs rank among top 29 NORED 
regions. (D) Deficiency of methylated CpG sites (red bars) in 1KO and DNMT1-rescued 1KO cells can be 
used to identify and demarcate the known Peg3 DMR. (E) NORED identifies Gipr/Eml2 locus (imprinted 
status unknown). (F) NORED identifies, gASM in Inpp5f locus. (G) NORED improves the demarcation of 
gASMs for Prader-Willi and Angelman syndromes (Snrpn/Snurf) (H) NORED demarcates larger region at 
Kcnq1/Kcnqot1. (I) NORED successfully identifies gASM and somatic ASM at the H19/Igf2 locus. (D–I) 







NORED: genome-wide detection of DNMT1-dependent methylation that is not recovered once abolished 
We took advantage of the previous observation to develop NORED, a new method to 
systematically identify genomic regions with non-rescued DMR. These NORED regions must have 
sufficient methylation in WT, near complete loss of methylation in 1KO, and minimum recovery of 
methylation in r1KO. We performed a receiver operating characteristic (ROC)-like analysis using a 
permutation-based approach to estimate the false positives at various methylation cutoffs for WT, 1KO, 
and r1KO ESCs (Supplemental Fig. S2.2A). At a false positive rate (FPR) of 0.01, 70 percent of CpG sites 
within gASMs had at least 25 percent methylation in WT, at most 5 percent methylation in 1KO, and at 
most 12.5 percent methylation in r1KO (Supplemental Fig. S2.2A). By contrast, genome-wide only 3.3 
percent of CpG sites met these criteria. We then clustered individual CpG sites into regions and ranked the 
resulting NORED regions based on the number of CpG sites included and the proportion of consecutive 
CpG sites that met the criteria (see Methods). To determine the false discovery rate (FDR) for NORED, we 
applied the clustering and scoring algorithms to permuted data and estimated the average FDR based on 
twenty permutations. 
NORED analyses identified 2468 regions at FDR = 0.02 (Fig. 2.2B, Supplemental Fig. S2.2B, and 
Supplemental Table S2.2). The highest ranked 207 regions (FDR < 5 x 10-3) are presented in Table 2.1. 
Only two gASMs, Slc38a4 and Gnas 1A, were not identified by NORED because neither of these regions 
had sufficient methylation in WT (Fig. 2.1A). Strikingly, all remaining 19 established gASMs had at least 
one NORED region within the highest 29 ranked regions (FDR < 6.8 x 10-4; Fig. 2.2B–C and Supplemental 
Fig. S2.2B).  
As exemplified by gASMs of Peg3, Inpp5f, Snrpn/Snurf, Kcnq1ot1/Kcnq1, and H19 from 
chromosome 7, NORED identified well-established gASMs (Fig. 2.2D, F–I) and potential gASMs 
(MacDonald and Mann, 2013) at Cdh15 (Chr 8qE1) and Nnat/Blcap (Chr 2qH1) (Table 2.1). At Peg3, 
NORED detected two regions overlapping the known gASM (gray bar in Fig. 2.2D): one 646 bp region that 
aligns with the established gASM start site and a second 4.2 kb region that covers the majority of the 4.5 kb 
gASM, but extends beyond the end site (Fig. 2.2D). At Inpp5, a single 1.1 kb NORED region covers the 
majority of the 1.4 kb gASM (Fig. 2.2F). Our NORED analyses defined two tandem ASMs of the 
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Snurf/Snrpn locus as 2.1 kb and 3.3 kb, respectively (Fig. 2.2G). Three NORED regions of 1.7 kb, 116 bp, 
and 1.6 kb were detected at Kcnq1ot1/Kcnq1, extending beyond the 2.1 kb gASM (Fig. 2.2H). H19 had a 
2.4 kb NORED region within the larger reported gASM (7.3 kb; Fig. 2.2I). NORED regions were also 
detected for Rasgrf1: one small (104 bp) within the 8.0 kb gASM and one larger 2.0 kb region extending 
beyond the end site of the gASM (Table 2.1 and Supplemental Table S2.2). 
Additional regions near, but not overlapping with known gASMs were discovered at Mest and 
Gtl2 (Meg3) (Fig. 2.1B–C, Table 2.1). NORED also identified additional imprinted ASM that are not 
considered gASM (Thorvaldsen et al., 2002), such as somatic ASM at H19 promoter (774 bp; Fig. 2.2I). 
Furthermore, we identified a 1.8 kb NORED region near Gab1, which is reported to have imprinted gene 
expression (Babak et al., 2015); however, no gASM close to this region on Chr 8qC2 has been reported 
(Table 2.1). Finally, NORED identified regions with unknown imprinting or ASM status, as exemplified by 
the 178 bp, 1.1 kb, 170 bp, and 91 bp intergenic regions between Gipr and Eml2 (Fig. 2.2E). This locus is 
within Chr 7qA3 and the nearest known gASM (Peg3/Usp29) is upstream within Chr 7qA1; the nearest 
downstream known gASM (Snrpn/Snurf) is within a Chr 7qB5. The boundaries of known ASMs and other 




Table 2.1 Identification, demarcation, and characterization of highest ranked NORED 












































* Indicates that NORED region overlaps bimodal (MethylMosaic) region 
Bold indicates NORED region overlaps known imprinted germline DMR 
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Table 2.1 (continued) Identification, demarcation, and characterization of highest ranked NORED 











































* Indicates that NORED region overlaps bimodal (MethylMosaic) region 
Bold indicates NORED region overlaps known imprinted germline DMR 
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Table 2.1 (continued) Identification, demarcation, and characterization of highest ranked NORED	
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* Indicates that NORED region overlaps bimodal (MethylMosaic) region 
Bold indicates NORED region overlaps known imprinted germline DMR 
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Table 2.1 (continued) Identification, demarcation, and characterization of highest ranked NORED 











































* Indicates that NORED region overlaps bimodal (MethylMosaic) region 
Bold indicates NORED region overlaps known imprinted germline DMR 
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Table 2.1 (continued) Identification, demarcation, and characterization of highest ranked NORED 






































* Indicates that NORED region overlaps bimodal (MethylMosaic) region 




MethylMosaic: genome-wide detection of bimodal methylation 
As described above, identified NORED regions include known imprinted gASMs, which have 
bimodal methylation patterns. To characterize genomic regions that have potential to exhibit allelic 
methylation patterns, we sought a genotype-independent approach that could be applied in homozygous 
WT ESCs such as J1 ESC line. The bimodal distribution of methylation patterns has long been used in 
conventional bisulfite Sanger sequencing to validate ASMs. Stimulated by the concept and experimental 
design, we implemented a computational program, MethylMosaic, to exploit the bimodal methylation 
patterns that are characteristic of imprinted ASMs. Notably, approaches based on similar concept have 
successfully identified ASMs (Fang et al., 2012; Peng and Ecker, 2012).  
To identify bimodal regions by ‘MethylMosaic,’ we first calculated the read-level methylation and 
then the proportion of hypomethylated reads (hypomethylation index) and the proportion of 
hypermethylated reads (hypermethylation index) around each CpG site within the mouse genome. We then 
determined the true positive rate (TPR; 21 well-characterized gASMs considered as true positives) for 
various cutoffs of hypo- and hypermethylation indices to identify bimodal CpG sites (see details in 
Methods). To calculate the FPR, we simulated ten null datasets by shuffling the methylation calls among 
reads at CpG positions. Importantly, the randomization of methylation among reads at each CpG site has 
the potential to alter read-level methylation, but keeps the CpG-level methylation intact. We calculated 
hypo- and hypermethylation indices and applied cutoffs (as described above) to identify bimodal CpG sites 
for null datasets, which were considered false positives. The FPR for each cutoff range was determined by 
averaging the FPR from null datasets. Based on the ROC curve, we selected the range from 0.2 to 0.75 as 
the bounds for hypermethylation and hypomethylation indices (Supplemental Fig. S2.3A). For the WT 
dataset and the null datasets, we clustered individual CpG sites into regions and ranked regions by the 
number of CpG sites. Null datasets were used to determine region-level FDR. 
MethylMosaic analyses identified 2487 regions as bimodal at FDR = 0.20 (Fig. 2.3A, 
Supplemental Fig. S2.3B, and Supplemental Table S2.3). Consistent with NORED, neither Slc38a4 nor 
Gnas 1A were identified as bimodal, presumably due to low methylation in WT (Fig. 2.1A). All remaining 
19 established gASMs were among the highest 32 ranked regions (FDR < 3.85 x 10-3; Fig. 2.3A–B and 
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Supplemental Fig. S2.3B). Of Peg3/Usp29 ASM, 166 consecutive CpG sites met criteria for hyper- and 
hypomethylation index cutoffs. From overlapping reads of CpG-centered windows, we retrieved 674 reads 
covering 169 CpG sites; 427 of those reads contained at least three CpG sites per read (Fig. 2.3C). 
Compared to 20–40 PCR clones in Bisulfite Sanger sequencing, hundreds of reads (up to 674 reads here) 
demonstrate the robustness of MethylMosaic. MethylMosaic also revealed bimodal distribution of hyper- 
and hypomethylated at Gipr/Eml2, Hcn2/Polrmt, Errfi1/Park7, and Hus1b/Exoc2 (Fig. 2.3D–G). At these 
four loci, we retrieved 151, 126, 168, and 83 reads having at least three CpG sites from 248, 163, 254, and 
146 total reads, respectively. 
Characterization of genomic loci that are NORED and have bimodal methylation 
As expected, both NORED and MethylMosaic identified 19 well-characterized gASMs. To 
characterize the extent to which other NORED regions have potential to exhibit allelic methylation 
patterns, we compared approximately 2500 regions presented for each method. Comparison demonstrated 
that only 8.4 percent (207) of 2468 NORED regions overlapped at least one bimodal region and only 2.2 
percent (152) of 2487 bimodal regions overlapped at least one NORED region (Supplemental Fig. S2.4A–
B). Therefore, the majority of NORED regions were not bimodal (Supplemental Fig. S2.4A).  
To rule out the possibility that the low rate of NORED that are also bimodal is driven by the 
number of regions presented for each method, we determined the proportion of bimodal NORED regions at 
multiple FDRs for MethylMosaic. For 2468 NORED presented in Supplemental Table S2.2, bimodal 
NORED regions would not become the majority of total NORED regions until MethylMosaic FDR = 0.74. 
For the 207 NORED (FDR = 0.005) regions presented in Table 2.1, 50.2 to 71.5 percent would be 
considered bimodal between FDR = 0.42 and FDR = 0.90 for MethylMosaic. We therefore conclude that 
NORED and MethylMosaic are complementary, but independent methods for identifying genomic regions 
with different characteristics. That is, gASM are both NORED and bimodal; however, there are indeed 
other genomic regions that are either NORED or bimodal, but not both. 
Of the top 207 ranked NORED regions presented in Table 2.1, 75 (36.2%) were bimodal. In 
addition to gASMs, NORED regions that had corresponding bimodal regions included Gipr/Eml2, 
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Hcn2/Polrmt, Errfi1/Park7, and Hus1b/Exoc2 (Fig. 2.3D–G). Note, Hus1b ASM is within the intron of 
Exoc2 gene. NORED regions at possible gASM of Nnat/Blcap and imprinted Gab1 were also identified as 
bimodal, whereas potential gASM at Cdh15 was not (Table 2.1). 
Characterization of genes associated with regions that are both NORED and bimodal, exclusively NORED, 
or exclusively bimodal 
Using Chemical and Genetic Perturbations (CGP) gene sets from MSigDB (see Methods), we first 
asked whether genes associated with 2468 NORED regions and genes associated with 2487 bimodal 
regions were enriched in imprinted genes. NORED regions were enriched for imprinted genes (27 genes, q 
= 2.03 x 10-21), whereas bimodal genes did not report imprinted genes within the top 100 enriched gene sets 
(Supplemental Tables S2.4–S2.5). MethylMosaic regions were enriched for the gene set of high CpG 
density promoters bearing both H3K4me3 and H3K27me3 histone modifications (167 genes, q = 1.80 x 10-
53; Supplemental Table S2.5). Notably, for genes associated with 207 regions considered both NORED and 










Figure 2.3 Read-level methylation reveals the bimodal distribution of hyper- and hypomethylated 
reads at gASMs and other NORED loci. (A) False discovery rate of MethylMosaic. (B) 19 gASMs rank 
among top 32 MethylMosaic regions. (C) MethylMosaic of known Peg3 gASM demonstrates the 
robustness of the approach. Peg3 has 674 reads, of which 427 have at least three CpG sites. (D–G) 
MethylMosaic analyses reveals bimodal distribution of hyper- and hypomethylated reads at NORED 
regions that are not established gASMs. (D) Gipr/Eml2 has 248 reads, of which 151 have at least three CpG 
sites. (E) Hcn2/Polrmt has 163 reads, of which 126 have at least three CpG sites. (F), Errfi1/Park7 and has 
254 reads, of which 168 have at least three CpG sites. (G) Hus1b/Exoc2 has 146 reads, of which 83 have at 
least three CpG sites. (C–G) Hypermethylation Index is abbreviated as Hyper-I and Hypomethylation 






To provide insight into potential functional implications for regions detected separately or by both 
NORED and MethylMosaic, we identified enrichment of CGP gene sets for 123, 1427, and 1627 gene 
identifiers associated with 207 bimodal NORED regions, 2261 exclusively NORED regions, and 2335 
exclusively MethylMosaic regions, respectively. Other than imprinted genes, disease-relevant gene sets 
identified for bimodal NORED-associated genes included nasopharyngeal carcinoma (22 genes, q = 5.28 x 
10-6), genes upregulated in mutated KRAS lung cancer model (10 genes, q = 7.69 x 10-4), pancreatic cancer 
(6 genes, q = 4.05 x 10-3), TP53 targets (11 genes, q = 2.24 x 10-2), Alzheimer's disease upregulated genes 
(13 genes, q = 3.07 x 10-2), female fertility (3 genes, q = 9.22 x 10-3) and metabolic syndrome (11 genes, q 
= 2.53 x 10-2; Supplemental Table S2.6).  
NORED exclusive-associated genes were also enriched nasopharyngeal carcinoma (163 genes, q = 
1.92 x 10-31), TP53 targets (113 genes, q = 6.18 x 10-24), Alzheimer’s disease upregulated genes (146 genes; 
1.98 x 10-26), and metabolic syndrome (99 genes, q = 4.06 x 10-16; Supplemental Table S2.7). Enrichment 
for genes hypermethylated in liver cancer (96 genes, q = 4.96 x10-22), lung cancer (43 genes, q = 5.41 x 10-
11), and lymphoma tumors of transgenic mice (16 genes, q = 9.23 x 10-10) was observed only in NORED 
exclusive-associated genes (Supplemental Table S2.7). Furthermore, NORED exclusive-associated genes 
were uniquely enriched in genes characterized by H3K27me3 with polycomb proteins (SUZ12 or EED) 
bound to promoters that experience de novo DNA methylation in cancers (18 genes, q = 6.94 x 10-9; 
Supplemental Table S2.7). 
Similar to bimodal NORED and NORED exclusive regions, MethylMosaic exclusive-associated 
genes were also enriched nasopharyngeal carcinoma (149 genes, q = 1.07 x 10-19), TP53 targets (126 genes, 
q = 3.13 x 10-26), Alzheimer's disease upregulated genes (205 genes, q = 9.61 x 10-52), and metabolic 
syndrome (125 genes, q = 1.31 x 10-24; Supplemental Table S2.8). Enrichment for genes upregulated in 
chronic myleogenous leukemia (151 genes, q = 2.07 x 10-32) and upregulated in uveal melanoma (104 




Independent characterization of genomic regions with bimodal methylation patterns with newly generated 
ESC lines 
We next aim to exploit regions with bimodal methylation patterns with experiments. Four 
scenarios could explain a genomic region bearing bimodal methylation patterns: (1) bona fide imprinted 
ASM (i.e., parent-of-origin dependent and genetics-independent); (2) genetics-dependent ASM but 
independent of parent-of-origin; (3) one allele with hypomethylation (or hypermethylation) in half of cells 
and the same allele with hypermethylation (or hypomethylation) in the remaining half of cells (named as 
switchable ASM); and (4) half of cells with biallelic hypermethylation and half of cells with biallelic 
hypomethylation (see illustration below ).  
To experimentally exploit these identified MethylMosaic regions in the mouse genome, we sought 
hybrid ESC lines with single nucleotide polymorphisms (SNPs) between two alleles for characterizations. 
We are interested in the characterization of genes with potential in neurological disorders. Therefore, we 
focused our validation on two ASMs: Hcn2 with known roles in epilepsy, inflammatory and chronic pain 
(Emery et al., 2011), and Park7 (or DJ-1) for Parkinson’s disease (Bonifati et al., 2003). We first used 
several available ESC lines; however, we did not detect the bimodal methylation patterns (data not shown). 
We reason that because these lines were generated many years ago, multiple passages might result in 
aberrant methylation patterns similar to loss of imprinting described in human ESCs (Rugg-Gunn et al., 
2007). In support of our reasoning, H19/Igf2 ASM was frequently lost in ESC lines (confirmed, data not 
shown). Alternatively, ASMs might be transient (Babak et al., 2015), and the developmental stage of inner 
cell mass might not be appropriate for ASMs. We therefore decided to generate our own mouse ESC lines 
from F1 hybrid mice (129S1/SvimJ and Cast/EiJ or C57BL/6J and Cast/EiJ). 
With DNA from two ESC lines (C57Cast and CastC57), we did bisulfite Sanger sequencing to 
examine methylation status of Hcn2/Polrmt ASM. We tried and succeeded with one pair of primers that 
cover 62 CpG sites, thereby enabling us to have a better insight of Hcn2/Polrmt ASM (Fig. 2.4A). Indeed, 
our data revealed allele-specific DNA methylation patterns: Cast allele (paternal) from C57Cast line was 
hypomethylated (23% methylation), whereas C57 allele (maternal) was hypermethylated (84% 
methylation) (Fig. 2.4A, top panel). Consistently, Cast allele (maternal) from CastC57 line was 
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hypomethylated (22% methylation), whereas C57 allele (paternal) was hypermethylated (71% methylation) 
(Fig. 2.4A, bottom panel). While bimodal methylation patterns are expected according to our 
MethylMosaic analyses (Fig. 2.3E), it is unexpected that this allele-specific methylation pattern is 
independent of parent-of-origin. Whether Cast allele was paternal or maternal copy, it was always 
hypomethylated.  
To reinforce our confidence with our results above, we generated two more ESC lines from strains 
129 and Cast, as biological replicates. Indeed, bisulfite Sanger sequencing data confirmed the allelic 
methylation patterns. Within 129Cast ESC line, 129 allele (maternal) was hypermethylated (74%), and Cast 
allele (paternal) was hypomethylated (17%); Within Cast129 ESC line, Cast allele hypomethylated (16%) 
and 129 hypermethylated (77%) (Fig. 2.4B). Again, the allele specificity of Hcn2 ASM was independent of 
parent-of-origin. Therefore, we conclude that Hcn2 ASM has indeed bimodal methylation patterns, as 
revealed by MethylMosaic data in J1 ESC line and bisulfite Sanger sequencing data in four independent 
ESC lines (129Cast, Cast129, C57Cast, and CastC57), and that Cast allele always has the hypomethylated 









Figure 2.4 Bisulfite Sanger sequencing with four F1 hybrid ESCs confirmed the AMS at 
Hcn2/Polrmt locus. (A–B) The “X” indicates a CpG site not present in allele. (A) The paternal Cast allele 
of ESC line from cross between C57 and Cast (top) was hypomethylated; the maternal Cast allele of ESC 
line from cross between Cast and C57 was hypomethylated (bottom). (B) The paternal Cast allele of ESC 
line from cross between 129 and Cast (top) was hypomethylated; the maternal Cast allele of ESC line from 
cross between Cast and 129 was hypomethylated (bottom). (C) DNA sequence alignment revealed a SNP-






One SNP variant of the Cast allele results in a binding motif for transcription factor at Hcn2/Polrmt ASM 
The hypomethylated Cast allele promoted us to ask whether this biased hypomethylation was 
related to genetic variations. There are three SNP variants around Hcn2 ASM. One variant (cytosine in 
rs240718423 in Cast allele), intriguingly, results in an additional CpG dinucleotide. The resulting sequence 
of TGCGCGC becomes the core consensus sequence TGCRCNC (R=A or G, N=any nucleotide) of a metal 
regulatory transcription factor MTF-1 (Fig. 2.4C). MTF-1 is a pluripotent regulator that regulates cell 
adaptation to various stress conditions (primarily exposure to heavy metal, and stresses of hypoxia and 
oxidative stress) (Selvaraj et al., 2005; Sims et al., 2012). In contrast, TGAGCGC in the allele of 129 or 
C57 is not a binding motif for MTF-1. Whether this MTF-1 predisposes Cast allele to low methylation 
during cycles of demethylation and methylation for the generation of Hcn2 ASM, however, remains to be 
determined. Another variant (adenine in rs259784301 in Cast allele), results in one less CpG dinucleotide 
in Cast than in 129 or C57 alleles (Fig. 2.4A–B). 
The difference of multiple SNP variants may predispose the Cast allele to hypomethylation, 
prompting us to examine the similar possibility of corresponding regions in J1 (inbred 129) ESCs. We did 
Sanger sequencing of PCR amplified products. As expected, the corresponding region did not contain any 
variants at known SNP positions or de novo mutations (Supplemental Fig. S2.5), ruling out the possibility 
of genetic variants in J1 ESCs at this locus. Therefore, we conclude that genetic variations are not 
necessary to render this Hcn2 region with bimodal methylation patterns, but the SNP-associated motif 
introduced in Cast allele may expose it to hypomethylation (Fig. 2.4). 
Independent validations of Park7 ASM reveal a random, switchable ASM 
Simultaneously, we have examined the Park7 ASM (see bimodal methylation in Fig. 2.3F) in four 
new ESC lines. The primers we used cover 18 CpG sites, and methylation status at paternal allele or 
maternal allele showed interesting patterns: Out of 35 PCR clones examined for CastC57 ESC line, 22 
clones were for methylation level (49%) of maternal Cast allele; 13 clones, for methylation level (54%) of 
paternal C57 allele (Fig. 2.5B). Intriguingly, half of clones from either Cast allele or C57 allele were 
hypermethylated or hypomethylated. Out of 24 PCR clones from an independent C57Cast ESC line, 12 
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clones were for methylation level (59%) of maternal C57 allele; the remaining 12 clones, for methylation 
level (43%) of paternal Cast allele. Consistently, about half of 12 clones were either hypomethylated or 
hypermethylated (Fig. 2.5C). Bisulfite Sanger sequencing data from two biological replicates (two ESC 
lines; Cast129 and 129Cast) reproduced observations above (data not shown). These data suggested a 
random, switchable allele-specific methylation pattern.  
Compared to Hcn2 ASM, the genetic differences between Cast allele and C57 or 129 allele of 
Park7 ASM did not result in a new binding motif for a potential transcription factor (data not shown), 
thereby not predisposing one allele for hypomethylation. Without a new binding motif, genetic variations 
of Park7 ASM presumably behave similarly with the Hcn2 ASM in J1 ESC line. The latter has no genetic 
variants. Collectively, we conclude that Park7 ASM indeed shows bimodal methylation pattern, and that 
the differences between Cast allele and C57 (or 129) allele did not result in a preference of one allele for 
hypomethylation.  
Conserved ASM at Hcn2/Polrmt locus in the human genome 
Having demonstrated bimodal methylation patterns of Hcn2/Polrmt ASM in five independent 
mouse ESC lines (J1, 129Cast, Cast129, CastC57, and C57Cast), we next explored the evolutionarily 
conserved ASM at Hcn2/Polrmt locus in the human genome for further validation. Because bimodal 
patterns were detected in five mouse ESC lines, but a recent examination of cortical neurons from the cross 
(129 x Cast) did not find ASM (Xie et al., 2012), we decided to examine human ESC line. In the human 
genome, the human Hcn2 and Polrmt genes have convergent genomic organization, similar to the mouse 
orthologs (Fig. 2.6). We designed two pairs of primers with one inside of the predicted ASM and the other 
outside (Fig. 2.6). Strikingly, monoclonal sequencing reads with 45 CpG sites from the ‘inside’ pairs have 
roughly half hypo- and half hypermethylated reads (Fig. 2.6A). In contrast, all PCR clones from the 





Figure 2.5 Four scenarios for regions with bimodal methylation patterns and Park7 ASM. (A) Four 
scenarios include: bona fide imprinted ASM; genetics-dependent ASM but independent of parent-of-origin; 
one allele with hypomethylation (or hypermethylation) in half of cells and the same allele with 
hypermethylation (or hypomethylation) in the remaining half of cells; and half of cells with biallelic 
hypermethylation and half of cells with biallelic hypomethylation. (B) Half of PCR clones were either 
hypermethylated or hypomethylated from the maternal Cast allele from CastC57 ESC line (left); similarly, 
half of PCR clones were either hypermethylated or hypomethylated from the paternal allele from CastC57 
ESC line. (C) Half of PCR clones were either hypermethylated or hypomethylated from the maternal C57 
allele from C57Cast ESC line (left); similarly, half of PCR clones were either hypermethylated or 




Figure 2.6 Bisulfite Sanger sequencing confirmed that transient DMR at Hcn2/Polrmt locus is 
conserved in the human genome. (A) Bisulfite Sanger sequencing revealed bimodal distribution of hyper- 
and hypomethylated reads. (B) Bisulfite Sanger sequencing revealed fully methylated reads from a 
neighboring control region. (C–D) Bisulfite Sanger sequencing revealed a de novo methylation process to 
cause hypermethylation of CpG sites from the hypomethylated allele upon differentiation of H1 ESCs into 
NPCs (C) or neurons (D). 
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The transient ASM at Hcn2/Polrmt locus participates in early embryonic development 
The observation that cortical neurons did not have a bimodal methylation pattern at Hcn2/Polrmt 
locus (Xie et al., 2012) (data not shown), suggests a role of Hcn2 ASM during development. We then 
examined Hcn2 ASM using in vitro differentiated neuron progenitor cells (NPCs) and neurons derived 
from H1 ESCs. Consistent with mouse cortical neurons, human NPCs and neurons became fully 
methylated, confirming the loss of the bimodal patterns at Hcn2/Polrmt locus upon differentiation (Fig. 
2.6C–D). Therefore, this ASM is transiently presented during early embryonic development. 
3. Discussion 
DNMT1-depenent methylation regions for mechanistic insights of disease susceptibility 
As the predominantly expressed DNMT especially in somatic cells, DNMT1 is the favorite 
enzyme out of three DNMTs for investigation (for example, the development of DNMT1 inhibitor in the 
treatment of cancers), and DNMT1-dependent methylation patterns are presumably important for 
understanding disease pathogenesis. Herein we have used/developed two approaches to characterize 
DNMT1-dependent methylation patterns at genomic regions in the mouse genome. The NORED approach, 
which is a newly developed method in this study, identified 2468 genomic regions dependent on DNMT1 
function. Among them, 207 regions also show bimodal methylation patterns (i.e., also MethylMosaic 
regions). Regions showing bimodal methylation patterns include 19 known imprinted gASMs. Relevant to 
human health, these gASMs and tissue-specific ASMs are particularly vulnerable to environment-induced 
perturbation (Jirtle and Skinner, 2007; Murphy and Hoyo, 2013; Susiarjo et al., 2013). Given the facts that 
gASMs and novel MethylMosaic regions share the feature of allelic methylation patterns, it is reasonable to 
expect that these MethylMosaic regions are also vulnerable to environmental exposure. Indeed, 
unpublished base resolution methylomes of endocrine disruptor-exposed mice reveal many such regions 
were impacted. We therefore expect that these NORED/MethylMosaic regions will be used extensively to 
inform studies in exposed mice in the future.  
Many genes from both NORED and MethylMosaic regions have potential in human diseases. 
Hcn2 (Fig. 2.3E, 2.4, 2.6) is responsible for hyperpolarization-activated cation (HCN) channel, which is 
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linked to the generation of cardiac pacemaker depolarization and the control of neuronal excitability and 
plasticity. Hcn2 is implicated in the pathogenesis of epilepsy (Chung et al., 2009; Ludwig et al., 2003) and 
linked to chronic pain as well (Emery et al., 2011). Polrmt is for mitochondrial transcription (Wanrooij et 
al., 2008). Additional neurological disorders, including Parkinson’s disease at Park7(DJ-1)/Errfi1 locus 
(Fig. 2.3F, 2.5) (Bonifati et al., 2003; Dawson et al., 2010). In addition to neurological activities, novel 
DMRs have potential roles in type 2 diabetes at the Gipr/Eml2 locus (Fig. 2.2E, 2.3D) (Saxena et al., 2010) 
and in cell cycle checkpoint at Hus1b/Exoc2 locus (Fig. 2.3G) (Hang et al., 2002) were identified. 
Altogether, our data open new windows to markedly improve the understanding of many complex human 
diseases (Piedrahita, 2011; Skaar et al., 2012; Smith et al., 2006; Weksberg, 2010). 
While bimodal regions were not reported as being enriched for imprinted genes (not within the top 
100 enriched gene sets from CGP), they were enriched for genes identified as having both active H3K4me3 
and inactive H3K27me3 histone modifications (within the top 5 enriched gene sets; Supplemental Table 
S2.5). This would be consistent with a scenario of allelic methylation, with an unmethylated allele having 
active histone marks and a methylated allele having inactive histone marks. Alternatively, it could be 
explained by a mixed cell population, with half of cells having active epigenetic marks and the other half 
having inactive marks. Notably, DNMT1-dependent regions were enriched for imprinted genes (within the 
top 20 enriched gene sets; Supplemental Table S2.4). Overall our results indicate that MethylMosaic 
identified bimodal regions, but imprinted genes are more obvious in NORED. 
Further reinforcing the importance of recognizing DNMT1-dependent regions for disease, 
NORED exclusive regions uniquely identified genes that are known to become de novo DNA methylated in 
cancer and genes that have previously been reported as hypermethylated in cancer (Supplemental Table 
S2.7). Perhaps reflecting the complexity of neurodegenerative and metabolic disorders, NORED-exclusive, 
MethylMosaic-exclusive, and bimodal NORED were all enriched for Alzheimer’s upregulated genes and 
metabolic syndrome network genes (Supplemental Tables S2.6–S2.8). Importantly, bimodal NORED 
regions were highly enriched in imprinted genes (highest ranked gene set) and uniquely enriched in female 
fertility genes, both of which could have implications ‘developmental origin of adult disease’ and 
‘transgenerational epigenetic inheritance’ (Supplemental Table S2.6). Enrichment analysis of CGP 
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reaffirmed the assertion that allelic methylation and DNMT1-depenence are separate characteristics that 
coincide at gASMs and additional bimodal NORED regions. 
NORED demarcates DNMT1-dependent methylation at ASMs 
Knowing the exact genomic region of an ASM is important to diagnose and understand the 
pathogenesis of imprinting disorders, such as Prader-Willi and Angelman syndromes (Kim et al., 2012; 
Skryabin et al., 2007). Prior examination of patient samples with microdeletions to define the location of 
ASMs is time consuming and limited by the availability of patient samples (Ohta et al., 1999). Systematic 
identification of all ASM sizes and characterization of alterable CpG methylation sites within ASMs in the 
mouse genome will be important (Barbaux et al., 2012; Court et al., 2014; Stelzer et al., 2013; Wang et al., 
2014; Xie et al., 2012). The boundaries for DNMT1-dependent methylation of known ASMs and other 
NORED regions were presented in Fig. 2.2, Table 2.1, and Supplemental Table S2.2. While the overall 
methylation at established gASM regions for both Rasgrf1 and H19 showed partial recovery in r1KO 
ESCs, both had smaller NORED regions, within the larger established gASMs, that were completely lost 
(and not rescued) in DNMT1-deficient cells (Fig. 2.2A, 2.2I). Overall, this suggests two possible scenarios: 
1) that only a subset of CpG sites within germline imprinted loci are NORED or 2) that NORED accurately 
defines CpG sites responsible for regulating parent-of-origin allelic methylation at imprinted loci. We favor 
the latter because it is consistent with the mechanistic understanding that DNMT1 is absolutely critical for 
maintaining parent-of-origin allelic DNA methylation at germline imprints (Biniszkiewicz et al., 2002; 
Hirasawa et al., 2008). 
A mosaic is comprised of smaller subunits from which a larger pattern emerges. Analogously, our 
‘MethylMosaic’ approach reveals DNA methylation patterns at a genomic region that is composed from 
whole genome bisulfite sequencing reads, based on the principles that each sequencing read represents a 
separate DNA molecule (see Methods). By evaluating read-level methylation, as opposed to CpG-level 
methylation, we observe emergent patterns at the molecular level that can be used to provide mechanistic 
insight. While many patterns could be explored, highly methylated and lowly methylated reads–which are 
quantified as hyper- and hypomethylation indices–have been presented here to detect genomic regions with 
bimodal methylation that occurs at ASMs (Fig. 2.3 and Supplemental Table S2.3). 
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By combining DNMT1-dependent DNA methylation loss with the bimodal methylation patterns 
characteristic of allelic methylation, we have presented regions that share epigenetic properties with 
gASMs. Unexpectedly, we identified additional regions (e.g., Park7 and Hcn2) that although both 
vulnerable and bimodal, do not display parent-of-origin dependent allelic methylation in reciprocal cross 
ESCs. While further detailed characterization of novel bimodal NORED regions is needed to examine 
parental and genetic influences on allelic methylation at other loci, we have validated parent-of-origin 
independent bimodal methylation of two loci, Park7 and Hcn2. 
Cross talk between genetics and epigenetics via non-imprinted ASMs in the mammalian genome  
Genetic variations have long been associated with common diseases. Over the past decades, 
numerous genome-wide association studies (GWAS) have been performed for many common diseases, 
including diabetes, autoimmune diseases, and neurological disorders (Simón-Sánchez and Singleton, 2008). 
Allele frequencies of hundreds of common variants are reported as statistically correlated with diseases. 
However, it is controversial whether these variants have biological relevance to disease pathogenesis and 
clinical prognosis or treatment (McClellan and King, 2010; Visscher et al., 2012). 
Contrary to early expectations of SNP variants disrupting protein-coding genes, the vast majority 
(about 88%) of GWAS-identified SNPs reside in intergenic or intronic regions, which puzzle the 
community for understanding their functional relevance. Herein, our investigations provide a clue that a 
single nucleotide difference (rs240718423 in Cast allele; Fig. 2.4C) could have functional relevance. This 
SNP variant may predispose Cast allele to be hypomethylated, whereas the other allele hypermethylated at 
Hcn2/Polrmt ASM. While further investigation is needed for demonstrating the influence of Hcn2/Polrmt 
ASM on the expression of Hcn2 and Polrmt, published data do confirm that the region surrounding this 
ASM is associated with inactive marks including H3K9me3, H4K20me3, and H3K27me3 and Hcn2 
promoter is associated with inactive H3K27me3 (see Fig. 6 in ref. (Mikkelsen et al., 2007)). These inactive 
marks are widely considered as inactive histone marks for repressing gene transcription (Barski et al., 2007; 
Dai and Wang, 2014; Wang et al., 2008). Because Hcn2 is highly expressed in ESCs, these inactive marks 
are expected to be associated with the silent allele (presumably hypermethylated 129 and C57 allele, not the 
hypomethylated Cast allele). Note, the coverage of the published ChIP-seq data was not enough to call 
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allelic chromatin marks (Mikkelsen et al., 2007). Altogether, our results combined with previously reported 
findings reveal a possibility that the difference at one single nucleotide could be amplified through 
alteration of local chromatin structure, thereby changing the fate of a gene on a given allele. 
Regional autosomal chromosome inactivation (ACI): an X-chromosome inactivation (XCI)-like mechanism 
in controlling autosomal genes in mammals? 
Not all genes on the inactivated X chromosome are silenced. In other words, it is a mechanism of 
regional inactivation of X chromosome. The selection of inactivated X chromosome in eutherian 
(placental) mammals, such as mice and humans, involves the transcription of a master regulator Xist (X-
inactive specific transcript), a long non-coding RNA, as well as the expression of antisense Tsix of Xist. 
DNA methylation and inactive histone modification marks are necessary for the inactivation of selected X 
chromosome.  
The feature above resembles that of Hcn2/Polrmt ASM and other ASMs. Methylation of CpG 
sites happens at one allele (e.g., C57 or 129), but not the other Cast allele at the Hcn2/Polrmt locus. 
Inactive histone modification marks including H3K9me3, H4K20me3, and H3K27me3 occupy the ASM 
and regions beyond the ASM (Mikkelsen et al., 2007). Given the fact that Hcn2 is highly expressed in 
ESCs (in report (Mikkelsen et al., 2007) and our own data) and that these three inactive marks are 
associated with silent genes (Barski et al., 2007; Wang et al., 2009), it is reasonable to expect that C57 or 
129 allele (when combined with Cast allele) was the repressed allele. In addition, our unpublished 
observation suggests that Hcn2/Polrmt ASM- (and other ASMs) derived repressive chromatin structure 
extend beyond ASM region. In other words, the ASM-derived repressive chromatin controls the expression 
of genes in a long genomic region, resembling the inhibition of genes by repressive chromatin on 
inactivated X chromosome. The expected switchable feature of some ASMs (at least Hcn2/Polrmt ASM in 
J1 and H1 ESC lines; Park7 ASM in four tested mouse ESC lines) resembles the observation of random 
inactivation of one of the two X chromosomes. Lastly, Hcn2/Polrmt locus also shares the feature of having 
a long non-coding RNA, BC1. Whether BC1 plays similar roles to Xist/Tsix in the case of inactivation of 
one X chromosome or to Kcnq1ot1 in the case of repression of non-imprinted allele at Kcnq1/Kcnq1ot1 
locus, however, requires further investigation. All together, these shared features raise the possibility that a 
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regional autosomal chromosome inactivation (ACI), like XCI mechanism, is controlling some autosomal 
genes. We envision that this ACI acts regionally (i.e., controlling only a subset of genes on a given 
autosome; not entire chromosome) and that these autosomal genes would be centered around the identified 
bimodal MethylMosaic ASMs. A close concept of “parallel to XCI” is also recently proposed from Dr. 
Edith Heard group (Gendrel et al., 2016). 
4. Materials and Methods 
Cell culture, DNMT1-rescued 1KO cells, and human ESC differentiation  
Mouse ES cells were cultured as described before (Li et al., 2015). Briefly, mouse ES cells (J1, 
1KO, DKO, TKO) were maintained without feeder cells on 0.1% gelatin coated Petri dish in DMEM 
medium supplemented with 15% FBS (ES cell grade), 2mM glutamine, 10uM mercapto-ethanol, 100U/ml 
LIF, Penicillin/Streptomycin mixture 100ug/ml, 1X non-essential amino acid. Cultured DNMT1 KO (1KO) 
cells were transfected with constructs expressing GFP-fused DNMT1 (kind gift of Dr. Heinrich Leonhardt 
(Spada et al., 2007)). DNMT1-GFP-rescued 1KO cells were sorted using facility of Bloomberg School of 
Public Health.  
Four hybrid ES cell lines were directly derived from the blastocysts, which were from the 
reciprocal crosses between mice on different genetic backgrounds (e.g., Cross between Cast/EiJ and 
129S1/SvimJ or cross between Cast/EiJ and C57BL/6J). Primary mouse embryo fibroblasts inactivated by 
Mitomycin C were used as feeder cells. ES Cells were expanded on pre-coated plates with 0.1% Gelatin in 
LIF (+) medium on feeder cells and then moved to feeder-free 2i medium (EMD Millipore) to get rid of 
feeder cells.  
The differentiation of human H1 ESCs (Wi Cell, Madison, WI) into neuronal progenitor cells 
(NPCs) and neurons were performed similarly using our developed RONA (rosette-type neural aggregates) 
method (Martin et al., 2014; Xu et al., 2016). Briefly, detached hESC colonies were grown in suspension in 
human ES cell medium without FGF2 (defined as knockout serum replacement medium) in low attachment 
6-well plates (Corning, Corning, NY), supplemented with Noggin (50ng/ml; R&D systems, Minneapolis, 
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MN) or Dorsomorphin (1µM, Tocris Bioscience, Bristol, UK) and SB431542 (10µM, Tocris Bioscience) 
from day 2 to day 6. Free-floating embryoid bodies (EBs) were attached and supplied with N2-induction 
medium (NIM) containing DMEM/F12 (Invitrogen, Carlsbad, CA), 1% N2 supplement (Invitrogen), 100 
µm NEAA (Invitrogen), 1 mM Glutamax (Invitrogen), and heparin (2 µg/ml; Sigma, St. Louis, MO) from 
day 7 to day 16. Highly compact 3-dimensional column-like neural aggregates were collected and 
maintained as neurospheres in Neurobasal medium containing B27 minus vitamin A (Invitrogen), 1 mM 
Glutamax 1 day. For neuronal differentiation, dissociated neurospheres were maintained in neural 
differentiation medium containing Neurobasal/B27 (NB/B27, Invitrogen), BDNF (20ng/ml, PeproTech, 
Rocky Hill, NJ), GDNF (20 ng/ml, Peprotech), ascorbic acid (0.2 mM, Sigma), and dibutyryl cAMP 
(0.5mM, Sigma). 
Bisulfite whole genome sequencing (BS-seq) library construction 
One to five micrograms of genomic DNA of DNMT1-rescued 1KO cells was fragmentized to 
200~500bp by Covaris S2 sonicator (Covaris, USA). End repairing was then performed following 
manufacturer’s instruction (End-It DNA end repair kit, Epicentre, USA). After Ampure XP (Sigma USA) 
purification, adenine was added to 3’ end with 3ml DNA Taq polymerase (M0267S, NEB) and 1mM dATP 
in 50ml reaction solution incubated at 70°C for 30 mins. After Ampure XP purification, 1ml of Illumina 
Trueseq adaptors were ligated with 4ml T4 DNA ligase (M0202L, NEB) in 40ml reaction solution and 
incubated at 16°C overnight. Fragments at 300-600 bp from adaptor-ligated DNA were collected from 2% 
agarose gel, and then bisulfite-treated using Imprint DNA modification Kit (MOD50-1 KIT, Sigma USA) 
as manufacturer instructed. PCR enrichment was performed to amplify the libraries, which were then 
collected from 2% agarose gel electrophoresis at size 300-600bp. Hi-seq 2000 was used for generating all 
deep-sequencing data. 
Data processing of BS-seq data 
Trim Galore version 0.4.0 using Cutadapt version 1.8.1 and FastQC version 0.11.2 was used to 
trim sequencing reads (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/). Bismark version 
0.14.5 (Krueger and Andrews, 2011) implementing Bowtie2 version 2.2.5 (Langmead and Salzberg, 2012) 
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was used to align trimmed reads to using options -N 1 -D 20 -R 3 -X 1000 --chunkmbs 1024. To generate a 
strain-specific reference genome for J1 and J1-derived ESCs, we substituted mouse strain 129S1 SNPs 
from Mouse Genomes Project (Keane et al., 2011) SNP Release version 5 (REL-1505-SNPs_Indels) into 
GRCm38/mm10 genome. Bismark deduplication was used to remove PCR duplicates from aligned pairs 
and Bismark methylation extractor was used to determine the methylation status of cytosines To prevent 
methylation bias at the ends of reads, we removed methylation calls in the first eight base pairs of each read 
(Krueger and Andrews, 2011). R version 3.2.2 was used for post-processing analyses. We merged CpG 
methylation calls on positive and negative strands into single, destranded CpG sites. 
Methylation of 21 well-characterized germline imprinted ASMs (gASMs) 
Well-characterized gASMs were defined as the 21 gASMs identified in common between two 
sources (Arnaud, 2010; MacDonald and Mann, 2013) (Supplemental Table S2.1). Methylation across a 
gASM was calculated as the average of all covered CpG sites. Comparison of methylation in WT, 1KO, 
DKO, and TKO at these loci was determined by pairwise Wilcoxon rank-sum tests (paired) and p-values 
were adjusted for multiple comparisons by Bonferroni method. 
No Restored DMRs (NORED) 
The concept for NORED is that in order for a CpG site to be considered not restorable in DNMT1-
rescued 1KO cells it would need to meet three criteria: 1) that it has sufficient methylation in WT, 2) that it 
experiences near complete methylation loss in 1KO, and 3) that it recovers minimum methylation in r1KO. 
To determine methylation levels in WT, 1KO, and r1KO ESCs to use as cutoffs for these criteria, we 
performed an ROC-like analysis using a permutation-based approach. Only CpG sites from autosomal 
chromosomes with at least 5x coverage in each cell type (WT, 1KO, and r1KO ESCs) were used. To 
estimate the false positives at various combinations of methylation cutoffs for WT, 1KO, and r1KO, we 
simulated twenty null datasets by swapping the cell type labels at each CpG site among the three ESCs. For 
WT, we tested 0.25 and 0.30 as minimum values. For 1KO, we tested 0.03 and 0.05 as maximum values. 
For combinations of WT and 1KO, we tested r1KO between WT and 1KO at increments of 0.005 for 
maximum values. We applied these criteria to null datasets and considered all positives identified as false 
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positives and all negatives as true negatives. FPR for each null dataset was calculated as the number of 
false positives divided by the sum of false positives and true negatives. FPR presented is the average FPR 
for twenty null datasets. We then applied the same cutoff combinations (described above) to the original 
data to identify positives and negatives. At FPR of 0.01, 70 percent of CpG sites within gASMs (defined as 
those in common from two sources (Arnaud, 2010; MacDonald and Mann, 2013)) had at least 25 percent 
methylation in WT, at most 5 percent methylation in 1KO, and at most 12.5 percent methylation in r1KO; 
genome-wide 3.3 percent of CpG sites met these criteria (Supplemental Fig. S2.2A). We therefore chose 
these values as the criteria to use to identify non-restored methylation at CpG sites. 
To identify NORED regions, we developed a simple scoring system to combine nearby non-
restored CpG sites into larger regions, allowing for an occasional restored CpG site to be included. At each 
CpG site, we assigned two points if it met the criteria and one point for each of the two proceeding and two 
following CpG sites that met the criteria, for a maximum point of six points per CpG position. We then 
clustered individual CpG sites in to regions with the regionFinder function from Bump Hunter (Jaffe et al., 
2012), using a cutoff of three points for inclusion. Cumulative score was used to rank regions, thereby 
taking into account both the number of CpG sites and the proportion of CpG sites within the region that 
meet the criteria. To determine the FDR for NORED, we applied the scoring and clustering algorithms to 
the permutated datasets to identify false positive regions. For each unique cumulative score in the original 
data, we calculated the number of regions considered positive at this threshold in the real data and in each 
null dataset. We then divided the number of false positives by the number of positives to calculate the FDR 
for each permuted dataset. The average FDR of twenty null datasets is presented as the FDR for the 
method. 
MethylMosaic 
In diploid organisms, gASM is characterized by one allele being methylated and the other allele 
being unmethylated. Conventional sequencing of PCR clones to confirm gASM prompted us to develop 
MethylMosaic. It is expected that roughly half of sequencing reads (or tags) from these regions carry high 
proportion of methylated CpG sites, while the other half carry high proportion of unmethylated sites, 
leading to a bimodal distribution of methylation at these regions. For regions without gASM, all sequencing 
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reads should have similar proportions of methylated CpG sites since the two parental chromosomes would 
have equivalent methylation level at these loci.  
To calculate read-level methylation for WT ESCs, the methylation of each CpG site within a 
sequencing read was determined by comparing read sequence with reference genome where a conversion 
from Cytosine on reference genome to Thymine on read sequence indicates unmethylated status and no 
such conversion indicates methylation. The overall methylation of a read is calculated by dividing the 
number of methylated CpG sites by the total CpG sites covered by the read.  
Hypomethylation and hypermethylation indices were introduced to identify bimodal regions. For 
each CpG site on autosomal chromosomes in the mouse genome, a window enclosing 300 bp upstream and 
300 bp downstream of that site was defined. Sequencing reads overlapping each window were retrieved 
and hypomethylation index was calculated as the proportion of reads with at most ten percent methylation. 
Similarly, hypermethylation index was calculated as the proportion of reads with at least ninety percent 
methylation. To select values of hypo- and hypermethylation indices to use as criteria to consider a CpG 
site bimodal, we applied various cutoff ranges (combinations of upper and lower bounds) to both hypo- and 
hypermethylation indices. We calculated the TPR as the proportion of 21 well-characterized gASMs, 
defined as those in common from two sources (Arnaud, 2010; MacDonald and Mann, 2013), identified for 
each cutoff range. To calculate the FPR, we simulated ten null datasets by shuffling the methylation calls at 
each CpG site among the reads that cover it. Notably, the randomization of methylation calls among reads 
at each CpG site has the potential to alter read-level methylation only. That is, the methylation at a given 
CpG site remains the same as it was prior to randomization. We calculated hypo- and hypermethylation 
indices and applied cutoff ranges (as described above) to identify the positive CpG sites within the null 
datasets (as described above). Because all positive CpG sites in the randomized data sets were considered 
false positives, we calculated the FPR for each cutoff range as the number of identified CpG divided by the 
number of CpG sites in the genome. The FPR was determined for each cutoff range by averaging the FPR 
from ten null datasets. We selected 0.2 for the lower bound and 0.75 for the upper bound as criteria for both 
hypermethylation and hypomethylation indices based on the ROC curve (Supplemental Fig. S2.3A). That 
is, we considered a CpG site to be bimodal if the proportion of hypomethylated reads within the defined 
	
 65 
window was at least 0.2 and at most 0.75 and the proportion of hypermethylated reads within the defined 
window was at least 0.2 and at most 0.75.  
To cluster individual CpG sites into regions, we combined consecutive bimodal CpG sites. For 
WT data, we ranked bimodal regions by the how many CpG sites were included. For each unique rank (ties 
were assigned to lowest rank), we determined the number of regions that would exceed the threshold for 
quantity of CpG sites within the region (i.e., number of regions considered positive at each rank). For each 
of the randomized data sets we combined individual false positive CpG sites into regions and calculated 
false positive bimodal regions as the number of regions exceeding the CpG site quantity threshold for a 
given rank of WT data. To calculate the FDR for each rank, we divided the number of false positive 
bimodal regions by the number of regions identified as positive in the WT data. FDR was calculated for 
each null data set and averaged to determine the region-level FDR for bimodal regions by MethylMosaic 
method. 
Enrichment Analyses for Chemical and Genetic Perturbations 
MSigDB version 5.2 was used to identify overrepresented gene sets for Chemical and Genetic 
Perturbations from Curated Gene Sets at an FDR less than 0.05 (Subramanian et al., 2005). For each region 
set, all genes overlapping the center of the region, with a transcription start site within +/- 100 bp from the 
center of a region, or nearest the gene (if region is intergenic and does not overlap gene annotations) were 
considered to associated with a region.  
Bisulfite Sanger Sequencing 
DNA was extracted from four hybrid ESC lines, H1 ESCs, H1-differentiated NPC/neurons using 
phenol/chloroform/isoamyl alcohol (25:24:1). About 10 µg of those DNA was bisulfite converted and 
purified by Sigma Aldrich’s Imprint® DNA Modification Kit following manufacturer’s protocol. Exact 2µl 
of the bisulfite converted DNA was used as template for PCR amplification with KAPA HiFi HotStart 
Uracil Plus (Boston) used for the PCR reaction. For Hcn2 ASM mouse amplification, the primer sequences 
were as follows: forward, GGT GTA GTA GGT AGA GTT TGG TTA G and reverse, CTC AAA AAT 
CAC AAA TTA AAA AAA A were used to amplify a 529 bp. For Park7 ASM, the primer sequences were 
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as follows: forward, TTT AGG TGA ATT TTT GGA ATT GTT T and reverse, CCT TCC CTA ACT ACT 
TAA ATT AAC AC were used to amplify a 334bp. Amplicons were ligated to PMD19 vectors (Clonetech) 
with T4 DNA ligase (M0202L, NEB) and transformed into DH-5α competent cells (NEB). Monoclonal 
bacteria colonies carrying the plasmid were cultured and picked up from plates with AMP and X-gal. All 
the colonies were sequenced at the Genewiz (Boston). 
For H1, H1-derived NPCs, and H1-derived neurons, primers based on conserved sequence of 
mouse genome: forward, GAG ATG GTG TAG TAG GT and reverse, ACC AAA TAT TAC ACT TAA 
AAA A were used to amplify a 977 bp fragment inside of the potential DMR in the human genome for 
HCN2 gene. Amplicons were ligated to TA vectors from PCR cloning Kit (Invitrogen) and transformed 
into DH-5α competent cells. Monoclonal bacteria colonies carrying the plasmid were cultured and picked 
up from plates with AMP and X-gal. All the colonies were sequenced at the Beckman Genomic Com 
(Danvers, Massachusetts). Sequenced reads were aligned back to the Bisulfite converted genome sequences 
by Seqman pro (Lasergene). PCR replicates were discarded and methylation for monoclonal reads was 
methylation was determined with BiQ analyzer (Bock et al., 2005). 
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Regional DNA methylation characteristics influence susceptibility to epigenetic 
perturbation from prenatal exposure to Bisphenol A in male fetal livers 
Chapter 3–Regional DNA methylation characteristics influence susceptibility to epigenetic perturbation 





Epigenetic modifications, such as DNA methylation, regulate genomic processes and serve at the 
interface between genes and the environment. Both cell- and tissue-specific regulation of epigenetic 
mechanisms contribute to maintenance of physiological homeostasis. Life stage-specific regulation of 
epigenetic processes is necessary for proper development. Nutritional and environmental exposures that 
alter epigenetic marks can contribute to disease pathophysiology or lead to increased risk for diseases at 
later life-stages. Imprinted genes and transposable elements represent two unique paradigms of epigenetic 
inheritance. As such, determining how the epigenetic marks at these genomic features are affected by 
exposure to environmental pollutants will provide insight into mechanisms of toxicity during critical 
periods of development. We previously reported a division of labor between DNA methyltransferase 
(DNMT) enzymes, DNMT1 and DNMT3a/3b, to suppress distinct types of retrotransposons. Additionally, 
DNMT1-dependent loss of methylation at known imprinted DMRs could not rescued by exogenous Dnmt1 
cDNA expression. To determine whether DNMT1-dependent genomic regions are more susceptible to 
environmental perturbation, we compared fetal liver methylomes from male C57BL/6J mice that were 
exposed in utero to Bisphenol A (BPA) through maternal supplemented diet (0 µg/kg bw/d, 10 µg/kg bw/d, 
or 10 mg/kg bw/d). We found that DNMT1-maintained and non-restorable genomic regions were more 
susceptible to environmental perturbation and had altered CpG methylation in response to BPA exposure. 
1. Introduction 
Early life exposure to nutritional and environmental stressors can influence phenotypes over 
multiple generations. At certain developmental stages during the mammalian lifecycle, up to three 
generations can be simultaneously exposed. That is, maternal exposures during the gestation period can 
affect the mother (F0), the developing fetus (F1), and the germ cells of the developing offspring (F2). 
Intergenerational inheritance refers to the molecular changes and phenotypes that result from direct 
exposure to multiple generations. Transgenerational inheritance occurs when molecular changes and 
phenotypes persist in subsequent generations (e.g., F3) that were not directly exposed to the stressor. 
Epigenetic modifications, such as DNA methylation, have been proposed as possible molecular mediators 
for non-genetic inheritance of environment-induced phenotypes at later life stages and/or across 
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generations. DNA methylation dynamics over the course of the mammalian lifecycle, specifically genome-
wide methylation reprogramming following fertilization and during germ cell specification, serve as a 
barrier for widespread epigenetic inheritance across generations. Nonetheless, parent-of-origin dependent 
methylation/expression of imprinted genes and transgenerational silencing of transposable elements are 
paradigms of epigenetic inheritance.  
Animal models used to explore mechanisms for environment-induced epigenetic changes from 
perinatal exposures have reported altered DNA methylation at several imprinted genes (Iqbal et al., 2015; 
Kang et al., 2014; Susiarjo et al., 2015) and metastable epialleles (Anderson et al., 2012; Dolinoy et al., 
2007b; Faulk et al., 2014). In the viable yellow agouti mouse model, the Avy mutation comes from an 
Intracisternal A Particle (IAP) element, a type of long terminal repeat (LTR) retrotransposon, insertion 
upstream of an endogenous gene that regulates coat color. DNA methylation level at the IAP insertion 
correlates with coat color in Avy/a heterozygotes and is sensitive to environmental pollutants, including 
Bisphenol A (BPA), and nutritional factors (Dolinoy et al., 2006; 2007b). Metastable epialleles with 
observable phenotypes (e.g., Avy and coat color) are used as biosensors for epigenotoxicity because of their 
vulnerability to epigenetic perturbation (Dolinoy, 2008). In addition to DNA methylation at metastable 
epialleles, DNA methylation at other repetitive element loci are used as an indicator of global methylation 
levels (Yang et al., 2004). 
In mammals, three DNA methyltransferase (DNMT) enzymes are responsible for adding methyl 
groups to DNA. DNMT1 is classified as the “maintenance” enzyme because has a preference for 
hemimethylated DNA in vitro (Bestor and Ingram, 1983; Gruenbaum et al., 1982) and localizes to 
replication foci to copy methylation information from parental strands to daughter strands following DNA 
replication (Leonhardt et al., 1992). DNMT3a and DNMT3b are considered “de novo” methyltranferases 
due to their role in establishing new methylation patterns in during embryonic development (Okano et al., 
1999). Once established by DNMT3a/3b in early embryos, methylation patterns will be “faithfully” 
transmitted in subsequent divisions of somatic cells. However, the aforementioned, traditional two-step 
model (i.e., DNMT3a/3b for establishment and DNMT1 for maintenance) does not explain the diversity in 
DNA methylation changes observed throughout the genome in response to environmental or genetic 
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influences. We have previously used mouse embryonic stem cells (mESCs) to show the extent to which 
genomic features depend on DNMT1 or DNMT3a/3b activity to maintain DNA methylation patterns. Most 
genomic features lost substantial methylation in the absence of either DNMT1 or DNMT3a/3b, thereby 
demonstrating that many genomic features rely on activity from both “de novo” and “maintenance” DNMT 
enzymes for maintaining full DNA methylation (Li et al., 2015). However, there appears to be division of 
labor between DNMT1 and DNMT3a/3b to suppress distinct types of retrotransposons in mouse embryonic 
stem cells (mESCs). Specifically, long terminal repeats (LTRs) tend to be maintained by DNMT1, whereas, 
LINEs were maintained by DNMT3a/3b. Our findings lead to an updated “coordination and division of 
labor model” for DNA methylation maintenance. Notably, IAP elements were predominantly DNMT1 
dependent, which suggests the DNA methylation maintenance paradigm at these loci influences their 
susceptibility to epigenetic perturbation from developmental exposures. 
DNA methylation is dramatically reduced at germline imprinted loci in the absence of either 
DNMT1 or DNMT3a/b and methylation at these loci is not restored by expression of exogenous Dnmt1 
cDNA in Dnmt1-/- mESCs (Chapter 2; (Tucker et al., 1996)). Whole genome bisulfite sequencing (WGBS) 
revealed approximately 2500 genomic regions that display this non-rescued DMR (NORED) characteristic 
in mESCs (Chapter 2). Distinct from most of the genome, the paternally and maternally inherited alleles at 
imprinted germline differentially methylated regions (gDMRs) have different methylation patterns (i.e., one 
allele fully methylated and the other unmethylated). The parent-of-origin-dependent allelic methylation at 
gDMRs arises from differential methylation patterns that had been established in male and female germ 
cells. Such allelic methylation at gDMRs is resistant to global demethylation during post-fertilization 
epigenetic reprogramming phase. The property of one-methylated-allele and the-other-unmethylated-allele 
emerges as bimodal methylation patterns (i.e., half of DNA molecules at a locus are methylated and the 
other half are unmethylated), which can be observed with targeted or genome-wide bisulfite sequencing 
methods. Analyses of WGBS data revealed approximately 2500 genomic regions with bimodal methylation 
patterns in mESCs. Approximately 200 NORED regions had bimodal methylation patterns, referred to as 
“bimodal NORED” regions. Bimodal NORED regions were comprised of known imprinted germline 
DMRs and additional loci of unknown imprint status.  
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The unique DNA methylation characteristics observed at germline imprints and retrotransposon 
families, raises the possibility that the epigenetic properties of these regions contribute their apparent 
susceptibility to exogenous factors. To examine the susceptibility of these features to epigenetic 
perturbation, we compared fetal liver methylomes from male C57BL/6J mice that were exposed in utero to 
physiologically relevant doses of BPA through maternal supplemented diet. Dose groups are referred to as 
“control” (0 µg/kg bw/d; n = 3), “lower” (10 µg/kg bw/d, n = 4), and “upper” (10 mg/kg bw/d, n = 4). We 
used previously identified genomic regions — hereinafter referred to as “bimodal exclusive”, “bimodal 
NORED”, “NORED exclusive”, “DNMT1-maintained”, and “DNMT3a/3b-maintained” — based on DNA 
methylation features exhibited in mESCs. We found that CpG sites within these genomic regions had 
higher propensity for altered methylation from prenatal exposure to BPA than CpG sites genome-wide. 
2. Results 
Propensity for altered methylation at CpG-sites in genomic regions with distinct DNA methylation 
characteristics in mESCs 
We examined DNA methylation in control livers and in livers from male mice fetuses that had 
been prenatally exposed to BPA. We focused on five classes of genomic “regions of interest” that had been 
previously identified in mESCs based on either 1) shared epigenetic characteristics observed at imprinted 
gDMRs or 2) distinct DNA methylation maintenance paradigms. Regions with imprint-like characteristics 
can be classified as exclusively bimodal, bimodal NORED, or exclusively NORED. DNMT1-maintained 
and DNMT3a/3b-maintained loci are considered to have distinct DNA methylation maintenance paradigms 
in contrast with the majority of CpG sites genome-wide, which required DNMT1 and DNMT3a/3b 
enzymes for full methylation in mESCs (Li et al., 2015). That is, DNMT1-maintained regions were 
resistant to methylation loss in the absence of DNMT3a/3b and DNMT3a/3b-maintained regions were 
resistant to methylation loss in the absence of DNMT1. Within each region type, overall CpG methylation 
profiles were similar among control, lower and upper groups (Fig. 3.1A and Supplemental Fig. S3.1–S3.5). 
Average CpG methylation percent for bimodal, bimodal NORED, and NORED regions ranged from 64.9 to 
65.5, 48.2 to 49.6, and 53.1 to 54, respectively. DNMT1-maintenance and DNMT3a/3b-maintenance 
regions were highly methylated in all dose groups (Fig. 3.1A and Supplemental Fig. S3.4–S3.5). With the 
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exception of bimodal NORED regions, methylation was slightly higher in the lower dose group relative to 
both control and upper dose groups. In bimodal NORED regions, average CpG site methylation decreased 
as dose increased. 
To determine whether regions displaying distinct DNA methylation characteristics observed in 
mESCs were more susceptible to perturbation from prenatal BPA exposure, we used WGBS data from 
control, lower, and upper dose groups to identify CpG sites with altered methylation genome-wide. We 
defined the altered methylation as being within the lower 0.5th percentile (hypomethylation) or the upper 
99.5th percentile (hypermethylation) of the test statistic for each pairwise comparison. To quantify the 
magnitude of association between CpG sites having altered methylation and residing within a region of 
interest, we use odds ratios (ORs). ORs are a commonly used approach for identifying an association 
between two variables (Edwards, 1963; Mosteller, 1968); Pubmed (NCBI Resource Coordinators, 2016) 
search for “odds ratio” returns over 200,000 results. As opposed to simply determining whether BPA 
altered methylation at CpG sites within our regions of interest, here we used ORs because we wanted to 
determine whether altered methylation was more likely to occur at CpG sites within specific genomic 
regions than CpG sites outside.  For each region class (e.g., bimodal), the odds of a CpG site having altered 
methylation and being within the region class was divided by the odds of a CpG site having altered 
methylation and not being within the region class. ORs were calculated for lower versus control (LvC), 






Figure 3.1 Prenatal BPA exposure altered CpG methylation within bimodal, bimodal NORED, 
NORED, DNMT1-maintained, and DNMT3a/3b-maintained genomic regions. (A) Violin plots of 
methylation profiles for control (n = 3), lower (n = 4), and upper (n = 4) dose groups from male fetal livers 
following in utero exposure to BPA. Bar (—) indicates median; point (n) indicates arithmetic mean. (B) 
Odds ratios for altered methylation at CpG sites within each region compared to CpG sites outside of each 
region for lower versus control (LvC), upper versus control (UvC), and upper versus lower (UvL) 
comparisons. Error bars represent 95 percent confidence intervals corrected for multiple tests (15) via 
Bonferroni method for alpha < 0.05.
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For all comparisons, all region classes exhibited significantly higher odds of having altered CpG 
sites, than genome-wide CpG sites not within the region class (Fig. 3.1B). P-values were adjusted (adj p) 
for multiple tests (15) using Bonferroni method. For bimodal exclusive regions, odds ratios (ORs) ranged 
from 1.87 to 2.12 (LvC: adj p = 1.21 x 10-74, UvC: adj p = 1.61 x 10-105, UvL: adj p = 4.68 x 10-119). For 
bimodal NORED regions, ORs ranged from 4.42 to 7.73 (LvC: adj p = 2.95 x 10-146, UvC: adj p = 1.30 x 
10-104, UvL: adj p = 4.68 x 10-119). For NORED exclusive regions, odds ratios ORs ranged from 1.40 to 
2.24 (LvC: adj p = 4.39 x 10-31, UvC: adj p = 3.35 x 10-55, UvL: adj p = 2.34 x 10-07). For DNMT1-
maintained regions, odds ratios ORs ranged from 1.40 to 2.28 (LvC: adj p = 1.06 x 10-16, UvC: adj p = 8.28 
x 10-22, UvL: adj p = 9.39 x 10-03). For DNMT3a/3b-maintained regions, odds ratios ORs ranged from 1.74 
to 2.63 (LvC: adj p = 6.01 x 10-24, UvC: adj p = 1.92 x 10-11, UvL: adj p = 2.51 x 10-06).  
Strikingly, bimodal NORED regions were most likely to have CpG sites with altered methylation. 
Since known imprinted gDMRs are included among the bimodal NORED regions, we wondered whether 
altered CpG sites were limited to known gDMRs. Examination of altered CpG sites within bimodal 
NORED regions demonstrates that altered methylation occurred in bimodal NORED regions not known to 
be imprinted, as well as in bimodal NORED regions within or near known imprinted gDMRs and (Table 
3.1). While the overall methylation profiles for bimodal NORED regions showed lower methylation with 
increasing dose (Fig. 3.1A), hypermethylated and hypomethylation CpG sites occurred within these 
regions. Overall, CpG sites tended to change in a consistent direction within a locus, but several imprint-
associated loci displayed both localized hypermethylation and hypomethylation within the larger imprinted 
region. 
We next examined the direction of change for CpG sites with altered methylation in DNMT1-
maintained and DNMT3a/3b-maintained regions. Altered CpG sites in DNMT1-maintained regions tended 
to be hypermethylated in lower dose compared to control dose (LvC: 65% of altered CpG sites were 
hypermethylated), but hypomethylated in upper dose compared to either control (UvC: 55% of altered CpG 
sites were hypomethylated) or lower (UvL: 59% of altered CpG sites were hypomethylated) dose. 
Interestingly, the majority of altered CpG sites within DNMT3a/3b-maintained regions were 
hypermethylated in all comparisons (LvC: 56%; UvC: 56%; UvL: 81%).  
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Table 3.1 Bimodal NORED regions with altered CpG site methylation 
Locus Lower vs. Control Upper vs. Control Upper vs. Lower 
Gtl2 (Meg3) ICR*a é ê ê 	 é 	ê 	
Gtl2 (Meg3)b é ê — é 
H19 ICRa ê — — 
H19 promoterb é —	 ê	
Igf2r ICRa —	 é — 
Kcnq1ot1 ICRa é ê é é 
Kcnq1/Kcnq1ot1b é é — 
Nespas-GnasXL ICRa ê ê — 
Peg1 (Mest)a é ê é é 
Peg10a ê ê ê 
Peg10/Sgce promoterb ê — — 
Peg13/Trappc9a é — — 
Peg13/Trappc9b é —	 —	
Rasgrf1 ICRa é — é 
Rasgrfb — —	 é 
Snrpn ICRa é é é ê 
Zrsr1/Commd1 (Murr1)a ê é é 
Zrsr1/Commd1 (Murr1)b ê — — 
H13/Mcts2b — —	 ê	
Ddx39b/H2-L ê — é 
Fhad1 ê — — 
Gm13212 — é — 
Hcn2/Bc1/Polrmt — é — 
Lmna é — — 
Mt3 — — ê 
Nat8l é é — 
Nupr1l ê — — 
Pigk — é — 
Rusc2 ê — — 
Tbcd/Zfp750 é — — 
Tmem40 é — ê 
Trim80 — ê ê 
4930481A15Rik ê	 —	 é 
chr6:127251339-127251463 ê	 —	 — 
chr10:79322231-79322387 é	 —	 — 
chr11:20446254-20446353 é	 —	 — 
* Imprint Control Region 
a Altered CpG site(s) within known germline differentially methylated region  
b Altered CpG site(s) near, but not within known germline differentially methylated region 
é Hypermethylation 
ê Hypomethylation 
é ê Small regions with either hypermethylation or hypomethylation within a larger genomic region  
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Prenatal BPA exposure induced genome-wide and regional shifts in methylation levels 
Genome-wide, methylation of CpG sites was strongly correlated between control, lower, and 
upper exposure groups (Fig. 3.2A–C). The Pearson’s r correlation coefficient for lower compared to control 
or upper was 0.98 (p < 1 x10-13) and the Pearson’s r correlation coefficient for upper compared to control 
was 0.99 (N = 20,041,855 CpG sites, p < 1 x10-13). At the CpG site level, correlation among dose groups 
was high for bimodal (N = 57,827 CpG sites), bimodal NORED (N = 4,014 CpG sites) and NORED (N = 
22,314 CpG sites) regions (Fig. 3.2D). DNMT3a/3b-maintained regions (N = 5,876 CpG sites) had slightly 
weaker similarity and DNMT1-maintained regions (N = 7,913 CpG sites) displayed the weakest similarity 











Figure 3.2 Characterization of genome-wide and regional differences in methylation in BPA-exposed 
and control fetal livers. (A–C) Correlation (Pearson’s r) between methylation at CpG sites genome-wide 
in lower vs. control (A), upper vs. control (B), and upper vs. lower (C). (D–E) Correlation coefficients for 
CpG site- (D) or region-level (E) methylation at five regions types and three comparisons: lower vs. control 
(LvC), upper vs. control (UvC), and upper vs. lower (UvL). (F–H) Bland-Altman plots showing genome-
wide CpG site methylation differences (Δ) between lower and control (F), upper and control (G), and upper 
and lower (H) dose groups. Average methylation (x-axis) indicates the average methylation at a CpG site 
for two dose groups within each comparison. Interquartile range (IQR) represents the middle 50 percent of 
the data as it is calculated by subtracting the 75th percentile and the 25th percentile change in methylation 
values. (I–J) Box plots showing CpG site- (I) or region-level (J) methylation differences for five region 
types and three comparisons: lower minus control (L-C), upper minus control (U-C), and upper minus 






To examine the region-level similarity in methylation between dose groups, we averaged the CpG 
site-level methylation across all CpG sites within each element of a region type. As such, each element of a 
region type has equal weight. Similar to the high correlation in methylation among dose groups observed at 
the CpG site level, bimodal (N = 2319 regions) and NORED (N = 2260 regions) regions displayed high 
correlation in region-level methylation, whereas bimodal NORED regions (N = 207 regions) had somewhat 
higher correlation at the region-level in the LvC comparison (Fig. 3.2E and Supplemental Fig. S3.1–S3.3). 
Both DNMT1-maintained (N = 808 regions) and DNMT3a/3b-maintained regions (N = 484 regions) had 
slightly lower correlations in region-level compared with CpG site-level methylation (Fig. 3.2E and 
Supplemental Fig. S3.4–S3.5). In contrast to genome-wide methylation, upper dose showed higher 
correlation with lower dose than with control in DNMT1-maintained regions (Fig. 3.2D–E). 
To further illustrate that BPA affects genome-wide and regional methylation, we examined the 
distribution of changes in methylation between the dose groups. For change in methylation, we calculated 
the change in methylation for individual CpG sites and report the median and the interquartile range (IQR; 
i.e., difference between 75th percentile and the 25th percentile change in methylation values) for all CpG 
sites. IQR, which encompasses the middle 50 percent of the data, is an indicator of dispersion. We found a 
slight global hypermethylation in lower dose compared to control and upper dose. For LvC, median 
genome-wide change in methylation was 1.2 percent and the interquartile IQR was 4.6 percent (Fig. 3.2F). 
For UvC, median genome-wide change in methylation was -0.06 and the IQR was 3.8 percent (Fig. 3.2G). 
For UvL, median genome-wide change in methylation was -1.2 and IQR was 4.3 percent (Fig. 3.2H). 
Despite a similar direction and magnitude of change in global methylation in lower compared to either 
control or upper dose group, CpG site methylation change varied more between lower and control than 
between lower and upper dose groups. 
We next characterized the distribution of CpG site-level methylation changes in our five regions of 
interest (Fig. 3.2I). For NORED and bimodal regions, median methylation change was less than one 
percent and followed the direction of the genome-wide shift toward slightly increased methylation in lower 
compared to control and upper dose groups. DNMT1-maintained and DNMT3a/3b-maintained regions also 
shifted toward increased methylation at lower dose (approximately two percent compared to either control 
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or upper), but had a larger shift in methylation than observed than genome-wide. Consistent with regional 
methylation profiles (Fig. 3.1A), median CpG site methylation decreased in bimodal NORED regions for 
all comparisons, with the largest shift toward hypomethylation observed in upper dose compared to control. 
For all comparisons, IQRs for difference in methylation among CpG sites were broadest for bimodal 
NORED regions (LvC IQR = 7.6%; UvC IQR = 5.5%; UvL IQR = 4.2 %) and greater than the genome-
wide IQRs. This indicates that methylation at CpG sites in bimodal NORED regions exhibited higher 
variation in BPA-induced methylation changes than CpG sites in other regions. Other regions had IQRs 
less than 5.5 percent, with the highest variation occurring within the LvC comparison for each region. 
NORED and bimodal regions varied least in the UvC comparison. DNMT1-maintainted and DNMT3a/3b-
maintained regions varied least in UvL comparison. 
We next examined the region-level change in methylation for the five region types. For region-
level change in methylation, we averaged the CpG site-level methylation across the CpG sites within each 
element of a region type and then calculated the change in methylation for each element. The median and 
IQR reported, therefore, represent the distribution of methylation differences for elements within each 
region type. At the region level, changes in methylation reflected those at CpG level (Fig. 3.2I–J and 
Supplemental Fig. S3.1–S3.5). That is, NORED, bimodal, DNMT1-maintained, and DNMT3a/3b-
maintained regions followed genome-wide shift toward increased methylation at lower dose, whereas 
bimodal NORED regions were more likely to have decreased methylation at both lower and upper dose 
compared to control. Region-level IQRs for changes in methylation also reflected those at the CpG level 
(Fig. 3.2I–J and Supplemental Fig. S3.1–S3.5). 
Characterization of methylation change at repetitive elements 
Having previously identified LTR-type retrotransposons among regions preferentially maintained 
by DNMT1 (Li et al., 2015), we suspected that the low correlation between dose groups observed in 
DNMT1-maintained regions might be reflected in certain repetitive element families. With the above 
findings in mind, we next examined the region-level methylation for repetitive elements. Correlation was at 
least 0.84 (p < 1 x10-13) for all repeat classes in all comparisons, which is higher than the correlation 




Figure 3.3 Characterization of region-level differences in methylation for repeat classes in BPA-
exposed and control fetal livers. (A–C) Correlation coefficients (A), median (B) and interquartile range 
(IQR) (C) for change (Δ) in methylation for three comparisons: lower vs. control (LvC), upper vs. control 
(UvC), and upper vs. lower (UvL). IQR measures the dispersion of the middle 50 percent of elements in 
each repeat class. DNMT1-maintained and DNMT3a/3b-maintained regions included for reference. 
Question mark (?) indicates uncertainty in classification.  
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Since correlation in DNMT1-maintained regions was weakest between lower and upper dose 
groups, we ranked repeat classes in descending order by Pearson’s r in lower versus control comparison. 
For LvC, Pearson’s r at repeat classes ranged from 0.85 to 0.99 (adj p < 1 x10-13). For UvC, Pearson’s r 
ranged from 0.86 to 0.99 (adj p < 1 x10-13). For UvL, Pearson’s r ranged from 0.84 to 0.99 (adj p < 1 x10-
13). Median methylation change for repeat classes ranged from and increase of 0.7 percent to 2.1 percent in 
LvC, a decrease of 0.6 percent to an increase of 0.3 percent in UvC, and a decrease of 0.8 percent to 2.1 
percent in LvC (Fig. 3.3B). This suggests that repeat classes experienced different propensities toward 
hypermethylation methylation at lower dose. The majority of individual members for each repeat class 
behaved consistently as indicated by low IQRs (Fig. 3.3C).  
Among the mouse retrotransposon classes, short interspersed elements (SINEs) showed the 
highest correlations between dose groups (range = 0.95-0.96, N = 911,561 elements, p < 1 x10-13), followed 
by LTRs (range = 0.91–0.93, N = 618,104, p < 1 x10-13) and LINEs (range = 0.88–0.91, N = 641,607 
elements, p < 1 x10-13; Fig. 3.3A). Our previous work indicated that certain retrotransposon families and 
subtypes had higher propensity to be methylated by DNMT1 (Li et al., 2015), we therefore examined 
correlation and methylation change among families of the retrotransposon classes. Pearson’s r for SINEs 
was at least 0.94, with the highest observed at tRNA-derived SINEs (range = 0.98–0.99, p < 1 x10-13; Fig. 
3.4A). For each comparison, median methylation change was similar across SINE families and IQRs were 
low (Fig. 3.4B–C). LTR retrotransposons showed a broader range of correlation coefficients (range = 0.90 
to 0.97, p < 1 x10-13), with the lowest of 0.90 observed at LTR and ERVL-MaLR in LvC comparison (Fig. 
3.4D). Gypsy, ERVL-MaLR, ERVK, ERVL, and ERV1 had median methylation changes greater than 1.7 
percent in LvC and less than -1.6 in UvL and IQRs less than 5 percent, demonstrating a relatively high 
propensity toward hypermethylation in lower dose group (Fig. 3.4 E–F). LINE families had the broadest 
range of correlation coefficients 0.79 to 0.98 (p < 1 x10-13; Fig. 3.4G). L1, the most prominent LINE family 
in the mouse genome, had the greatest median change in methylation in LvC (+2.03%) and in UvL (-
1.88%; Fig. 3.4H). LINE RTE-BovBs were resistant changes in methylation and had low IQRs in all 




Figure 3.4 Characterization of region-level differences in methylation for mouse retrotransposon 
families in BPA-exposed and control fetal livers. (A–I) Correlation coefficients (A, D, G), median (B, E, 
H) and interquartile range (IQR) (C, F, I) for change (Δ) in methylation at SINE (A–C), LTR (D–F), and 
LINE (G–I) families. Three comparisons are lower vs. control (LvC), upper vs. control (UvC), and upper 
vs. lower (UvL). IQR measures the dispersion of the middle 50 percent of elements in each retrotransposon 
class. DNMT1-maintained and DNMT3a/3b-maintained regions included for reference. Question mark (?) 
indicates uncertainty in classification.  
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LTR subtypes within the ERVK family have been associated with metastable epialleles (Dolinoy 
et al., 2007a) and display high DNMT1-dependence (Li et al., 2015; Okano et al., 1999; Tsumura et al., 
2006). For ERVK LTR subtypes, Pearson’s r ranged from 0.68 to 0.98. Further examination revealed 17 
ERVK retrotransposon subtypes with correlation coefficients at or below 0.80 in any comparison (Fig. 
3.5A). In LvC, 57.1 percent had a median change in methylation of at least 1.89, which indicates that the 
majority of ERVK subtypes had higher overall methylation increase than DNMT1-maintained regions (Fig. 
3.5B). Many ERVK subtypes also exhibited more variation in methylation change at lower dose than 
DNMT1-maintained regions; IQRs were higher than 4.85 for 35.3 percent of ERVK subtypes (Fig. 3.5C). 
Among the LTR ERVK subtypes with relatively low correlation coefficients were IAPEz (LvC: r = 0.68, N 
= 5632 elements, adj p < 1 x10-13) and IAPLTR1 Mm (LvC: r = 0.80, N = 1450 elements, adj p < 1 x10-13; 
Fig. 3.5A). Closer inspection of IAPEz elements indicates a median methylation increase of 2.1 percent and 
an IQR of 5.2 percent in LvC (Supplemental Fig. S3.6). Interestingly, closer inspection of IAPLTR1 Mm 
elements reveals a median methylation increase of only 0.85 percent, which was the sixth lowest increase 
among ERVK family elements, and an IQR of 5.3 percent in LvC, which was the eighteenth highest among 
the 276 ERVK element subtypes examined (Supplemental Fig. S3.7). The majority of IAPLTR1 Mm 
elements had decreased methylation in upper compared to lower dose; the median decease in methylation at 









Figure 3.5 Characterization of region-level differences in methylation for ERVK family LTR 
retrotransposons in BPA-exposed and control fetal livers. (A) Heatmap of correlation coefficients for 
methylation level at ERVK LTR subtypes for lower compared to control (LvC), upper compared to control 
(UvC), and upper compared to lower (UvL) dose groups. Twenty subtypes with lowest correlation 
coefficients in LvC comparison are shown above line. Twenty subtypes with highest correlation 
coefficients in LvC comparison are shown below line. (B-C) Region-level methylation differences (Δ): 
each point represents the median (B) and interquartile range (IQR) (C) of methylation difference for 
elements in each subtype (i.e., each subtype has one point). IQR measures the dispersion of the middle 50 







Correlation among LTR subtypes within the ERVL-MaLR family was generally homogenous 
(Fig. 3.6A). The lowest correlation among ERVL-MaLR elements was observed in MLT1E-int; however, 
this family had five representative elements and the correlation was not significant (LvC: r = 0.4, adj p = 1; 
UvL: r = 0.01, adj p = 1). For ERVL-MaLR subtypes with at least ten representative elements, correlation 
coefficients ranged from 0.77 to 0.98; the lowest was observed for MLT1G1 in UvC comparison (r = 0.77, 
adj p = 1.2 x 10-4, N = 32 elements). In LvC, the majority of ERVL-MaLR subtypes, 52.8 percent, had a 
median change in methylation lower than that observed for DNMT1-maintained regions (Fig. 3.6B). 
ERVL-MaLR exhibited less variation in methylation change at lower dose than DNMT1-maintained 
regions; IQRs were higher than 4.85 for only 17.92 percent subtypes (Fig. 3.6C). 
Finally, we examined L1 subtypes. Pearson’s r ranged from 0.76 to 0.96. Only one subtype 
L1M3a had a correlation coefficient less than 0.80 (r = 0.76, adj p = 8.13 x10-12, N = 64 elements; Fig. 
3.7A). In LvC, 48.9 percent and 77.10 percent of L1 subtypes had higher median methylation change than 
DNMT1-maintained and DNMT3a/3b-maintained regions, respectively. Only 15.3 percent and 3.1 percent 










Figure 3.6 Characterization of region-level differences in methylation for ERVL-MaLR family LTR 
retrotransposons in BPA-exposed and control fetal livers. (A) Heatmap of correlation coefficients for 
methylation level at ERVL-MaLR LTR subtypes for lower compared to control (LvC), upper compared to 
control (UvC), and upper compared to lower (UvL) dose groups. Twenty subtypes with lowest correlation 
coefficients in LvC comparison are shown above line. Twenty subtypes with highest correlation 
coefficients in LvC comparison are shown below line. (B-C) Region-level methylation differences (Δ): 
each point represents the median (B) and interquartile range (IQR) (C) of methylation difference for 
elements in each subtype (i.e., each subtype has one point). IQR measures the dispersion of the middle 50 

























Figure 3.7 Characterization of region-level differences in methylation for LINE L1 retrotransposons 
in BPA-exposed and control fetal livers. (A) Heatmap of correlation coefficients for methylation level at 
LINE L1 subtypes for lower compared to control (LvC), upper compared to control (UvC), and upper 
compared to lower (UvL) dose groups. Twenty subtypes with lowest correlation coefficients in LvC 
comparison are shown above line. Twenty subtypes with highest correlation coefficients in LvC 
comparison are shown below line. (B-C) Region-level methylation differences (Δ): each point represents 
the median (B) and interquartile range (IQR) (C) of methylation difference for elements in each subtype 
(i.e., each subtype has one point). IQR measures the dispersion of the middle 50 percent of elements for 










DNA methylation characteristics at imprint and imprint-like regions increase these regions’ susceptibility 
to BPA-induced epigenetic perturbation 
Based on previous studies, it was not surprising to find altered methylation at several imprinted 
genes. Perinatal exposure to BPA has been shown to induce methylation changes and/or reduce parent-of-
origin-dependent allelic bias in gene expression at several imprinted genes (Iqbal et al., 2015; Kang et al., 
2014; Susiarjo et al., 2013). In this study, we identified altered methylation at the gDMR for Gtl2 (Meg3), 
H19, Igf2r, Kcnq1ot1, Nespas-GnasXL, Peg1, Peg10, Peg13/Trappc9, Rasgrf1, Snrpn, and 
Zrs1/Commd1(Murr1). Interestingly, within several known gDMRs, we observed hypomethylation and 
hypermethylation of CpG sites, depending on the location within the larger region. This could indicate local 
dysregulation of methylation that controls specific genes or transcript variants within an imprinted region. 
In addition to gDMRs, we observed altered methylation at bimodal NORED regions within 
imprinted gene clusters. We identified altered CpG sites near seven gDMRs that had altered methylation 
and near one gDMR, H13/Mcts2, where we did not observe changes within the associated gDMR. This 
likely reflects site-specific regulation of imprinted gene clusters. For example, the H19 promoter is 
considered a somatic DMR (sDMR) that does not exhibit differential methylation between sperm and 
oocyte, but develops parent-of-origin dependent methylation during early embryonic development 
(Thorvaldsen et al., 2002). For H19, the gDMR and sDMR are typically methylated on the paternal allele 
and unmethylated on the maternal allele (Thorvaldsen et al., 2002). Therefore, the increase in methylation 
at the H19 promoter could be indicative of aberrant methylation gain on the maternal allele. 
Altered methylation outside of known gDMRs was not limited to CpG sites within known 
imprinted gene clusters. Prenatal BPA exposure affected CpG sites within 17 novel bimodal NORED 
regions. This suggests imprinted clusters and novel bimodal NORED regions share epigenetic 
characteristics that influence the likelihood for an altered epigenetic state in response to prenatal BPA 
exposure. That an increased propensity for altered methylation occurred at exclusively NORED and 
exclusively bimodal regions further supports the assertion that epigenetic attributes associated with non-
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restorable DNMT1-dependent methylation and bimodal methylation patterns contribute to regional 
susceptibility to epigenetic disturbances. 
DNA methylation maintenance paradigm influences BPA-altered methylation 
In addition to epigenetic characteristics observed at imprinted loci and bimodal NORED regions, 
the distinct methylation maintenance paradigms at some loci also increase the chance that CpG sites will be 
altered by prenatal BPA exposure. DNMT1-maintained and DNMT3a/3b-maintained regions were more 
likely to have CpG sites with altered methylation in the top 99.5th percentile or bottom 0.5th percentile than 
genomic regions relying on the cooperativity between the enzymes for methylation maintenance. In other 
words, methylation patterns maintained by both maintenance DNMT1 and de novo DNMT3a/3b were more 
resistant to perturbation. 
Both loss of DNA methylation through disruption of maintenance and gain of methylation through 
de novo methylation can contribute to aberrant DNA methylation patterns in response to toxicant exposure. 
Overall, CpG sites within DNMT1-maintained regions appear to follow the direction of genome-wide 
changes, but showed more extreme hypermethylation at lower dose. This is consistent with the idea that 
different classes of sequences show varying degree of susceptibility to gain of methylation from de novo 
enzymatic activities of DNMT1 (Biniszkiewicz et al., 2002). Indeed, more CpG sites were within the top 
99.5th percentile (hypermethylated) than the bottom 0.5th percentile (hypomethylated) in LvC comparison 
and more CpG sites were within the bottom 0.5th percentile than in the top 99.5th percentile for UvC and 
UvL comparisons.  
In contrast, many CpG sites within DNMT3a/3b regions appear to favor increased methylation at 
upper dose compared to control or lower dose. Despite the genome-wide shift toward higher methylation at 
lower dose, more CpG sites were within the top 99.5th percentile than in the bottom 0.5th percentile in UvL 
comparison, which indicates site-specific hypermethylation in the upper exposure group. Others have 
identified regions with poor DNMT1-dependent maintenance that are compensated for with de novo 
DNMT3a/3b-dependent methylation (Liang et al., 2002). Therefore, it is possible that DNMT3a/3b-
dependent regions experience a probabilistic methylation loss, but targeted de novo methylation gain 
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leading to high interindividual variability for methylation loss, but low interindividual variability for 
methylation gain. Consistently, overexpression of different DNMT enzymes has been shown to lead to 
hypermethylation of distinct targets (Choi et al., 2010). Overall our findings suggest that DNA methylation 
maintenance paradigm as well as site-specific de novo methylation contribute to BPA-induced changes in 
methylation patterns.  
Repetitive elements show variation in BPA-induced methylation changes 
The distinct, dose-dependent responses of preferentially DNMT1-maintained and preferentially 
DNMT3a/3b-maintained regions to BPA-induced methylation changes prompted us to examine the 
methylation changes of repetitive elements throughout the genome. We have previously demonstrated that 
certain types of IAP retrotransposons are resistant to methylation loss in the absence of DNMT3a/3b (Li et 
al., 2015). In other words, they retain relatively high methylation with only DNMT1 present. In addition, 
others have shown that overexpression of Dnmt1 in mESCs increases global methylation and leads to 
hypermethylation of IAP elements, including at IAP elements that had become hypomethylated in 
DNMT1-deficient cells, but not the CpG islands at nonimprinted genes (Biniszkiewicz et al., 2002). 
However, others have shown that DNMT1 alone could not restore methylation at specific sequences that 
had been efficiently maintained by DNMT1 prior to 5-aza-2’-deoxycytidine treatment (Liang et al., 2002). 
In the study, Liang et al. classified several DNA fragments as highly DNMT1-dependent (CI-f fragments) 
or highly DNMT3a/3b-dependent (CII-d fragments). Treatment with 5-aza-2’-deoxycytidine reduced 
methylation levels of both fragment types in WT mESCs. After 5-aza-2’-deoxycytidine was removed, the 
methylation at both CI-f and CII-d fragments was increased. In Dnmt1-/- mESCs, CI-f fragments were not 
remethylated after 5-aza-2’-deoxycytidine removal. Furthermore, they demonstrated that in Dnmt3a-/-
/Dnmt3b-/- mESCs, methylation of CII-d fragments was reduced by 5-aza-2’-deoxycytidine treatment, but 
restored once 5-aza-2’-deoxycytidine was removed. In other words, DNMT3a/3b alone could restore 
methylation at DNMT3a/3b-dependent repetitive sequences after methylation reduction from transient 
treatment with 5-aza-2-deoxycytididine, whereas restoration of methylation at DNMT1-maintained regions 
required activity from both DNMT1 and DNMT3a/3b (Liang et al., 2002). We proposed that the 
maintenance and de novo methylation activity from the combined action of three enzymes at a given repeat 
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locus could lead to varied epigenetic responses among repetitive elements in response to environmental 
exposures. We therefore, analyzed the similarities in region-level methylation changes between dose 
groups for repeats at different levels of hierarchical classification from the broad category of repeat class 
through specific subtypes of retrotransposon families.  
Among retrotransposon classes, SINE elements showed the highest correlations in region-level 
methylation between exposure groups (Fig. 3.3A). SINE families were relatively homogenous in terms of 
overall methylation changes observed, whereas LINE and LTR displayed greater heterogeneity among 
families (Fig. 3.4). LINE L1 family and several LTR families (Gypsy, ERVL-MaLR, ERVK, ERVL, and 
ERV1) exhibited the largest overall changes in methylation at lower dose, indicating that these families 
have high propensity for de novo methylation at low dose BPA exposure (Fig. 3.4E, H). ERVL-MaLR LTR 
subtypes were relatively homogenous in correlations between dose groups (Fig. 3.6). 
LINE L1 subtypes displayed a broad range (0.20) of correlations between dose groups (Fig. 3.7). 
The majority of LINE L1 subtypes showed methylation increases at lower dose BPA that were higher than 
those of DNMT3a/3b-maintained regions, but lower than those of DNMT1-maintained regions (Fig. 3.7B–
C, 3.3J). A small proportion of LINE L1 subtypes showed more variation in response to lower dose BPA 
than either DNMT1 or DNMT3a/3b-dependent regions (Fig. 3.7C, 3.3J). Together, this suggests that in 
general, LINE L1 subtypes experience de novo methylation at low dose BPA, LINE L1 subtypes display 
heterogeneity between subtypes, and most LINE L1 elements behave homogenously within a subtype. 
LTR ERVK subtypes, which include IAPs, displayed a very broad range of correlation 
coefficients (Fig. 3.5A). The majority of subtypes had methylation gains greater than those of DNMT1-
maintained regions and over one-third of subtypes showed greater variation than DNMT1-maintained 
regions (Fig. 3.5B–C, 3.3J). Among those with the lowest correlation coefficients between exposure 
groups, IAPEz-int, IAPLTR1a_Mm, and IAPLTR1_Mm have been ranked as the top three LTR subtypes 
for DNMT1-dependent methylation maintenance; IAPLTR3-int was rank ninth and IAPEy-int was ranked 
eleventh (Li et al., 2015). None of the LTRs among the 20 ERVK subtypes with highest correlations 
between dose groups were considered to have a high degree of DNMT1-dependence (Fig. 3.5A). While the 
link between dependency on DNMT1 and regional vulnerability to BPA has yet to be explored, BPA has 
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been shown alter Dnmt1 levels in livers of adult male mice (Ke et al., 2016) and in zebrafish (Danio rerio) 
in a dose- and tissue-specific manner (Laing et al., 2016).  
In addition to displaying a proclivity for DNMT1-dependent maintenance, IAPLTR1 Mm 
elements have been associated with metastable epialleles (Faulk et al., 2013) that are responsive to 
epigenetic perturbation from environmental and nutritional stressors, including BPA (Dolinoy et al., 2006; 
2007b). Intriguingly, IAPLTR1 Mm elements were more resistant to de novo methylation gain at lower 
dose BPA and tended to have a higher propensity for methylation loss at upper dose levels than other 
ERVK LTRs examined. Although, not evaluated on a genome-wide basis, studies using targeted methods 
to compare the degree of intraspecies variation at specific IAPLTR1 Mm loci have shown that individual 
copies of IAPLTR1 Mm demonstrate substantial intraspecies variability in methylation levels, but that the 
methylation averaged across all 21 IAP elements tested for each animal is highly consistent (Faulk et al., 
2013). We speculate that this could reflect a probabilistic methylation gain or loss at individual copies of 
IAPLTR1 Mm elements within the genome of a single organism, but an overall stable level of methylation 
in the absence of exposure. Consistent with the idea that “global methylation of repetitive loci does not 
necessarily reflect locus specific deviation” (Faulk et al., 2013), this implies that shifts in genome-wide 
average DNA methylation among retrotransposons may not necessarily be indicative of changes at specific 
loci. Indeed, individual copies of IAPLTR1 Mm elements demonstrated a substantial degree of variability 
in response to BPA exposure in this study. Our results support that regional epigenetic context (e.g., higher-
order chromatin structure) combines with genomic context and environmental influences to determine 
locus-specific DNA methylation. Future work should explore the interindividual variability in genome-
wide and locus-specific repetitive element responses to prenatal BPA exposure. Furthermore, studies 
interested in identifying loci with environment-influenced changes in DNA methylation should include 
examination of DNMT levels to determine their contribution to intraspecies variability. 
4. Conclusions 
In summary, our work has demonstrated that epigenetic properties characteristic of imprinted 
gDMRs and certain transposable element families increase the likelihood that a genomic region will be 
susceptible to epigenetic perturbation from exposure to environmental compounds. DNMT1-dependent, 
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non-restorable methylation loss (i.e., NORED) and bimodal methylation patterns are distinct epigenetic 
characteristics that occur at, but are not exclusive to, imprinted germ line DMRs. CpG sites within genomic 
regions that displayed either characteristic were more likely to have altered CpG site methylation compared 
to CpG sites genome-wide. Genomic regions displaying both characteristics, including several imprinted 
gDMRs, were the most likely to have altered CpG methylation. DNA methylation maintenance paradigms 
influenced region-level methylation changes between dose groups. DNMT1-maintained regions and 
retrotransposon types with high DNMT1 dependence (e.g., IAPLTR1 Mm) displayed relatively low 
correlation in region-level methylation levels following in utero exposure to physiologically relevant doses 
of BPA. Overall, our results imply a role for DNMT1-mediated mechanisms driving BPA-induced 
methylation changes at imprinted genes and certain retrotransposons. Species-specific differences in 
imprinted regions and repetitive elements imply potential for mechanistic concordance rather than, or in 
addition to, phenotypic concordance from environmental and nutritional exposures. 
5. Materials and Methods 
Data set is unpublished data (see Chapter 4 for library construction and data processing details). 
DNMT1-maintained and DNMT3a/3b-maintained regions obtained from (Li et al., 2015). NORED, 
bimodal, and bimodal NORED regions are from Chapter 2. Repeat classification obtained by downloading 
RepeatMasker (Smit et al., 2013) track for mouse mm10 genome from UCSC Table browser (Karolchik et 
al., 2004; Kent et al., 2002). 
For each pairwise, dose-group comparison, altered CpG sites were defined as those within the top 
99.5th percentile (hypermethylation) or bottom 0.5th percentile of the t-statistic distribution (i.e., 1% of 
CpG sites were considered altered genome-wide). ORs were calculated for CpG sites within each region 
having altered methylation compared to autosomal CpG sites for bimodal, NORED, and bimodal NORED 
regions or compared to all CpG sites for DNMT1-maintained and DNMT3a/3b-maintained regions. P-
values and confidence intervals for ORs were calculated with two-sided Fisher’s exact test using ‘exact2x2’ 
R package (Fay, 2010) and corrected for multiple comparisons (15 comparisons total for our other regions 
of interest) to control family-wise error rate below 0.05 
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To examine the correlation and change in methylation between dose groups, we averaged the 
smoothed CpG site methylation estimates across all biological replicates for control (n = 3), lower (n = 4), 
and upper (n = 4) exposure levels. For region-level analyses we used the ‘perRegion’ option of the 
getMeth() function from the ‘bsseq’ R package to obtain the average per-region methylation estimate for 
each replicate prior to calculating the dose group average (Hansen et al., 2012). Pearson’s r was calculated 
and p-values were adjusted for 563 tests with Bonferroni correction.  
6. List of Supplemental Materials 
Supplemental Figures S3.1 to S3.7 (Appendix II) 
Figure S3.1 Methylome characterization: bimodal regions 
Figure S3.2 Methylome characterization: bimodal NORED regions 
Figure S3.3 Methylome characterization: NORED regions 
Figure S3.4 Methylome characterization: DNMT1-maintained regions 
Figure S3.5 Methylome characterization: DNMT3a/3b-maintained regions 
Figure S3.6 Methylome characterization: IAPEz 




DNA methylation-mediated pathway perturbation provides broad insight into 
Bisphenol A-induced metabolic abnormalities in male mice from prenatal exposure 
Chapter 4–DNA methylation-mediated pathway perturbation provides broad insight into Bisphenol A-




(This work was completed as collaboration between the Wang Lab (Johns Hopkins University) and 
Bartolomei Lab (University of Pennsylvania). Bartolomei Lab conducted animal exposures, RNA-
sequencing, and RNA-sequencing data analyses. SNM was responsible for DNA methylation experiments 
and associated analyses, except for Ingenuity Pathway Analyses. SNM wrote Results and Methods Sections 
pertaining to DNA methylation and contributed to Abstract, Introduction, and Discussion.) 
Abstract 
Increasing evidence has demonstrated that environmental exposure induced-fetal reprogramming 
events are linked to metabolic disorders; the precise mechanisms, however, are unclear. The goal of the 
study is to elucidate molecular mechanisms underlying metabolic abnormalities in male mice exposed in 
utero to 10 µg/kg/day and 10 mg/kg/day of bisphenol A (BPA). We used whole genome bisulfite 
sequencing and RNA sequencing to determine if exposure altered DNA methylation and/or transcription of 
metabolic genes. Our combined -omics approach revealed that BPA exposure produced dose-dependent 
alterations in the methylome and transcriptome of mouse fetal liver. BPA exposure perturbed DNA 
methylation and/or transcription in pathways related to metabolic homeostasis, indicating that both DNA 
methylation-mediated and DNA methylation-independent mechanisms may contribute to prenatal 
programming of adult metabolic phenotypes. Future work focusing on these pathways may provide critical 
insight into risk assessment and management of metabolic diseases with underlying environmental causes. 
1. Introduction 
Exposure to various environmental factors during pregnancy is linked to compromised fetal 
metabolic health, a paradigm known as the developmental origin of health and disease (DOHaD).  Altered 
nutrients, environmental or occupational exposure, and maternal factors can significantly impact the long-
term health outcome of the fetus and increase susceptibility to adult diseases including obesity, diabetes, 
and cardiovascular abnormalities (Barouki et al., 2012). More recently, studies further suggested that 
altered in utero programming due to exposure to environmental factors also influences health of the 
subsequent generations (Carone et al., 2010; Radford et al., 2014; Skinner, 2014; Xin et al., 2015). 
	
 98 
Elucidating molecular mechanisms of early environment-induced developmental reprogramming 
has been one of most important goals for DOHaD researchers. Research that ultimately identifies and 
elucidates susceptible developmental genes, as well as the associated pathways, provides not only critical 
insights into the mechanisms of DOHaD, but also potentially facilitates future prevention and intervention 
strategies. Recent studies have reported diverse mechanisms or biomarkers that predict the health outcome 
of a fetus, including altered hormone levels leading to the disappearance of sexually dimorphic endpoints 
(Vigé et al., 2008), accelerated telomere shortening in response to stress (Entringer et al., 2011), and 
aberrant epigenetic modifications in response to various environmental insults (Ho et al., 2017). The latter 
mechanism has been a focus of the DOHaD field as increasing studies have reported the ability of 
environmental factors to alter DNA methylation and histone modifications at development- and disease-
relevant genes in animal models and humans. Additionally, global and genome-wide analyses have started 
to elucidate developmental gene programming events susceptible to environmental insults, including 
endocrine-disrupting chemical (EDC) exposure and maternal undernutrition (Iqbal et al., 2015; Radford et 
al., 2014; van Esterik et al., 2014). Correlating these gene-specific and genome-wide changes to 
environmental exposures is an important approach for dissecting DOHaD mechanisms, and more 
importantly, investigating these associations in model systems with characterized developmental 
phenotypes is key to extracting the most useful information. 
Among the relevant environmental factors, there has been enormous interest in studying 
epigenetic perturbations following exposure to the common EDC bisphenol A (BPA). One of the most 
produced chemicals worldwide, BPA is used in plastics, food and beverage packaging, and various other 
consumer products. Ubiquitous contamination of BPA in the environment, combined with its links to 
adverse health outcomes (Saal and Hughes, 2005), makes this chemical an intriguing and important model 
EDC to study. More importantly, as a representative environmental estrogen, studies on BPA may provide 
further insights into the epigenetic mechanisms linked to developmental effects induced by this class of 
common chemicals (McLachlan, 2016). Previous studies have shown that BPA exposure induces 
epigenetic misregulation at genes associated with human disease (Bromer et al., 2010; Susiarjo et al., 2013; 
Wong et al., 2015). More recently, Iqbal et al., (2015) conducted a genome wide DNA methylation using 
methylated CpG island recovery assay (MIRA) in JF1 X OG2 mice exposed to 0.2 mg/kg/day BPA and 
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other EDCs. The study did not detect significant DNA methylation changes on de novo DNA methylation 
at CpG islands, promoters, imprinted differentially methylated regions (DMRs), intracisternal A particle 
(IAP) retrotransposons, and along the Y chromosome, although the exposure paradigm had not been shown 
to induce significant gene expression changes at DNA methylation-regulated developmental genes 
including at imprinted genes (Kang et al., 2011). In a separate study, Van Esterik et al., (2015) performed 
the digital restriction enzyme analysis of methylation (DREAM) in adult female C57BL/6 X FVB mouse 
liver exposed in utero to 3000 µg/kg bw/day BPA. The study found few differentially methylated genes 
that are potentially linked to adult metabolic phenotypes. Given that BPA exposure has been significantly 
linked to metabolic phenotypes (Alonso-Magdalena et al., 2015) and that epigenetic misregulations are 
associated with its exposure (Ferreira et al., 2014; Singh and Li, 2012; Xin et al., 2015), most genome-wide 
DNA methylation studies to date have not provided satisfying mechanistic insights into the link between 
exposure and phenotypes. 
Previously, our laboratory demonstrated that in utero exposure of C57BL/6 mice to 10 mg/kg 
bw/day and 10 µg/kg bw/day BPA altered DNA methylation patterns at imprinted control regions (ICRs) 
and caused aberrant expression of imprinted genes (Susiarjo et al., 2013). We subsequently showed that 
gestational exposure in F0 female mice produced glucose intolerance and abnormal insulin function in F1 
and F2 adult male offspring (Susiarjo et al., 2015). Using a similar exposure paradigm, in this study we 
conducted whole-genome bisulfite sequencing (WGBS) and RNA sequencing (RNA-seq) on livers from 
embryonic day (E) 18.5 male mice, to gain a broad perspective on potential molecular mechanisms 
underlying the prenatal programming of adult metabolic phenotypes. By examining liver tissue from 
control and BPA exposed late gestation F1 mouse fetuses, we have identified relevant genome-wide 
methylation and gene expression changes from prenatal exposure that occur prior to birth in a tissue crucial 
to adult metabolic homeostasis. 
We have used this model system in the current global and genome-wide studies to elucidate how 
early developmental exposure to the representative EDC BPA may predispose an individual to metabolic 
disease later in life. BPA exposure was linked to altered expression of developmentally important genes 
and epigenetic changes in late gestation (E18.5) F1 mouse fetuses. Changes to gene expression do not 
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necessarily require methylation changes. As such, another goal of the study was to understand how 
environmental perturbation influenced gene expression through DNA methylation-mediated and DNA 
methylation-independent pathways. Our results demonstrated that BPA exposure was linked to dose-
dependent alterations of the methylome and transcriptome and that our multi-omics approach suggested 
that alterations in lipid metabolism explained partly the perturbed metabolic homeostasis phenotype in this 
mouse model. 
2. Results 
BPA exposure results in dose-specific alteration of genome-wide mRNA expression 
Distinct biochemical profiles of BPA-exposed mouse fetuses, especially in the upper dose 
exposure group, suggested that in utero exposure to environmental chemicals significantly altered 
metabolic programming as early as late gestation (Susiarjo et al., 2017). Previously, we demonstrated that 
early life BPA exposure was linked to metabolic abnormalities in the male mice during adulthood (Susiarjo 
et al., 2015). We showed that the metabolic phenotype was partially associated with increased expression 
of the imprinted insulin-like growth factor 2 (Igf2) gene (Susiarjo et al., 2015). Our metabolomics data 
demonstrated that early metabolic effects of BPA exposure involved alteration of various important 
biochemical pathways, further suggesting that the mechanisms leading to adulthood disease were far more 
complex than single gene-based pathways (Susiarjo et al., 2017). We subsequently performed RNA-seq to 
identify genes that were relevant to BPA exposure-associated metabolic phenotypes by searching for 
differentially expressed genes (DEGs) between BPA-exposed and control mice. The RNA-seq experiment 
was conducted on individual E18.5 fetal livers (n=3 per exposure group), representing a subset of samples 
that were analyzed in the metabolomics described in (Susiarjo et al., 2017). The number of reads per 
sample in our RNA-seq study ranged from 35-72 X 106 with approximately 90% of the reads aligned to the 
reference sequences (Supplemental Table S4.1). The mean of insert length in our fetal liver samples ranged 
from 127 to 139 bp, and the aligned sequences were distributed similarly across the different samples, with 
approximately 53-64% and 25-33% to coding regions and untranslated regions (UTR), respectively 
(Supplemental Table S4.1). Hierarchical clustering of biological replicates, designated as control 1–3 (C1–
C3), lower 1–3 (L1–L3), and upper dose 1–3 (U1–3), showed that DEGs in C1–C3 were distinctively 
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grouped together and were more similar to each other relative to DEGs in L1–L3 or U1–U3 (Fig. 4.1A).  
This clustering, however, indicated that although L1 and L3 were similar to each other, L2 showed more 
similarity to the upper dose BPA biological replicates (Fig. 4.1A), indicating interindividual variation 
among the lower dose exposure group.  
 
Figure 4.1 Characterization of BPA-induced mRNA expression changes. (A–C) Lower vs. control (L 
vs C), upper vs. control (U vs C), and upper vs. lower (U vs L) dose group comparisons. (A) Hierarchical 
clustering of methylation in biological replicates at DEGs: Y-N-N indicates that region was identified as 
differentially methylated in L vs C, but not in U vs C or U vs L; N-N-Y indicates that region was not 
considered differentially methylated in L vs C or U vs C, but identified as a DEG in U vs L; etc. (B–C) 
Overlap of genome-wide upregulated DEGs (B) and downregulated DEGs (C) among comparisons. 
In contrast to metabolomics data that showed mild metabolic changes induced by lower dose BPA 
exposure (Susiarjo et al., 2017), our RNA-seq study demonstrated clearly that lower dose exposure 
produced significantly more differentially expressed genes (DEGs) than upper dose: 1184 genes were 
differentially expressed relative to controls, representing 1122 and 62 upregulated and downregulated 
genes, respectively (Fig. 4.1B–C and Supplemental Table S4.2). In the upper dose exposure group, we 
found 129 DEGs relative to control fetal liver (Fig. 4.1B–C and Supplemental Table S4.2) in which 119 
and 10 exhibited increased and decreased expression, respectively (Fig. 4.1C). The 1184 and 129 DEGs 
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observed in the lower dose and upper dose BPA, respectively, were mostly mutually exclusive, as we 
observed only 6 overlapping DEGs (2610015P09Rik, Arid4b, BC005561, Cfap36, Serf1 and Socs2). 
Intrigued by the significantly larger DEGs in the lower dose, we also compared genome-wide gene 
expression of fetal liver samples in the upper dose exposure group directly to the lower dose and found 
2123 DEGs (Supplemental Table S4.2), representing 161 and 1962 upregulated and downregulated genes 
in the upper BPA dose samples, respectively. The data suggest that each BPA dose exposure produced very 
distinct effects on mouse fetal liver transcriptome.  
For insight into relevant biological pathways affected in our BPA mouse model, we utilized the 
Ingenuity Pathway Analysis (IPA). IPA revealed that the DEGs were involved in various canonical 
pathways and toxicological functions (Supplemental Tables S4.3–S4.5). Comparison of the top 10 
canonical pathways, biological, and toxicological functions (Supplemental Table S4.6) in all pairwise 
comparison groups (i.e., control vs. upper, control vs. lower, and upper vs. lower) showed that distinct 
biological pathways were perturbed in each exposure group. We observed only two overlapping pathways 
(Microphage migration inhibitory factor or MIF regulation of innate immunity and Wnt signaling pathway) 
in both the control vs. lower dose and upper vs. lower dose comparisons, with common genes including 
Jun, Pla2g1b, Pla2g4f, Nos2, Sox11, Sox17, Rarg, Wnt2, Wnt5a, and Sfrp2 genes. 
Linking the RNA-seq data to results from our metabolomics (Susiarjo et al., 2017), we searched 
for biological pathways and genes relevant to lipid, amino acid, peptide, or glucose metabolism that were 
altered in BPA-exposed fetal liver. Some potentially relevant pathways that differed between control and 
upper dose exposure, in which we saw the more significant changes of the metabolome, included 
cholesterol biosynthesis pathway, fatty acid metabolism, and the FXR activation known to be the limiting 
rate step in bile acid production (Supplemental Table S4.4). These analyses suggest that altered 




Global epigenomic profiling of in utero BPA-exposed fetal livers reveals mechanistic insights 
Epigenetic marks, including DNA methylation, regulate stage- and tissue-specific gene expression 
and can be mitotically inherited. Altered epigenetic marks due to early life environmental exposures is a 
potential molecular mechanism underlying exposure-related phenotypic consequences later in life. To 
determine how altered DNA methylation contributes to mechanisms of early life BPA exposure-induced 
metabolic abnormalities (Susiarjo et al., 2015; 2017), we conducted WGBS in the liver of control (n = 3; 
designated Ca, Cb, and Cc), lower dose (n = 4; designated La, Lb, Lc, and Ld), and upper dose (n = 4; 
designated Ua, Ub, Uc, and Ud) BPA-exposed E18.5 male fetuses to generate base-resolution methylomes 
(see Materials and Methods). Methylomes were generated for a subset of samples that were analyzed in the 
metabolomics described in (Susiarjo et al., 2017). We generated 2.47 billion paired-end reads and retained 
1.31 billion deduplicated, unique best hit paired-end alignments for an average of 120 million paired-end 
reads per sample. Median methylation level of CpG sites ranged from 66.6 percent to 70.2 percent for 
control fetal livers, 68.4 percent to 75.5 percent for lower dose, and 67.7 percent to 69.9 percent for upper 
dose (Supplemental Fig. S4.1A). Median coverage for CpG sites on autosomal and sex chromosomes 
ranged from 7X to 9X for control, 3X to 7X for lower dose BPA, and 5X to 15X for upper dose BPA 
tissues (Supplemental Fig. S4.1B–L).  
To identify altered methylation patterns among BPA-exposed tissues, we used the statistical model 
described in (Hansen et al., 2012) that performs well on low-coverage WGBS data (Hansen et al., 2014; 
Harten, 2015; Ziller et al., 2015). We used the method to perform local-likelihood smoothing to increase 
the accuracy of methylation estimates, calculate modified t-statistics, and combine single-CpG sites into 
differentially methylated regions (DMRs; see Materials and Methods). To control the FDR of DMRs, we 
used empirical null modeling (Efron, 2007). Notably, local false discovery rates (lfdrs) were more stringent 
than q-values (Supplemental Fig. S4.2J–O). Our WGBS analysis showed that lower dose BPA exposure 
produced more DMRs (892) in fetal liver relative to upper dose (152) when compared to controls. 
Furthermore, we detected substantially more (2603) DMRs when upper dose was compared to lower dose 
BPA relative to other pairwise comparisons (Supplemental Table S4.7).  
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To compare individual methylation differences among fetal livers from all exposure groups, we 
performed hierarchical clustering of methylation values for individual replicates from each exposure group 
at merged DMRs (i.e., DMRs identified in all pairwise comparisons with overlapping DMRs merged into a 
single DMR; see Materials and Methods), which revealed four distinct groups (Fig. 4.2). One group 
consisted of all control replicates. A second group had all upper dose replicates. Interestingly, the lower 
dose replicates formed two distinct clusters, with each cluster consisting of two replicates (Fig. 4.2). 
Control replicates were the most similar to each other, followed by upper dose replicates. Upper dose 
replicates were more similar to control than to any lower dose replicates. Intriguingly, the lower dose 
replicates Lb and Ld were more similar to the control and upper samples than to La and Lc samples. La and 












Figure 4.2 Hierarchical clustering of methylation in biological replicates at merged DMRs indicates 
dose-dependent responses to prenatal BPA and heterogeneity among lower dose replicates. Lower vs. 
control (L vs C), upper vs. control (U vs C), and upper vs. lower (U vs L) dose group comparisons. YNN 
indicates that region was identified as differentially methylated in L vs C, but not in U vs C or U vs L; 
NNY indicates that region was not considered differentially methylated in L vs C or U vs C, but identified 
as a DMR in U vs L; etc. Lower dose BPA exposure produced 892 DMRs and upper dose exposure 
produced 152 DMRs when compared to controls. Upper dose versus lower dose produced 2603 DMRs. 
Control dose replicates form a single cluster. Upper dose replicates form a single cluster. Lower dose 
replicates display heterogeneity, forming two groups with two replicates in each group. The cluster of two 







Although our clustering of samples by DMRs from the pairwise comparisons indicated substantial 
methylation differences among tissues from the lower dose exposure mice, closer examination revealed that 
two samples within each lower dose cluster have similar changes of methylation patterns at a subset of 
DMRs. For example, all samples from the lower dose group shared similar dark lines (i.e., hypermethylated 
regions; Fig. 4.2), and this subset of DMRs appear to form three dose-dependent groups, reinforcing our 
confidence with the quality of our epigenomic profiling. Furthermore, each pairwise comparison produced 
relatively unique genome-wide DMRs, as evidenced by the relatively few shared DMRs (Fig. 4.3A). 
Similarly, the subset of DMRs classified as “promoter only” displayed minimal overlap between the three 
pairwise comparisons (Fig 4.3B). Consistent with our gene expression data, our DNA methylation data 
demonstrate that lower and upper dose BPA exposure produced distinct responses and that lower dose 
replicates displayed heterogeneity, suggestive of interindividual variability. 
Given potentially different roles of intergenic, promoter, and gene body methylation patterns in 
maintaining genome stability and regulating gene expression (Li et al., 2015; Lorincz et al., 2004; 
Seisenberger et al., 2010; Stein et al., 1982; Wagner et al., 2008; Walsh et al., 1998; Wu et al., 2010; Yang 
et al., 2014), we examined the distribution of DMRs at intergenic and genic regions. While the different 
doses produced relatively unique DMRs, the DMRs were similarly distributed based on their genomic 
region classifications of intergenic, promoter only, promoter and gene body, and gene body only (Fig. 
4.3C). For all comparisons, we observed that the majority of the DMRs were hypermethylated (Fig. 4.3D). 
Although all four genomic classifications showed more hypermethylated DMRs, we noted that intergenic 




Figure 4.3 Characterization of BPA-induced methylation changes in pairwise comparisons. (A–E) 
Lower vs. control (L vs C), upper vs. control (U vs C), and upper vs. lower (U vs L) dose group 
comparisons. (B–C) Overlap of genome-wide DMRs (B) and promoter only DMRs (i.e., DMRs within 2kb 
upstream to 1 kb downstream a transcription start site that do not overlap the gene body of another 
transcript) (C) among comparisons. (D) Distribution of DMRs among genomic regions: intergenic, 
promoter only, promoter & gene body, and gene body only. (E) Number of hypo- and hypermethylated 
DMRs. (F) Proportion of hypo- and hypermethylated DMRs within each genomic feature. 
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Previously, studies have suggested that genomic context and CpG density influence the functional 
impact of CpG methylation (Blattler and Farnham, 2013; Li et al., 2015). CpG Islands (CGIs) are genomic 
regions with high CpG density and high GC content (Gardiner-Garden and Frommer, 1987). Cancer and 
tissue-specific methylation differences tend to occur in the 2 kilobase (kb) regions flanking CGIs, known as 
CGI shores (Materials and Methods), rather than within CGIs (Irizarry et al., 2009). In this study, DMRs 
from BPA-exposed tissues were significantly nearer to CGIs than expected (p < 0.01) and highly 
significantly overrepresented at CGI shores (binomial test, p < 1 x 10-10), and CGI shelves (binomial test, 
p < 0.01; Materials and Methods) for all pairwise comparisons (Fig. 4.4A–B). DMRs at CGIs were slightly 
enriched in the lower (binomial test, p < 0.01, observed/expected = 2.35) and upper dose (binomial test, p < 
0.05, observed/expected = 2.44) vs. control comparisons, but not in the upper vs. lower dose BPA 
(binomial test, p = 0.1). For CGI shores, DMRs were highly enriched when tissues from lower 
(observed/expected = 20.1) and upper (observed/expected = 21.9) doses were compared to controls; fewer 
DMRs at CGI shores were observed when the upper dose BPA group was compared to lower dose 
(observed/expected = 19.1). In contrast, DMRs at CGI shelves were moderately enriched when the lower 
(observed/expected = 3.42) and upper (observed/expected = 4.47) dose groups were compared to controls 
and slightly enriched in the upper vs. lower dose comparison (observed/expected = 2.46). Overall, the 
DMRs were similarly overrepresented at gene-associated regions (combined promoter and gene body 
regions; see Materials and Methods) for all pairwise comparisons (lower vs. control: binomial test, p < 10-
16, observed/expected = 1.72; upper vs. control: binomial test, p = 8.9 x 10-16, observed/expected = 1.74; 
upper vs. lower: binomial test, p < 10-16, observed/expected = 1.78; Fig. 4.4C).  
The relationship between methylation and gene expression is complex, nonlinear and context 
dependent (Lay et al., 2015; Rishi et al., 2010; Wan et al., 2015). Furthermore, recent studies have revealed 
a role for DNA methylation in regulating the use of alternate promoters (Gifford et al., 2013; Maunakea et 
al., 2010) and in incorporating alternate exons into mRNA transcripts (Maunakea et al., 2013; Shukla et al., 
2011; Yearim et al., 2015), which suggests that gene-associated DMRs could influence transcript-level 
rather than gene-level expression. To further characterize the genic context of BPA exposure-induced 
DMRs identified in this study, we asked whether the DMRs overlapped with specific categories of genic 
features: within 2 kb upstream of transcription start site (-2 kb TSS), within 100 bp upstream or 
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downstream from TSS (+/- 100 bp TSS), first exon, downstream exon, first intron, downstream intron, 5’ 
untranslated region (UTR), 3’ UTR, and coding DNA sequence (CDS) exon (see Materials and Methods). 
Because genic features are not mutually exclusive (e.g., a DMR within the first exon could overlap both the 
3’ UTR and the CDS) and DMRs can overlap different features of multiple genes or transcripts (e.g., a 
DMR within 2kb of the TSS for one gene could also be within the intron of an overlapping gene), we used 
Jaccard index and permutation tests to determine enrichment or depletion of DMRs at features along genic 
regions (Fig. 4.4D). DMRs for all comparisons were enriched within 2kb upstream of TSSs (p < 0.01), but 
depleted at TSSs (lower vs. control: p < 0.01, upper vs. control: p < 0.05, upper vs. lower: p < 0.01). DMRs 
were not significantly enriched at first exons for any comparison, although showed a trend toward 
enrichment at first exons (p <0.10) in upper vs. lower DMRs. DMRs were enriched at first introns in lower 
vs. control (p < 0.05) and lower vs. upper (p < 0.01) DMRs. DMRs were depleted at downstream exons (p 
< 0.01), downstream introns (p < 0.01), and CDS exons (p < 0.01, p < 0.05, p < 0.01) for all comparisons. 
DMRs were also depleted from 5’ UTRs in lower vs. control (p < 0.01) and 3’ UTRs in upper vs. lower (p 
< 0.01). Depletion at TSSs and lack of enrichment at first exons suggests that changes in methylation are 
not necessarily expected to be inversely associated with gene expression. Overall, locations of gene-
associated DMRs indicate potentially complex relationships between BPA-induced methylation changes 
and gene regulation.  
DNA methylation-mediated pathway perturbation demonstrates functional differences among dose groups 
To gain insight into potential functional implications of altered DNA methylation, we integrated 
genic DMRs with gene expression levels from RNA-seq to explore biological pathways perturbed in BPA-
exposed tissues through IPA (Supplemental Table S4.8). Nine canonical pathways were enriched (-log(p-
value) > 1.3) for lower vs. control DMRs and five canonical pathways were enriched (-log(p-value) > 1.3) 
for upper vs. control DMRs (Supplemental Tables S4.9–S4.10). Only one pathway, the GPCR-mediated 
Nutrient Sensing in Enteroendocrine Cells, was shared between lower vs. control and upper vs. control 
DMRs (Supplemental Tables S4.9–S4.10). 
Consistent with distinct responses for lower and upper dose BPA exposure, we observed many 
(37) enriched (-log(p-value) > 1.3) canonical pathways for upper vs. lower dose DMRs; two of these 
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pathways (Pyrimidine Ribonucleotides De novo Biosynthesis and Pyrimidine Ribonucleotides 
Interconversion) were shared by lower vs. control DMRs and two pathways (Sphingomyelin Metabolism 
and Ephrin B Signaling) were shared by upper vs. control DMRs (Supplemental Table S4.11). 
Furthermore, upstream regulators analyses indicated activation of RICTOR (bias-corrected z-score = 2.046) 
in lower compared to control and inhibition of RICTOR (bias-corrected z-score = -2.954) with activation of 
SCAP (bias-corrected z-score = 2.738) in upper compared to lower dose BPA livers (Supplemental Tables 
S4.9, S4.11). Further supporting SCAP/SREBP signaling as a distinguishing factor between lower and 
upper dose BPA responses, gene set analysis indicated that promoter DMRs from the upper vs. lower dose 
comparison were enriched for genes with SREBP1 binding motifs (TCANNTGAY, q-value = 1.32 x 10-5; 
NATCACGTGAY, q-value = 3.07 x 10-5; Supplemental Table S4.12). 
 
Figure 4.4 Spatial correlation between DMRs and CGI or gene-associated features. (A–C) Lower vs. 
control (L vs C), upper vs. control (U vs C), and upper vs. lower (U vs L) comparisons. (A) Violin and box 
plots showing distribution of distance from DMRs to center of nearest CGI. (B–C) Binomial enrichment of 
DMRs at CpG Islands (CGIs), CGI shores, CGI shelves (B), and gene-associated regions (e.g., promoter or 
gene body) (C) (*p < 0.05, **p < 0.01, ***p < 1 x 10-10). (D) Overlap of DMRs at genic features within 




Accumulating evidence has demonstrated that adult onset metabolic diseases, including obesity, 
diabetes, and cardiovascular disease, are linked to reprogramming events during fetal development. 
Importantly, the incidence of these disorders has arisen during just the past few decades and increasing data 
have shown that the trend is attributed to environmental factors (Thayer et al., 2012). Because the timeline 
of disease occurrence overlaps with the introduction and increasing use of man-made chemicals in our 
environment, one hypothesis is that exposure to these compounds alters fetal reprogramming events and 
predisposes individuals to metabolic disease. Despite support from animal and human studies, the 
mechanisms linking exposure to the phenotypes are unclear, and furthermore, it is unknown whether 
different environmental factors act through distinct mechanisms or whether core mechanisms exist. 
Elucidating the relevant mechanisms will provide important insights into risk management and disease 
prevention for the protection of the health of our future generations.  
The goal of the current study is to elucidate pathways that underlie metabolic abnormalities 
induced by early life exposure to environmental chemicals using the mouse model. Previously, our 
laboratory had demonstrated that early life exposure to BPA induced multigenerational, male-specific 
perturbations of metabolic health in mice (Susiarjo et al., 2015). In the study, we have used a combined -
omics approach to determine how transcriptional and epigenetic changes are linked to altered metabolome 
in BPA-exposed mice. We selected BPA as a representative environmental chemical due to its widespread 
presence in the environment and because most people are exposed to this compound. Furthermore, because 
many of its characteristics are shared with other environmental contaminants (McLachlan, 2016) that have 
also been linked to developmental abnormalities in humans and animals, elucidating molecular mechanisms 
relevant to BPA exposure can provide general insights into how xenobiotics impact our health. 
DNA methylation-independent pathway perturbation 
Changes in mRNA levels do not necessarily require substantial alterations to DNA methylation 
changes. In addition to pathways associated with DMRs, we observed pathways that were not directly 
associated with DNA methylation changes. Through the utilization of the multi -omics approach, we have 
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discovered some potentially important metabolic pathways relevant to environmental exposure as modeled 
by BPA. Metabolomics, for example, revealed that in utero BPA exposure resulted in misregulation of lipid 
metabolism (Susiarjo et al., 2017). Specifically in the upper dose exposure group, BPA exposure 
upregulated levels of primary and secondary bile acids (Susiarjo et al., 2017).  Bile acids are 
“physiologically detergent” molecules that facilitate the absorption of dietary lipids and vitamins in the gut 
(Taoka et al., 2016). Synthesized from cholesterol in the liver, bile acids are signaling molecules that 
regulate lipid, glucose, and energy metabolism through the action of the bile acid-activated nuclear 
receptor, the Farnesoid X Receptor or FXR (Taoka et al., 2016). Increasing evidence has demonstrated that 
perturbed bile acid function is linked to altered glucose homeostasis and other metabolic abnormalities.  
Consistent with these observations, IPA using our RNA-seq data implicated the FXR activation and 
cholesterol biosynthesis (Supplemental Tables S4.4, S4.6) as pathways perturbed in upper dose BPA 
exposed-mice, suggesting that BPA exposure-induced metabolic abnormalities are linked to misregulation 
of genes relevant to bile acid and/or cholesterol synthesis. These findings suggest that bile acid metabolism 
could represent a common pathway implicated in environmental exposure-induced metabolic changes.  
Although we did not identify perturbed FXR pathways in our DNA methylation data, upper dose 
fetal livers had promoter hypermethylation and decreased expression of Tcf4 (Transcription factor 4) 
compared to lower dose fetal livers. Tcf4 is a basic helix-loop-helix (bHLH) transcription factor that has 
recently been identified as a risk locus for primary sclerosing cholangitis in humans (Ellinghaus et al., 
2013; Forrest et al., 2014). Primary sclerosing cholangitis is characterized by inflammation of hepatic bile 
ducts, which can lead to accumulation of bile in the liver (Forrest et al., 2014; Li et al., 2017). Our data 
suggests a possible indirect link between BPA-induced, DNA methylation-associated gene expression 
change of Tcf4 and hepatic bile acid dysregulation. Additional studies are needed to determine downstream 
targets of TCF4-mediated signaling and whether bile acid abnormalities precede or result from altered Tcf4 
expression. 
DNA methylation-associated pathway perturbation 
BPA altered DNA methylation and mRNA expression of nutrient sensing genes, free fatty acid 
receptor 4 (Ffar4) and protein kinase C-zeta (Prkcz). FFAR4 (GPR120) is an omega-3 fatty acid (ω-3 FA) 
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receptor that plays a role in lipid sensing and mediates protective effects from dietary ω-3 FAs (Da Young 
Oh et al., 2010; Ichimura et al., 2012). WGBS data showed increased methylation in lower (66.8%) and 
upper (65.9%) dose group compared to control (49.2%) in the first intron (chr19:38098849-38099269; 6 
CpG sites) of Ffar4. Lower dose had significant decreased expression (-2.47 log2 fold-change; FDR = 
0.02) and upper dose and had moderate, but non-significant, decreased expression (-0.11 log2 fold-change). 
Prkcz is involved in insulin signaling (Chen et al., 2015) and has two transcript variants, determined by 
alternate promoter usage, that encode for atypical protein kinase C (PKC) enzymes: the first variant 
encodes PKCζ with a catalytic domain and an autoinhibitory regulatory domain; the second variant lacks 
the regulatory domain (Hernandez et al., 2011). For lower vs. control comparison, we identified a DMR 
(15.9% increased methylation) at the promoter of the transcript variant that encodes for the constitutively 
active isoform (chr4:155346128-155347203; 23 CpG sites; fourth intron of transcript for autoinhibited 
PKCζ). Although not retained after lfdr correction, we also observed increased methylation in upper 
(51.5%) compared to control (43.1%) fetal livers. Prkcz had significantly increased mRNA expression 
(2.32 log2 fold-change, FDR = 0.03) in lower and moderate, but non-significant, increased mRNA 
expression (0.3 log2 fold-change) in upper compared to control fetal livers. DMR location suggests 
potential for transcript-specific regulation of Prkcz. Additional studies are needed to determine whether 
increased methylation is suppressing transcription of the constitutively active isoform while increasing 
expression of the autoinhibited isoform or increasing transcription of both isoforms. Taken together, these 
data demonstrate DNA methylation-mediated alterations to nutrient sensing in BPA exposed mice with 
potential implications for metabolic health. 
Furthermore, metabolomics data showed significant upregulation of glutamate in the upper dose 
relative to lower (Susiarjo et al., 2017). Recent studies have demonstrated the role of cytosolic glutamate as 
a key molecule linking glucose metabolism to incretin/cAMP action to amplify insulin secretion (Gheni et 
al., 2014). Interestingly, previously we found that F1 males exposed to both upper and lower dose BPA 
during in utero development developed glucose intolerance (Susiarjo et al., 2015). F1 males exposed to 
upper dose BPA were insulin resistant, but their islets exhibited normal glucose-stimulated insulin release, 
in contrast to islets isolated from males in the lower dose that showed significantly reduced glucose-
stimulated insulin release. Consistent with these observations, IPA using both RNA-seq and WGBS data 
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revealed glutamate receptor signaling to be one of the pathways that was differentially regulated in the 
lower vs. upper dose exposure groups, suggesting that either changes in glutamate receptor signaling are 
linked to insulin secretory defects in the lower dose group and/or they have protective effects on islets from 
males exposed to upper dose BPA. These observations suggest that multiple approaches are required to 
elucidate mechanistic pathways underlying metabolic diseases induced by environmental exposure. 
Moreover, future works should include investigation of glutamate signaling in environmental exposure-
induced perturbed glucose homeostasis. 
Greater number of DEGs and DMRs at lower dose than upper dose 
The RNA-seq and WGBS data revealed significantly more DEGs and DMRs in livers from lower 
dose BPA exposure relative to upper dose. This could be due to the observation that the upper dose 
produced significantly more substantial changes in metabolism (Susiarjo et al., 2017). We previously 
reported that F1 male mice exposed to upper dose BPA had increased body fat and developed glucose 
intolerance and insulin resistance as adults, while the phenotype of the lower dose-exposed mice was 
milder (Susiarjo et al., 2015). Additionally, lower BPA dose exposure may produce more complex changes 
relative to upper dose, changes that involved both non-metabolic and metabolic perturbations as shown by 
the DEGs and DMRs. Alternatively, the inconsistencies could originate from technical limitations and may 
be explained by the restricted number of major metabolite classes analyzed by the Metabolon 
DiscoveryHD4 platform used in the metabolomics study (Susiarjo et al., 2017). This limitation contrasts 
with the less biased techniques of RNA-seq and WGBS. Furthermore, changes of the transcriptome and/or 
methylome may not immediately affect the metabolome. 
Heterogeneity in response to lower dose exposure 
Intriguingly, gene expression and methylation studies revealed that BPA exposure, especially the 
lower dose, produced heterogeneous responses among genetically identical mice. In the WGBS, our data 
clustered mice from the lower dose exposure group into two distinct groups: one group with somewhat 
similar DNA methylation pattern to control and upper dose fetal livers and a second group distinct from 
both control and upper dose fetal livers. These data suggest that BPA-induced DNA methylation changes 
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may follow a bimodal (or multimodal) distribution. Notably, multimodal shifts in methylation patterns from 
lower dose exposure provide an attractive explanation of observed bimodal shift in distribution of coat 
colors in Avy/a offspring at lower dose BPA (Anderson et al., 2012). Using a developmental exposure 
model with coat color of Avy/a offspring as a biosensor of nutritional and environmental exposure-induced 
epigenetic perturbation (Dolinoy, 2008) reviewed in (Martos et al., 2015), Anderson and coworkers 
demonstrated that coat color displayed a bimodal response to lower BPA exposure (Anderson et al., 2012). 
That is, they showed decreased proportions of mottled (the modal value for phenotype in controls) and 
increased proportions of both slightly mottled (phenotype indicative of decreased methylation) and 
pseudoagouti (phenotype indicative of increased methylation). Combined with a higher standard deviation 
in methylation at the Avy locus at lower dose relative to controls reported in the study (Anderson et al., 
2012), the changes in coat color phenotype support the genome-wide results from our WGBS data that 
lower dose BPA produces heterogeneity in DNA methylation at some loci. While further studies with more 
biological replicates at targeted loci are needed to characterize the bimodal (or multimodal) response, the 
observed heterogeneity in response to lower dose BPA exposure provides a unique model for exploring 
interindividual variability in response to environmental exposures. 
Concordance with previous studies 
To our knowledge, this is the first study that employs multiple-omics with the goal of dissecting 
DNA methylation-mediated and DNA methylation-independent pathways related to EDC exposure. A 
study conducted by van Esterik and coworkers investigated solely the genome wide DNA methylation 
changes in adult liver of C57BL/6JxFVB hybrid mice that were exposed to 3000 µg/kg bw of BPA during 
gestation and lactation via maternal diet. In this model system, they had found female-specific obesity and 
metabolic impairment (van Esterik et al., 2014). Through DREAM, the authors identified 19 sites with at 
least 10% DNA methylation differences and unadjusted p < 10-2 (van Esterik et al., 2015). Upon 
comparison with our WGBS data, we observed that 10 out of the 19 genes were also differentially 
methylated in our study prior to false discovery rate correction: 4 DMRs exclusively in the lower dose 
(Evpl, Col4a4, Scube3, and Tcf3), 1 in the upper dose group (F8a), and 5 that were differentially 
methylated in both the upper and lower exposure groups (Chordc1, Dpt, Pcdh15, Atp2b2, and Taf7l). In 
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Iqbal et al (2015), the authors studied the potential transgenerational inheritance of altered epigenome in 
JF1XOG2 hybrid mice exposed to EDCs including 100 mg/kg/day vinclozolin and 200 µg/kg/day BPA. 
They studied altered DNA methylation at imprinted and non-imprinted loci in various embryonic tissues, 
including the liver. Altered methylation of the Dlk1 and Ascl2 genes (Iqbal et al., 2015) were also observed 
in our current study. While our results have confirmed previous findings, the multi-omics approach has 
revealed considerably more information. 
Study Limitations 
Although we have identified methylation-associated and methylation-independent pathway 
perturbations from prenatal exposure to BPA, our data is from a single developmental stage. This makes 
integrating the data in a way that informs causal inference into molecular mechanisms difficult because we 
cannot determine the temporal dependence of the observed differences among DNA methylation and gene 
expression data. In other words, from a single time point we cannot differentiate between whether the 
observed DNA methylation changes result in or are the result of changes in gene expression. We can, 
however, conclude that these coinciding changes precede the metabolic phenotypes observed in adult 
animals. As such, we have provided unprecedented insight into physiologically relevant pathways that have 
potential importance for adult and multigenerational phenotypes.  
Additionally, changes observed in exposed fetuses could be transient and return to baseline once 
the stimulus (i.e., BPA exposure) is removed. Importantly, a transient change could still result in altered 
fetal programming if the temporary change initiates a cascade of events that eventually lead to an altered 
physiological outcome. However, the details for these mechanisms are beyond the scope of this work. To 
determine the extent to which these pathways are causally involved in fetal reprogramming, future time-
course studies in postnatal through the adult life stages are needed to follow the DNA methylation and gene 
expression changes reported here. 
4. Conclusions 
In summary, we have demonstrated that in utero exposure to BPA significantly altered methylome 
and transcriptome of the fetus in a dose-dependent manner. Integration of methylation and gene expression 
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data indicates a potential role for DNA-methylation mediated perturbation of RICTOR/MTORC2, 
SCAP/SREBP, nutrient sensing, and glutamate pathways. In addition, we observed that many changes 
occurred in pathways related to lipid metabolism, specifically cholesterol biosynthesis and bile acid 
regulation that were not directly associated with DNA methylation changes. The multi-omics approach 
used in the current study is a powerful method to elucidate pathways disrupted by BPA that could provide 
biomarkers to predict future disease susceptibility and potential therapies. Our findings suggest that DNA 
methylation-mediated and DNA methylation-independent gene expression changes likely work 
simultaneously to culminate in altered fetal programming in response to environmental exposures. As such, 
future mechanistic studies should focus on how both altered signaling pathways and epigenetic marks 
coordinate to regulate these pathways in metabolic disorders. 
5. Materials and Methods  
Mouse information 
Six weeks old virgin C57BL/6J female mice were exposed to control, 10 µg/kg bw of BPA (lower 
dose), and 10 mg/kg/bw of BPA (upper dose) through diet (Envigo Inc, Madison, WI) two weeks prior to 
mating, and exposure continued during mating until E18.5. At E18.5, pregnant mice were sacrificed, and 
we isolated liver tissues from the fetuses. The sex of the fetuses was determined by physical appearance of 
the gonads, and confirmed by sex-specific PCR. Liver tissues from both males and females were weighed, 
snap frozen, and stored at –80° C until analysis. We previously reported male-specific metabolic 
phenotypes (Susiarjo et al., 2015), so therefore, although we collected both male and female fetal tissues in 
this work, only male fetuses were included in the RNA-seq and WGBS studies.  
RNA sequencing 
Total RNA was extracted from mouse fetal liver tissues using the RNeasy Mini Kit (Qiagen) and 
quantified using a NanoDrop spectrophotometer. Approximately 10 µg of total RNA was used to isolate 
polyadenylated (polyA) using the Dynabeads mRNA DIRECTTM Purification kit (Thermo Fisher 
Scientific, Waltham, MA ). RNA-seq library preparation was prepared using the ScriptSeq v2 technology 
(Illumina, San Diego, CA) according to manufacturer protocol. Briefly, approximately 50 ng of poly(A)+ 
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RNA was fragmented and reverse transcribed using random primers containing a 5’-tagging sequence. The 
5’-tagged cDNA was then tagged at its 3’ end by the terminal-tagging reaction to yield di-tagged, single-
stranded cDNA. Following purification, the di-tagged cDNA was amplified by limited cycle PCR, which 
completed the addition of the Illumina adaptor sequences, amplified the library for subsequent cluster 
generation, and added Illumina index barcodes. The amplified RNA-seq library was analyzed using qPCR 
(Kapa Biosystems, Wilmington, MA) and BioAnalyzer (Agilent Technologies, Santa Clara, CA) for 
quantity and quality assessment, respectively. Equal moles of each library were pooled and re-quantified by 
qPCR (Kapa Biosystems, Wilmington, MA) and sequenced using the NextSeq 500 platform (Illumina, San 
Diego, CA). 
As quality control, paired-end reads were trimmed using Trimmomatic (Bolger et al., 2014) with a 
mild trimming criterion (Phred < 3), and assessed using FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc). Concordant paired reads with good quality 
were mapped to reference genome (mm10) using STAR (Dobin et al., 2013) (mapping quality >=10), and 
assessed using RSeQC (Wang et al., 2012). The expression level of genes was quantified using HTSeq 
(Anders et al., 2015) and DESeq2 (Love et al., 2014) was used to determine differentially expressed genes 
(false discovery rate < 0.05).  
Whole genome bisulfite sequencing 
WGBS libraries were constructed as described in (Li et al., 2015). Genomic DNA (250 ng - 1 µ𝐠) 
was sheared to 200-500 bp with Bioruptor Plus sonication device (B01020001, Diagnode, Denville, NJ). 
After purification with Agencourt Ampure XP (A63881, Beckman Coulter, Brea, CA), end repair of 
sheared DNA was performed with End-It DNA End Repair Kit (ER81050, Epicentre, Madison, WI). DNA 
was purified with Agencourt Ampure XP and adenine was added with 10 𝝁l of 1 mM dATP and 3 𝝁l Taq 
DNA polymerase (M0267S, New England Biolabs [NEB], Ipswich, MA) in a 50 𝝁l reaction, incubated at 
72°C for 30 minutes. Following purification with Agencourt Ampure XP, Illumina Truseq adapters were 
ligated to adenylated DNA fragments with 4 𝝁l T4 DNA ligase (M0202L, NEB, Ipswich, MA) in a 40 𝝁l 
reaction, incubated for 30 minutes at room temperature and then 16oC overnight. Adapter-ligated DNA 
fragments were size selected to 350-600 bp with 2% agarose gel and MinElute Gel Extraction Kit (28604, 
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Qiagen, Hilden, Germany). Size-selected fragments were bisulfite treated with Imprint DNA Modification 
Kit (MOD50-1, Sigma-Aldrich, St. Louis, MO) and PCR amplified (12-14 cycles) with KAPA HiFi 
HotStart Uracil+ ReadyMix (KK2802, Kappa Biosystems, Wilmington, MA). Amplified libraries were gel 
purified with 2% agarose gel and MinElute Gel Extraction Kit. Qubit dsDNA HS Assay (Q32854, Life 
Technologies, Eugene, OR) and High Sensitivity DNA Kit for Agilent 2100 Bioanalyzer (5067-4626, 
Agilent Technologies, Waldbronn, Germany) were used to determine library concentration and size, 
respectively. Beckman Coulter Genomics performed paired-end sequencing (2 x 100 bp or 2 x 125 bp; 
Danvers, MA). 
Sequencing reads were trimmed with Trim Galore version 0.4.0 
(www.bioinformatics.babraham.ac.uk/projects/trim_galore/) using Cutadapt version 1.8.1 (Martin, 2011) 
and FastQC version 0.11.2 (www.bioinformatics.babraham.ac.uk/projects/fastqc/) with options --paired --
three_prime_clip_R1 3 --three_prime_clip_R2 3 --clip_R2 2. Trimmed reads were aligned to 
GRCm38/mm10 genome with Bismark version 0.14.5 implementing Bowtie2 version 2.2.5 (Langmead et 
al., 2009) and options -N 1 -D 20 -R 5 -X 1200 --chunkmbs 1024. PCR duplicates were removed from 
aligned pairs with deduplicate_bismark and methylation status of cytosines was determined by 
bismark_methylation_extractor, ignoring calls in the first six base pairs of each read to prevent methylation 
bias from the end repair step of library construction (Krueger and Andrews, 2011). CpG methylation calls 
from opposite strands were merged into a single call per CpG (Krueger and Andrews, 2011). 
Identification of Differentially Methylated Regions and Local False Discovery Rate 
Post-processing analyses were carried out in R version 3.2.2. Technical replicates were merged 
and CpG sites covered by more than 500 reads were removed to eliminate regions with potential PCR bias 
(Akalin et al., 2012). Smoothed methylation estimates were determined using a local-likelihood method 
and modified t-statistics were calculated for single CpG sites that had at least 2X coverage for at least 2 
replicates in each exposure group in the comparison. Differentially methylated regions (DMRs) were 
constructed by combining consecutive CpG sites in the lower 2.5th and upper 97.5th percentiles into 
hypomethylated and hypermethylated DMRs, respectively, with the bsseq R package (Hansen et al., 2012). 
To determine the local false discovery rate (lfdr), we applied empirical null hypothesis modeling to the 
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single-CpG corrected t-statistics (Efron, 2007). After transforming t-statistics into z-scores (Efron, 2007), 
we calculated p-values, lfdr, and q-values (tail-area based false discovery rate) using the fdrtool (Strimmer, 
2008) R package (Supplemental Fig. S4.2). Correlation among CpG sites violates the independence 
requirement of tail-area-based multiple hypotheses testing correction methods; therefore, we used empirical 
null modeling to control the false discovery rate (FDR) of DMRs (Efron, 2007). DMRs containing at least 
one CpG with an lfdr less than 0.2 were retained. 
Hierarchical Clustering, Annotation, and Enrichment Analyses 
For hierarchical clustering, DMRs for each pair-wise comparison (i.e., control vs. lower dose, 
control vs. upper dose, and lower vs. upper dose) were merged to generate a set of non-overlapping DMRs. 
Average methylation across each merged DMR was calculated for individual biological replicates. Samples 
were clustered by Ward’s method with Euclidean distances and visualized as heatmap using NMF R 
package (Gaujoux and Seoighe, 2010). For annotation, DMRs were assigned to promoters, gene body, or 
intergenic with annotations from TxDb.Mmusculus.UCSC.mm10.knownGene (R package) based on the 
location of the DMR midpoint. We defined promoters as the region between 2 kb upstream and 1 kb 
downstream of a transcription start site (TSS), and gene body as 1 kb downstream from TSS to the 
transcription end site (TES). Genome-wide enrichment at CpG islands (CGIs), CGI shores, CGI shelves, 
and gene-associated regions was determined by two-sided binomial test. CGIs were downloaded from 
UCSC mm10 unmasked CpG Islands track. CGI shores are defined as 2 kb regions flanking CGIs that do 
not overlap a CGI (Irizarry et al., 2009) and CGI shelves are defined as 2 kb regions flanking CGI shores 
that do not overlap a CGI or CGI shelf (Bibikova et al., 2008). We defined gene-associated regions as 2 kb 
upstream from a TSS to TES (i.e., containing promoter and gene body of a transcript). Distance from CGI 
midpoint to DMR midpoint and absolute distance permutation test (100 permutations) was performed with 
GenometriCorr R package (Favorov et al., 2012). Overlap of DMRs at genic features within gene-
associated regions was calculated by Jaccard index and significance of overlap was determined by 
permutation test. We identified genic features—within 2 kb upstream of TSS (-2 kb TSS), within 100 bp 
upstream or downstream from TSS (+/- 100 bp TSS), first exon, downstream exon, first intron, downstream 
intron, 5’ untranslated region (UTR), 3’ UTR, and coding DNA sequence (CDS) exon—for mm10 
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transcripts with annotations from TxDb.Mmusculus.UCSC.mm10.knownGene (R package). Null 
distributions for permutation tests were constructed by randomly distributing each DMR along the 
overlapping genic region and calculating Jaccard index for a specific genic feature (100 permutations). 
Genic regions for Jaccard permutation tests were defined as 2kb upstream from TSS to TES, with regions 
containing multiple overlapping genes or transcripts merged into a single genic region. Binomial and 
Jaccard permutation tests were performed with GenometriCorr R package (Favorov et al., 2012).  
Pathway Analyses and Gene Set Enrichment for Transcription Factor Binding Targets 
For RNA-seq and/or WGBS studies, pathway and functional analyses were generated through the 
use of QIAGEN's Ingenuity Pathway Analysis (IPA®, QIAGEN Redwood City, 
www.qiagen.com/ingenuity). MSigDB version 5.1 was used to identify transcription factors and 
overrepresented Transcription Factor Binding Site (TFBS) in promoters of genes with promoter DMRs 
with the Transcription Factor Targets gene set and FDR less than 0.05 (Subramanian et al., 2005). 
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Conclusions and Future Directions 




The overall goal of this work was to increase the understanding of how environmental stressors 
may alter epigenetic states by identifying and characterizing genomic features that are susceptible to 
epigenetic perturbation during early development. Our perspective is that better knowledge of the 
molecular basis for how epigenetic marks, such as DNA methylation, are established and maintained 
throughout the mammalian genome will contribute to identifying the role that epigenetic mechanisms play 
in human disease, specifically diseases with an environmental component. Ultimately, determining how the 
heritability and plasticity of epigenetic states contribute to mechanisms of toxicity from intergenerational 
and transgenerational exposures will allow us to distinguish between biomarkers of exposure (e.g., 
correlated genome-wide changes) and causal molecular pathways that contribute to disease pathology. 
In the first part of Chapter 1, we reviewed literature on epigenetic inheritance across multiple 
generations. In contrast to non-mammalian eukaryotes, the mammalian life cycle reduces the likelihood 
that environment-induced epigenetic changes would be inherited, independent from genetic inheritance, 
through the germline. Nonetheless, transgenerational silencing of transposable elements and selective 
parent-of-origin-dependent regulation of genomic imprints serve as examples of epigenetic inheritance 
across multiple generations in mammals. We explained the inherent difficulties in identifying 
multigenerational phenotypes and in connecting molecular changes to disease states in humans. Knowledge 
of molecular events linking prenatal exposures to adult phenotypes through somatic inheritance of 
environment-induced epigenetic changes in rodent models is also limited. Furthermore, interspecies 
differences in genomic features associated with epigenetic inheritance (e.g., retrotransposons and imprints) 
limits the direct extrapolation of phenotypes observed in mice to humans. We proposed that a molecular 
understanding of epigenetic inheritance in animal models would allow for mechanistic extrapolation to 
identify the analogous features within the human genome. That is, if we can identify the molecular 
mediators acting on mouse genomic elements, then we could discover genomic elements (e.g., genes) 
affected by those mediators in humans and explore the association between candidate human genes and 
disease etiology.  
To that end, we previously characterized the extent to which mouse genomic features relied on 
different DNA methlytransferase (DNMT) enzymes, DNMT1 or DNMT3a/3b to retain their methylation in 
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mouse embryonic stem cells (mESCs) (Li et al., 2015). Those findings led to an updated coordination and 
division of labor model for DNA methylation maintenance, described in the second part of Chapter 1. In 
the updated model, we proposed that the majority of CpG sites rely on the coordination of enzymatic 
activities from DNMT1 and DNMT3a or 3b. However, a subset of genomic regions, which retained high 
methylation in the absence of DNMT3a/3b, was considered to have DNMT1-dependent maintenance. 
Similarly, regions that were resistant to methylation loss in the absence of DNMT1 were considered to have 
DNMT3a/3b-dependent maintenance. 
In this work, we sought to determine whether certain genomic regions displayed differential 
vulnerability to epigenetic perturbation. In Chapter 2, we began with a genetic knockout model, using 
DNMT1-deficient mESCs with exogenous Dnmt1 cDNA expression. In this genetic model of epigenetic 
perturbation, we described how germline imprinted regions were susceptible to non-restorable DNA 
methylation loss, despite genome-wide increase in methylation levels in “rescued” DNMT1-deficient 
mESCs compared to DNMT1-deficient mESCs.  
We developed a bioinformatic approach to identify 2500 regions throughout the genome that had 
non-rescued DMRs (NORED). We demonstrated that NORED is a novel and robust method. We then 
applied a second bioinformatic approach, MethylMosaic, to quantify read-level (as opposed to CpG site-
level) methylation genome-wide to identify 2500 genomic regions with bimodal methylation patterns. This 
characteristic DNA methylation pattern emerges at imprinted loci in bisulfite sequencing reads–where one 
read represents a single DNA molecule–from one fully methylated and one unmethylated allele. A 
systematic comparison of regions detected by NORED and MethylMosaic demonstrated that these two 
approaches are complementary, but independent methods for identifying distinct DNA methylation 
characteristics. Use of reciprocal hybrid cross embryonic stem cells, which allowed us to distinguish 
between parent-of-origin and genetic influences on allelic methylation, demonstrated that regions with 
epigenetic properties in common with imprinted genes are not necessarily imprinted.  
Taken together, results reported point to several paradigm shifts. First, monoallelic methylation 
and DNMT1-dependence are distinct epigenetic characteristics and both occur at imprinted gDMRs. 
Second, having both bimodal methylation and DNMT1-dependence, is not restricted to imprinted gDMRs. 
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Including regions at 19 established imprinted gDMRs, we identified 207 regions with at least 123 
potentially associated genes that were detected by both methods. Experimental data demonstrate that at 
least two of these loci, Hcn2 (Chapter 2, Fig. 2.4) and Park7 (Chapter 2, Fig. 2.5), have bimodal 
methylation patterns that are parent-of-origin independent in hybrid embryonic stem cells. This new 
evidence for probabilistic regulation of bimodal methylation patterns leads to the novel concept of 
‘switchable’ allelic methylation, reminiscent of random X-chromosome inactivation (XCI).  
Importantly, distinguishing between three groups–exclusively bimodal, exclusively DNMT1-
dependent, and both bimodal and DNMT1-dependent–defined by combining the two methods has 
functional implications for common diseases. The separation into groups is particularly informative for 
mechanistic studies in pharmacology, nutrition, and toxicology. Monoallelically expressed genes could be 
considered susceptible to a single hit from a mutagen (or drug) because there is not a second expressed 
allele to compensate. DNMT1-dependent regions could be targets for DNMT inhibitors or exposures 
affecting methyl donors (e.g., nutrition and arsenic), working through epigenetic mechanisms.   
Notably, regions identified by both approaches are expected to exhibit vulnerability to both 
genetic and epigenetic drugs/toxicants/nutritional exposures. While monoallelic expression is recognized as 
a rationale for the susceptibility of imprinted genes to mutagenic stressors or de novo mutations, the 
additional layer of DNMT1 dependence represents a fundamental shift in the underlying assumptions about 
the inherent vulnerability of imprinted gDMRs. Furthermore, the identification of non-imprinted regions 
that share these two attributes with imprinted gDMRs, greatly expands the pool of candidate genes for 
‘developmental origin of adult disease’ and ‘transgenerational epigenetic inheritance.’ We envision that our 
characterization of DNMT1-dependent regions and regions with bimodal methylation patterns will be 
informative for analyses of methylation differences in response to toxicant/drug exposure. 
In Chapter 3 we sought to determine whether DNA methylation characteristics associated with 
gDMRs and certain classes of transposable elements increased susceptibility to epigenetic perturbation 
from prenatal exposure to Bisphenol A (BPA). We found that CpG sites within regions with imprint-like 
DNA methylation properties (bimodal, bimodal NORED, and NORED) or distinct DNA methylation 
maintenance paradigms (DNMT1 maintained or DNMT3a/3b maintained) had increased likelihood for 
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BPA-induced DNA methylation changes compared to CpG sites genome-wide. Bimodal NORED regions 
exhibited the most striking effect and included altered CpG sites from both known imprinted loci and loci 
not identified as imprinted. DNMT1-maintained regions had the lowest correlations in CpG site- and 
region-level methylation between dose groups. Characterization of retrotransposons indicated considerable 
differences in response to BPA among subtypes of ERVK family LTR retrotransposons. Several ERVK 
family subtypes that displayed the lowest correlations in region-level methylation between dose groups had 
been previously identified as highly DNMT1 dependent (Li et al., 2015), including IAPLTR1 Mm 
elements. 
In Chapter 4 we aimed to explore the functional relevance of altered DNA methylation from 
prenatal BPA exposure. We identified dose-dependent, BPA-induced DNA methylation changes in several 
genes with potential consequences for metabolic health. The broad perspective on DNA methylation 
change-associated functional pathways presented here illuminated prospective molecular mediators of 
adult, and possibly intergenerational, metabolic phenotypes. However, detailed mechanistic studies are 
needed to establish a role for these changes in disease etiology. Specifically, studies should be conducted to 
examine potential pathways across multiple time points throughout the life course of the animals. 
Future studies should explore the relationship between intraspecies variability in site-specific 
methylation and DNMT1-dependent DNA methylation. Our work raises the possibility that DNMT1-
maintained regions could be more variable due to inefficiency of DNMT1 leading to probabilistic loss of 
methylation. This also raises the question of whether environmental exposure-induced shifts (e.g., BPA) in 
methylation level at these loci is more likely because BPA-altered methylation is mediated by specific 
targeting of DNMT1, either directly or indirectly through signaling pathways leading to transcription factor 
recruitment toward or sequestration from certain genomic regions. This would have implications for 
identifying functional consequences of loci with environment-influenced changes in DNA methylation. 
This work indicates that environmental stressors working through epigenetic mechanisms may exhibit 
probabilistic dose-responses if the genes contributing to the phenotypes of interest rely predominantly on 
DNMT1 for methylation maintenance. 
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Finally, our present work focused almost exclusively on DNA methylation. Other epigenetic 
marks, such as a wide variety of histone modifications, play a role in epigenetic regulation of genomic loci. 
As such other epigenetic mechanisms are likely to be important in determining region- and locus-specific 
susceptibility to epigenetic perturbation. It is possible that DNA methylation changes described here are 
representative of the epigenetic state at a genomic locus, but not necessarily the causal molecular driver for 
activation or silencing of gene or repeat element transcription. However, the internal normalization of 
bisulfite sequencing is more conducive to making site-specific comparisons across samples than count-
based, genome-wide methods. For count-based methods it is impossible to distinguish between lack of 
coverage at a site and zero signal, whereas with WGBS it is possible to quantify zero methylation at a 
covered CpG site. As such, DNA methylation changes are an indicator of epigenetic perturbation. 
Therefore future studies should aim to understand how the interaction between DNA methylation and other 
epigenetic marks (e.g., histone modifications) contribute to regional susceptibility to epigenetic 
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Supplemental Table S2.1 Methylation across well-characterized, imprinted (gASMs) 
Imprinted gASMa Position (mm10b) WTc 1KOc DKOc TKOc r1KOd 
H19 ICR chr7:142586025-142586025 0.6718 0.0662 0.1225 0.0098 0.1389 
Rasgrf1 ICR chr9:89880290-89880290 0.6919 0.1217 0.1586 0.0010 0.2721 
Gtl2/Meg3 ICR chr12:109534883-109534883 0.4846 0.0329 0.3062 0.0039 0.0652 
Gpr1 chr1:63200726-63200726 0.3686 0.0106 0.0130 0.0075 0.0223 
Mcts2 (H13) chr2:152687433-152687433 0.3755 0.0077 0.0029 0.0043 0.0138 
Nespas-GnasXL ICR chr2:174301063-174301063 0.4624 0.0185 0.0811 0.0066 0.0370 
Gnas 1A ICR chr2:174329137-174329137 0.1721 0.0367 0.0327 0.0051 0.0911 
Peg10 chr6:4749483-4749483 0.3898 0.0088 0.0289 0.0063 0.0206 
Nap1L5 (Herc3) chr6:58907397-58907397 0.3486 0.0102 0.0149 0.0020 0.0174 
Peg1/Mest chr6:30739966-30739966 0.4668 0.0145 0.0041 0.0046 0.0337 
Peg3 ICR chr7:6731546-6731546 0.4374 0.0076 0.1501 0.0069 0.0082 
Snrpn ICR chr7:60006697-60006697 0.3590 0.0056 0.0302 0.0038 0.0079 
Inpp5f_v2 (Inpp5f) chr7:128688735-128688735 0.4479 0.0165 0.1271 0.0007 0.0511 
Kcnq1ot1 ICR chr7:143296905-143296905 0.3931 0.0052 0.0042 0.0030 0.0051 
Plagl1 chr10:13092325-13092325 0.5321 0.0347 0.0952 0.0086 0.0575 
Grb10 ICR chr11:12027097-12027097 0.3187 0.0098 0.0047 0.0050 0.0286 
Zrsr1 (Commd1/Murr1) chr11:22974212-22974212 0.4402 0.0065 0.0060 0.0046 0.0092 
Peg13/Trappc9 chr15:72810912-72810912 0.5334 0.0096 0.1620 0.0023 0.0153 
Slc38a4 chr15:97055299-97055299 0.0112 0.0294 0.0242 0.0133 0.0216 
Igf2r ICR chr17:12742950-12742950 0.4472 0.0154 0.0386 0.0057 0.0259 
Impact chr18:12975001-12975001 0.4133 0.0075 0.0029 0.0043 0.0022 
a Imprinted germline allele-specific methylation (gASM; also referred to as imprinted germline DMRs) in common from two sources 
(Arnaud, 2010 PMID: 20501788; MacDonald and Mann, 2013 PMID: 23893518) 
b Positions from mm9 for gASMs (MacDonald and Mann, 2013 PMID: 23893518) converted to UCSC mm10 with LiftOver from 
UCSC Genome Browser (https://genome.ucsc.edu/cgi-bin/hgLiftOver; Kent, 2002 PMID: 12045153) 
c Methylation at gASMs for wild type (WT, J1) and DNMT-deficient ESCs including the loss of maintenance DNMT1 (Dnmt1-/-, 
1KO), of de novo DNMT3a/3b (Dnmt3a-/-/Dnmt3b-/-, DKO), and of all three (Dnmt1-/-/Dnmt3a-/-/Dnmt3b-/-, TKO). Average 
methylation of imprinted gASMs is significantly lower in 1KO (0.023), DKO (0.067), and TKO (0.005) compared to WT (0.417, p 
= 1.1 x 10-5). Compared to TKO, gASMs have significantly higher methylation in both 1KO (p = 5.7 x 10-6) and DKO (p = 6.3 x 
10-4). Difference in methylation of gASMs between 1KO and DKO is not significant (p = 0.085). P-values determined by pairwise 
Wilcoxon rank-sum tests (paired) and adjusted for multiple comparisons by Bonferroni method. 





Supplemental Figure S2.1 Coverage and methylation level for WT, 1KO, r1KO, DKO, and TKO 
embryonic stem cells (ESCs). (A–E) Coverage per CpG site in WT (A), 1KO (B), r1KO (C), DKO (D), 
and TKO (E) ESCs. (F) Distribution of CpG methylation for CpG sites with minimum coverage of five in 
ESCs. Global average methylation for all covered CpG sites in WT, 1KO, r1KO, DKO, and TKO was 




Supplemental Figure S2.2 NORED method evaluation. (A) ROC-like curve for individual CpG sites that 
meet three NORED criteria at various cutoffs for WT, 1KO, and r1KO. Cutoff for WT parameter is a circle 
for 0.25 and a triangle for 0.30. Cutoff for 1KO parameter is indicated by color. Each circle/triangle 
represents a tested r1KO value for combinations of WT and 1KO. For r1KO values are between WT and 
1KO cutoffs at increments of 0.005. Circle with black outline indicates values for three parameters to select 
individual CpG sites to combine into regions (r1KO = 0.125). (B) Proportion of gASMs identified 
compared to region-level FDR 
 
 
Supplemental Figure S2.3 MethylMosaic method evaluation. (A) ROC-like curve for CpG-centered 
windows at various cutoffs for hypermethylation and hypomethylation indices (see Methods) Red point 
indicates bounds for indices (0.2–0.75) to select CpG-centered windows to combine into regions. (B) 





















































Supplemental Figure S2.4 Overlap of NORED and MethylMosaic demonstrates that two methods are 
independent, but complementary. (A) Proportion of NORED regions that are also bimodal in 
MethylMosaic at various FDRs for each method. Total number of NORED regions at each FDR cutoff is 
listed to the right. (B) Proportion of MethylMosaic regions that are also NORED at various FDRs for each 
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Supplemental Figure S3.1Characterization of region-level methylation within bimodal regions in 
BPA-exposed and control fetal livers. (A, E, I) Region-level methylation for bimodal regions from three 
control (A), four lower (E), and four upper (I) dose replicates. (B, C, F) Bland-Altman plots showing 
distribution of region-level methylation differences (Δ) between lower and control (B), upper and control 
(C), and upper and lower (F) dose groups at bimodal regions. Average methylation (x-axis) indicates the 
average methylation at each region for two dose groups within the comparison. Median (maroon dashed 
line) methylation difference was 0.74%, -0.024%, and -0.78% for lower and control (B), upper and control 
(C), and upper and lower (F), respectively. Interquartile range (IQR) represents the middle 50 percent of 
the data as it is calculated as the difference between 75th percentile and the 25th percentile change in 
methylation for the regions. IQR (orange dashed line) was 4.47%, 3.96%, and 4.48% for lower and control 
(B), upper and control (C), and upper and lower (F), respectively. Cyan dashed line is at 1.5 x IQR. (D, G, 
H) Correlation (Pearson’s r) for region-level methylation at bimodal regions for three comparisons: lower 




Supplemental Figure S3.2 Characterization of region-level methylation within bimodal NORED 
regions in BPA-exposed and control fetal livers. (A, E, I) Region-level methylation for bimodal NORED 
regions from three control (A), four lower (E), and four upper (I) dose replicates. (B, C, F) Bland-Altman 
plots showing distribution of region-level methylation differences (Δ) between lower and control (B), upper 
and control (C), and upper and lower (F) dose groups at bimodal NORED regions. Average methylation (x-
axis) indicates the average methylation at each region for two dose groups within the comparison. Median 
(maroon dashed line) methylation difference was -0.088%, -0.44%, and -0.49% for lower and control (B), 
upper and control (C), and upper and lower (F), respectively. Interquartile range (IQR) represents the 
middle 50 percent of the data as it is calculated as the difference between 75th percentile and the 25th 
percentile change in methylation for the regions. IQR (orange dashed line) was 6.57%, 4.82%, and 5.64% 
for lower and control (B), upper and control (C), and upper and lower (F), respectively. Cyan dashed line is 
at 1.5 x IQR. (D, G, H) Correlation (Pearson’s r) for region-level methylation at bimodal NORED regions 




Supplemental Figure S3.3 Characterization of region-level methylation within NORED regions in 
BPA-exposed and control fetal livers. (A, E, I) Region-level methylation for NORED regions from three 
control (A), four lower (E), and four upper (I) dose replicates. (B, C, F) Bland-Altman plots showing 
distribution of region-level methylation differences (Δ) between lower and control (B), upper and control 
(C), and upper and lower (F) dose groups at NORED regions. Average methylation (x-axis) indicates the 
average methylation at each region for two dose groups within the comparison. Median (maroon dashed 
line) methylation difference was 0.62%, -0.23%, and -0.77% for lower and control (B), upper and control 
(C), and upper and lower (F), respectively. Interquartile range (IQR) represents the middle 50 percent of 
the data as it is calculated as the difference between 75th percentile and the 25th percentile change in 
methylation for the regions. IQR (orange dashed line) was 4.79%, 3.83%, and 4.42% for lower and control 
(B), upper and control (C), and upper and lower (F), respectively. Cyan dashed line is at 1.5 x IQR. (D, G, 
H) Correlation (Pearson’s r) for region-level methylation at NORED regions for three comparisons: lower 




Supplemental Figure S3.4 Characterization of region-level methylation within DNMT1-maintained 
regions in BPA-exposed and control fetal livers. (A, E, I) Region-level methylation for DNMT1-
maintained regions from three control (A), four lower (E), and four upper (I) dose replicates. (B, C, F) 
Bland-Altman plots showing distribution of region-level methylation differences (Δ) between lower and 
control (B), upper and control (C), and upper and lower (F) dose groups at DNMT1-maintained regions. 
Average methylation (x-axis) indicates the average methylation at each region for two dose groups within 
the comparison. Median (maroon dashed line) methylation difference was 1.9%, -0.076%, and -2.0% for 
lower and control (B), upper and control (C), and upper and lower (F), respectively. Interquartile range 
(IQR) represents the middle 50 percent of the data as it is calculated as the difference between 75th 
percentile and the 25th percentile change in methylation for the regions. IQR (orange dashed line) was 
4.85%, 4.68%, and 4.26% for lower and control (B), upper and control (C), and upper and lower (F), 
respectively. Cyan dashed line is at 1.5 x IQR. (D, G, H) Correlation (Pearson’s r) for region-level 
methylation at DNMT1-maintained regions for three comparisons: lower vs. control (D), upper vs. control 




Supplemental Figure S3.5 Characterization of region-level methylation within DNMT3a/3b-
maintained regions in BPA-exposed and control fetal livers. (A, E, I) Region-level methylation for 
DNMT3a/3b-maintained regions from three control (A), four lower (E), and four upper (I) dose replicates. 
(B, C, F) Bland-Altman plots showing distribution of region-level methylation differences (Δ) between 
lower and control (B), upper and control (C), and upper and lower (F) dose groups at DNMT3a/3b-
maintained regions. Average methylation (x-axis) indicates the average methylation at each region for two 
dose groups within the comparison. Median (maroon dashed line) methylation difference was 1.6%, -
0.16%, and -1.9% for lower and control (B), upper and control (C), and upper and lower (F), respectively. 
Interquartile range (IQR) represents the middle 50 percent of the data as it is calculated as the difference 
between 75th percentile and the 25th percentile change in methylation for the regions. IQR (orange dashed 
line) was 5.20%, 4.76%, and 5.02% for lower and control (B), upper and control (C), and upper and lower 
(F), respectively. Cyan dashed line is at 1.5 x IQR. (D, G, H) Correlation (Pearson’s r) for region-level 
methylation at DNMT3a/3b-maintained regions for three comparisons: lower vs. control (D), upper vs. 




Supplemental Figure S3.6 Characterization of region-level methylation within IAPEz 
retrotransposons in BPA-exposed and control fetal livers. (A, E, I) Region-level methylation for IAPEz 
elements from three control (A), four lower (E), and four upper (I) dose replicates. (B, C, F) Bland-Altman 
plots showing distribution of region-level methylation differences (Δ) between lower and control (B), upper 
and control (C), and upper and lower (F) dose groups at IAPEz elements. Average methylation (x-axis) 
indicates the average methylation at each element for two dose groups within the comparison. Median 
(maroon dashed line) methylation difference was 2.1%, 2.7 x 10-4%, and -2.1% for lower and control (B), 
upper and control (C), and upper and lower (F), respectively. Interquartile range (IQR) represents the 
middle 50 percent of the data as it is calculated as the difference between 75th percentile and the 25th 
percentile change in methylation for the elements. IQR (orange dashed line) was 5.20%, 5.05%, and 4.97% 
for lower and control (B), upper and control (C), and upper and lower (F), respectively. Cyan dashed line is 
at 1.5 x IQR. (D, G, H) Correlation (Pearson’s r) for region-level methylation at IAPEz elements for three 




Supplemental Figure S3.7 Characterization of region-level methylation within IAPLTR1 Mm 
retrotransposons in BPA-exposed and control fetal livers. (A, E, I) Region-level methylation for 
IAPLTR1 Mm elements from three control (A), four lower (E), and four upper (I) dose replicates. (B, C, F) 
Bland-Altman plots showing distribution of region-level methylation differences (Δ) between lower and 
control (B), upper and control (C), and upper and lower (F) dose groups at IAPLTR1 Mm elements. 
Average methylation (x-axis) indicates the average methylation at each element for two dose groups within 
the comparison. Median (maroon dashed line) methylation difference was 0.85%, -0.63%, and -1.5% for 
lower and control (B), upper and control (C), and upper and lower (F), respectively. Interquartile range 
(IQR) represents the middle 50 percent of the data as it is calculated as the difference between 75th 
percentile and the 25th percentile change in methylation for the elements. IQR (orange dashed line) was 
5.31%, 4.68%, and 5.08% for lower and control (B), upper and control (C), and upper and lower (F), 
respectively. Cyan dashed line is at 1.5 x IQR. (D, G, H) Correlation (Pearson’s r) for region-level 
methylation at IAPLTR1 Mm elements for three comparisons: lower vs. control (D), upper vs. control (G), 
and upper vs. lower (H)
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Supplemental Table S4.1 Alignment metrics for RNA-seq data. 










Control1 75/75 50236,339 90.76% 12.46% 9.24% 0.99 
Control2 75/75 48,427,199 90.07% 14.31% 9.93% 0.99 
Control3 75/75 38,842,843 90.84% 17.03% 
 
9.16% 0.99 
Lower1 75/75 50,321,213 89.35% 8.74% 10.65% 0.94 
Lower2 75/75 46,876,155 91.69% 13.68% 8.31% 1.02 
Lower3 75/75 42,534,926 90.18% 
 
8.95% 9.82% 1.04 
Upper1 75/75 46,926,847 91.34% 
 
15.17% 8.66% 1.14 
Upper2 75/75 35,930,488 
 
94.01% 17.74% 5.99% 1.16 
 
Upper3 75/75 72,909,842 93.96% 17.74% 6.04% 1.1 
Reads = number and length of reads (bp) 
# of reads = total number of reads passing filter 
% total aligned = percentage of reads passing filter that aligned to the reference including abundant reads 
% abundant = percentage of reads that align to abundant transcripts such as mitochondrial and ribosomal sequences 
% unaligned = percentage of reads that do not align with reference sequences 
median CV coverage uniformity = the median coefficient of variation of coverage of the 1000 most highly expressed transcripts, as 





























Supplemental Figure S4.1 Genome-wide coverage and methylation for WGBS samples. (A) Violin 
and box plots of CpG methylation for control (Ca, Cb, and Cc), lower (La, Lb, Lc, and Ld), and upper dose 
(Ua, Ub, Uc, Ud) male fetal livers. (B–L) Sequencing reads coverage of autosomal and sex chromosome 
CpG sites for WGBS samples. Control dose replicates: Ca, Cb, and Cc (B–D). Lower BPA dose replicates 









Supplemental Figure S4.2 Distribution of statistics for single-CpG methylation differences in BPA-
exposed male fetal livers. (A–O) Lower vs. control (L vs C), upper vs. control (U vs C), and upper vs 
lower (U vs L) refer to pairwise comparisons between control (n = 3), lower (n = 4), and upper (n = 4) dose 
groups. (A–C) Bsmooth bsseq (R package) t-statistics. (D–F) T-statistics transformed to z-scores. (G–I) P-
values calculated from z-scores. (J–L) Tail-area-based false discovery rate (q-value). (M–O) Empirical 
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